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Cystic fibrosis (CF) is the most common life-threatening monogenic autosomal 
recessive disease in Caucasians, and results from mutations in the cfir gene. These 
mutations lead to an inmmno-compromised lung, pancreatic insufficiency, bilary 
disorders, infertility and diabetes. The inability to clear respiratory pathogens and 
chronic lung damaging inflammation are the major causes of mortality in CF 
patients. From the relative narrow spectrum of opportunistic bacteria able to infect 
the CF lung, members of the Burkholderia cepacia complex (Bee) are arguably the 
greatest cause of anxiety for CF patients and their carers. Originally described as 
onion pathogens the Bee have emerged as major pulmonary pathogens of CF patients 
over the past three decades. The worst-case scenario is the onset of a fatal necrotizing 
pneumonia with bacteraemia, known as "cepacia syndrome", that occurs in 20% of 
all infected CF patients. In addition, Bee are inherently resistant to all classes of 
antibiotics and antimicrobial peptides (AMPs) with the result that successful 
treatment of cepacia syndrome is rare. 
The Bee genomes display a number of putative virulence factors, none of which has 
been unequivocally and solely associated with CF lung infection. However, as the 
main problem of Bee infections is without question the virtually untreatable chronic 
inflammatory airway infection which leads to the fatal deterioration of the lung, a 
number of Bcc-specific virulence factors are thought to be involved in bacterial 
pathogenesis. Here we investigated two Bee putative virulence factors; 
exopolysaccharides (BPS) which play roles in enhanced pulmonary persistence, and 
lipopolysaccharides (LPS) which causes pulmonary inflammation and have been 
linked to extremely high cationic AMP resistance. The aims of this thesis were: first, 
to investigate induction of BPS biosynthesis of the Bee in response to the original 
onion host; second, to investigate the structure of B. cenocepacia LPS, and to 
characterise enzymes involved in LPS modification. 
Members of the Bee, previously described as non-mucoid, produced copious 
amounts of BPS when onion extract was provided as a sole nutrient. When 
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investigating the onion extract content, it was found that fructose, sucrose and 
alcohol sugars were able to induce this change in phenotype. Interestingly, none of 
the virulent B. cenocepacia BT-12 isolates was able to produce BPS on any medium 
tested. This loss of BPS phenotype correlated with an 11 bp deletion in bceB, which 
is part of the bce gene cluster associated with the biosynthesis of cepacian, a 
previously characterised Burkholderia BPS. It has been proposed that instead of a 
non-mucoid to mucoid conversion, which is strikingly characteristic of P. aeruginosa 
infections in CF patients, members of the Bee revert from a mucoid to a non-mucoid 
phenotype, suggesting a role for BPS in initial persistence, and that a loss of mucoidy 
may lead to increased virulence. 
Bee LPS has previously been shown to be constitutively modified with 4-amino-4-
deoxy-fl-L-arbinose (L-Ara4N). The enzymes involved in L-Ara4N biosynthesis 
were recently shown to be essential for B. cenocepacia viability. In this study, UDP-
glucose dehydrogenase (Ugd) and 4-amino-4-deoxy-fl-L-arbinose transferase (AnT), 
the first and last enzymes of the biosynthetic pathway, were investigated. Of the 
three putative ugd genes detected in the B. cenocepacia J2315 genome, only two 
encoded enzymes with Ugd activity. ugdBcAL2946 is required for full polymyxin B 
(PMB) resistance and is found in a gene cluster with LPS core modifying enzymes; 
and UgdBCAM08SS is found in the bce cluster involved in BPS biosynthesis. Together, 
these two Ugds are essential for the viability of B. cenocepacia. UgdBcAJr0855 is also 
able to compensate for the loss of UgdBca2946 in vivo. Only one arnT candidate gene 
was found in the B. cenocepacia J2315 genome, which was associated with the am 
gene cluster. A conditional mutant of this arnT was previously shown to be essential 
for viability. In this present study, the protein expressed by the B. cenocepacia J2315 
arnT appeared to restore growth of the B. cenocepacia conditional AarnT mutant 
XOAI 1 under repressive conditions, and was also able to restore resistance of a 
PMB sensitive E. coli AamnT mutant. Thus, the L-Ara4N biosynthetic enzymes may 
be an Achilles' heel of B. cenocepacia. Inhibitors to any of the enzymes in the L-
Ara4N biosynthetic pathway could potentially be used alone, or in combination with 
other antimicrobial agents that would, under normal conditions, not be able to 
penetrate the outer membrane. 
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1.1. Cystic Fibrosis 
1.1.1 Molecular basis of cystic fibrosis 
Cystic fibrosis (CF) is the most common severe monogenic autosomal recessive 
disease in Caucasians. With an incidence rate of 1 in 2500, there are presently around 
8000 people in the UK with CF (www.cftrust.org.uk). CF results from mutations in 
the cfir gene which encodes the ABC transporter protein the cystic fibrosis 
transmembrane conductance regulator (CFTR). In healthy epithelial membranes, 
CFTR is essential to maintain ion and fluid homeostasis. CFTR is expressed in 
various organs, for example in the gastrointestinal, hepatobilary, reproductive and 
respiratory tracts. Its main function is to regulate liquid volume on epithelial surfaces 
through chloride secretion and inhibition of sodium absorption. CFTR has also been 
proposed to be involved in regulating other ion channels, 11CO3 concentration, pH, 
endosome fusion and intravesicular trafficking, apoptosis and protection from cell 
transformation (Riordan, 2008). Mutations in the cftr gene can lead to different 
pathophysiological outcomes, affecting synthesis, processing or regulation of the 
CFTR, or producing a partly defective CFTR (Ratjen & Doting, 2003). Disease 
outcome can vary depending on the inherited mutation. To date there are 1604 
different types of cftr mutations (www.genet.sickkids.on.calcftr/). The most common 
mutation is A17508, which is found in 70% of patients on at least one allele 
(www.ornl.gov/sciltechresources/Human_Genome/posters/chromosome/cftr.shtlm). 
This malfiunctional CFTR leads to impaired chloride secretions and enhanced sodium 
absorption, dehydration and plugging of mucous secretions in ducts of exocrine 
glands. This can lead to pancreatic insufficiency, bilary disorders, infertility and 
diabetes and provide an immuno-compromised lung environment suitable for chronic 
airway infection by opportunistic infections. Inability to clear respiratory pathogens 
and chronic lung damaging inflammation are the major causes of mortality in CF 
patients. 
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1.1.2 Diagnosis, pathophysiology and prognosis for CF patients 
In the UK, and increasingly elsewhere, all newborn babies are screened for CF with a 
Guthrie blood spot test, which screens for raised levels of immunoreactive 
trypsinogen; that is followed by a sweat test if positive (Davies et al., 2007), and 
identification of a CF mutation via buccal cells (de Vries et al., 2006). Today, early 
diagnosis, aggressive nutritional rehabilitation and high dose antimicrobial 
chemotherapy have improved prognosis significantly and a person with CF can now 
live until the age of 50 years, although the average life expectancy is 31 years (Davies 
et al., 2007). 
CF affects the upper and lower airways, pancreas, bowel and reproductive tracts, but 
it is lung infections that are the most problematic and potentially fatal. With a non-
functional CFTR, the lung environment is prone to opportunistic infections, and there 
are several hypotheses as to why that is: for example, some believe that CFTR-
induced inflammation precedes infection; or that pH changes result in altered 
epithelial receptors enabling bacteria to bind and colonise (Ratjen & Doting, 2003). A 
recent study by Teichgraber and colleagues showed that, in a mouse model, a 
dysfunctional CFTR leads to more alkaline pH which was associated with increased 
levels of ceramide in the lung, which correlated with constitutive inflammation in an 
uninfected lung and also increased the susceptibility of Pseudomonas aeruginosa 
infection (Teichgraber et al., 2008). Additionally, Hamai et al. showed that decreased 
CFTR expression or expression of a defective CFTR results in increased sphingolipid 
synthesis and affects ceramide composition, perhaps to increase membrane stability 
(Hamai et al., 2009). Other hypotheses are the inactivation of salt-sensitive cationic 
antimicrobial peptides (AMPs), such as defensins, and the isotonic fluid depletion 
hypothesis (Ratjen & Doting, 2003). In the first case, it is believed that increased 
sodium levels in the airway surface fluid impair the activity of charged peptides of the 
host immune system, thus limiting a major antimicrobial lung defence. However, 
there is growing consensus that the most important defect is the impaired mucociliary 
clearance due to depleted periciliary liquid and increased mucus viscosity, enabling 
bacteria to attach and colonise in the mucus. 
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In healthy individuals, inhaled bacteria encounter the mucus blanket lining the major 
airways, and are either destroyed by epithelial defences or efficiently removed by 
mucociliary clearance, then swallowed and destroyed by stomach acids. In the CF 
lung the mucus blanket is dehydrated and mucociliary clearance is impaired enabling 
opportunistic bacteria to colonise. In addition, these CF pathogens have evolved ways 
of resisting the other innate immune defences of the lung. 
Several studies have implicated direct roles for the wild type CFTR protein in the 
innate immune response. For example, it has been shown that CFTR acts as an 
epithelial receptor for binding, internalising and clearing of P. aeruginosa infection, 
and that the cfir mutations lead to impaired endocytosis and increased bacterial 
burden in the CF lung (Pier et aL, 1997)). In addition, an intact CFTR is involved in 
regulating phagosome acidification in macrophages aiding effective killing of 
bacteria (Di et at, 2006). 
The major pathophysiological outcome of CF lung infection is the repeating cycle of 
inflammation due to bacterial aggravation, imbalance between proteases and protease 
inhibitors, pro- and anti-inflammatory cytokines and probably oxidants and 
antioxidants (Tummler & Kiewitz, 1999). The fact that bacteria cannot be cleared 
leads to expression of tissue damaging neutrophil elastase and increased number of 
neutrophils which eventually leads to frustrated phagocytosis and neutrophil 
breakdown and release of high molecular weight DNA that increase viscosity of the 
secretions which contribute to the reduced mucociliary clearance (Gibson et aL, 
2003). This vicious circle of inflammation leads to lung tissue damage and eventually 
loss of lung function. 
A last resort for many patients is lung transplantation. However, depending on 
infection status, all patients are not offered this option. For example, patients infected 
with species from the Burkholderia cepacia complex (Bee) are excluded from the 
transplant list. Unfortunately, Bee infected individuals are also excluded from all 
ongoing clinical trials. 
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Treatment of many CF pathogens is difficult and requires combinations of aerosolised 
and intravenous antibiotics, anti-inflammatory agents and osmolytes to improve 
mucociliary clearance. These treatments are time-consuming, unpleasant and involve 
repeated hospital visits. In general, current treatments at best slow the decline of lung 
function. 
Antimicrobial peptides, such as aerosolised colistin (polymyxin E), in combination 
with ciprofloxacin are being used strategically against early P. aeruginosa infection 
(Hoiby et at, 2005); macrolides are also used to reduce inflammation (Taccetti et at, 
2008). Hypertonic saline is widely used to improve mucociliary clearance, but 
hexitols are currently in clinical trials as a more pleasant tasting alternative (Daviskas 
et at, 2005; Wills, 2007; www.pharmaxis.com.au). Ongoing research focuses mainly 
on gene therapy (Griesenbach & Alton, 2008). Since CF is a single gene defect, gene 
therapy should in theory work. However, until this technology delivers a clinically 
useful method able to control the expressing gene stably in the correct organs, 
antimicrobial therapy is the best option. 
1.1.3 Identification of CF pathogens 
There are surprisingly few opportunistic pathogens that are able to infect the CF lung. 
Generally, Staphylococcus aureus and Haemophilus influenzae are most common in 
infants and young children. P. aeruginosa, which is the major CF pathogen, infects 
children and young adults, and later adult infection can be caused by members of the 
Bcc, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, non-tuberculous 
mycobacteria and fungi including Aspergillus spp. (Tummler & Kiewitz, 1999) 
Once established in the CF lung, some of the pathogens become very problematic. 
These include mucoid P. aeruginosa and multi-drug resistant and highly 
transmissible strains of the Bce. It is crucial that these isolates are correctly identified 
as misidentification can have detrimental consequences in terms of incorrect 
treatments, potential segregation and transplantation issues. 
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Identification of CF pathogens is normally based on sputum bacteriology. This can be 
challenging and may require the aid of reference laboratories. A combination of 
phenotypic, genotypic and biochemical tests are carried out to ensure correct 
identification, but even then it can be very difficult to identify certain isolates. An up 
to date knowledge of microbial taxonomy plays a major role in bacterial identification 
and developing genotyping methods to characterise individual strains for 
epidemiological studies. Today the gold standard genotyping methods are considered 
to be pulse-field gel electrophoresis (PFGE) and multi locus sequence typing 
(MLST). These are both time consuming and expensive to use and require analysis 
expertise. 
1.2. The Burkholderia cepacia complex 
Table 1: The Burkholderia cepacia complex 
Genomovar I B. cepacia 
Genomovar II B. multivorans 
Genomovar III B. cenocepacia 
Genomovar IV B. stab/I/s 
Genomovar V B. vietnamensis 
Genomovar VI B. dolosa 
Genomovar VII B. ambjfaria 
Genomovar VIII B. anthina 
Genomovar IX B. pyrrocinia 
Genomovar X B. ubonensis 
Genomovar XI B. latens 
Genomovar XII B. dffusa 
Genomovar XIII B. arboris, 
Genomovar XIV B. seminalis 
Genomovar XV B. metallica 
In this thesis, "Bee" refers to Genomovar J-IX (in bold) as 
Genomovar X-XV have only recently been added to the complex 
and have not been previously investigated. 
1.2.1 Taxonomy 
B. cepacia is a Gram-negative bacterium which was first identified by Burkholder in 
1950 as the causative agent of soft rot of onions (Burkholder, 1950). It was given the 
name Pseudomonas cepacia due to its phenotypic resemblance to P. aeruginosa. 
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With improved taxonomic methods P. cepacia, as well as closely related 
Pseudomonas mallei and Pseudomonas pseudomallei, were re-classified as 
Burkholderia (Yabuuchi et at, 1992). Vandamnie and colleagues then found that the 
species B. cepacia is in fact a group of genetically distinct species, initially referred to 
as genomovars (Vandamme et al., 1997). This group, named the Burkholderia 
cepacia complex (Bcc) currently consists of 15 closely related species (Table 1) 
(Coenye et at, 2003; Mahenthiralingam et at, 2000; Vanlaere et at, 2008). Since the 
identification of the last 6 species were published very recently, for the purpose of 
this thesis the term "Bcc" refers to the first 9 species of the complex. 
1.2.2 Plant growth promotion, bioremediation and antifungal properties 
Although the Bcc were originally described as plant pathogens, they also have many 
environmentally useful properties. The Bcc promotes growth of many important 
crops such as peas, maize, rice and wheat, and protects plants from fungal infections. 
They produce a variety of antifungal compounds such as cepacin, altercidins, 
pyrrolnitrin, cepacidins and siderophores (Berg et at, 2005). On the other hand, a 
Burkholderia species was found to live as a symbiot inside the fungus Rhizopus 
inicrosporus and it was shown that a mycotoxin, believed to be produced by the 
fungus, was in fact produced by Burkholderia (Partida-Martinez & Hertweck, 2005). 
Burkholderia species have demonstrated important bioremediation properties. For 
example, B. vietnamiensis G4 degrades trichloroethylene polluted ground water 
aquifers, B. xenovorans LB400 degrades polychlorinated biphenols and B. 
phenolirupirix AC100 degrades 2,4,5-trichlorophenoxyacetate (O'Sullivan & 
Mahenthiralingam, 2005). As they are able to grow on a diverse range of carbon 
substrates they could be useful against oil and fuel industry contamination. Since 
these species are highly beneficial in the environment the US Environmental 
Protection Agency was asked to approve the use of members of the Bcc for bio 
control. This caused great debate due to the potential clinical hazard to immuno-
compromised individuals. Early arguments were based on the premise that 
environmental and clinical Bcc were different. However, many clinical isolates of the 
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Bcc are in fact identical to strains found in the environment (Holmes et at, 1998), and 
as the Bcc are not found in the commensal flora, they are likely to be directly 
acquired from the environment or nosocomially. The Bcc have been found in river 
water, in the rhizosphere, on onions and maize, but also in pharmaceutical solutions, 
detergents, on hospital equipment, in shampoo, cosmetics and toiletries as well as in 
industrial settings (Mahenthiralingam et at, 2008). They can survive for long periods 
of time in solutions with high antibiotic concentrations or with minimal nutrients such 
as saline bags used in hospitals. 
1.2.3 Clinical manifestations 
The Bcc primarily infect patients with CF and chronic granulomatous disease (CGD). 
The outcome of CF and COD is in both cases an immuno-compromised lung 
environment. COD is caused by mutations in genes encoding subunits of the 
superoxide-generating NADPH oxidase in phagocytes, rendering these cells unable to 
perform oxidative killing (Heyworth et at, 2003). In addition, Bcc are resistant to the 
other phagocytic killing mechanisms, including non-oxidative killing by cationic 
AMPs. 
The clinical significance of B. cepacia infection in CF patients was first described in 
1984 by Isles and colleagues, and has since emerged as a major CF pathogen (Isles et 
at, 1984). The worst-case scenario is the onset of "cepacia syndrome" - a fatal 
necrotizing pneumonia with bacteraemia that occurs in 20% of all infected CF 
patients and which is very difficult to treat. In fact, there have only been three 
successful cases to date (Ka.zachkov et at, 2001; Weidmann et at, 2008) (Grimwood 
and Tweed, personal communication). 
Within the Bcc, B. cenocepacia and B. multivorans are the most prevalent species in 
CF infections (Govan et at, 2007). However, with the exception of B. ubonensis, all 
Bcc species have been recovered from CF lungs. The clinical outcome varies to some 
extent depending on species, and strains within a species. For example, regardless of 
strain, B. cenocepacia is associated with rapid decline in lung function and is the 
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species mostly associated with the "cepacia syndrome", whereas, B. pyrrocinia, B. 
anthina and B. ambfaria are rarely isolated and have not been shown to have the 
same detrimental effect as B. cenocepacia and B. multivorans (Reik et at, 2005). 
Although B. multivorans is not considered to be as virulent as B. cenocepacia, some 
strains of B. multivorans have been responsible for serious outbreaks and multiple 
fatalities (Whiteford et at, 1995). The severity of infection is thought to be related to 
the ability of the Bcc bacteria to invade respiratory epithelial cells and cause sepsis, 
which is more common for B. multivorans and B. cenocepacia (Keig et al., 2002). 
However, B. stabilis can invade epithelial cells without any clinical manifestation 
(Schwab et at, 2002). 
Some Bcc strains have been shown to be particularly transmissible among patients. 
Outbreaks have mainly been associated with three distinct B. cenocepacia epidemic 
clones: the ET-12 clone, the PHDC clone and the Midwest clone, and particular 
strains of B. multivorans. The ET-12 lineage caused the largest epidemics in Canada 
and Europe in the late 1980s and throughout the 1990s (Govan et at, 1993). Spread 
probably occurred at CF patient summer camps and from socialising in hospitals. The 
route of spread is thought to occur by aerosol droplet and direct physical contact or 
contaminated surfaces, or from contaminated disinfectants or the environment. 
Segregation of patients has been the only successful method to keep Bcc from 
spreading, a method with huge social and psychological implications for the patients 
(Govan et at, 2007). 
B. cenocepacia has been the most problematic species of the Bcc so far. Apart from 
being one of the most prevalent and most transmissible species, it is also the most 
difficult one to treat, and has been shown to lead to the highest post-transplant 
mortality (Murray et at, 2008). 
1.2.4 Putative virulence factors and survival mechanisms 
The Bcc are known to have large genomes of 6-9 Mb distributed between multiple 
replicons. To date, over 30 Burkholderia genome sequencing projects have been 
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undertaken. The average size of each genome is 7.5 Mb containing approximately 
7000 genes out of which 10% or more is foreign DNA acquired from horizontal gene 
transfer often associated with genomic islands, prophages and insertion sequences 
(Holden et at, 2008; Mahenthiralingam et al., 2008). A very useful website, 
www.burkholderia.com, currently contains 20 genomes with clinical and 
environmental isolates. A recent addition was the genome of the ET-12 isolate B. 
cenocepacia J2315 which was recently annotated and contains 3 chromosomes and a 
large plasmid amounting to 8 Mb (Holden et al., 2008). This strain was isolated 
during the ET-12 outbreak in Edinburgh in 1989 and is the type strain for this clonal 
lineage of transmissible strains (Govan et at, 1993). Studying the genomes of the Bee 
species reveals many putative virulence factors, none of which have been proven to 
be directly responsible for the deterioration of the CF lung. Evidence from various 
model systems (mouse, rat, plant and nematode) has suggested the importance of 
individual virulence factors, but the results depend on the infection model used 
(Bernier et at, 2003). In addition, studies of Bee infections in CF patients also 
suggest a key role of host—pathogen interactions, since clinical outcome in individual 
patients cannot be predicted even during epidemic outbreaks when multiple patients 
are infected by the same strain (Govan et at, 1993). However, various putative 
virulence factors have been investigated by a number of laboratory groups, and their 
roles are listed in Table 2 and summarised below. 
To control expression of a variety of virulence factors and to adapt to different 
environments many bacteria use two-component regulatory systems JCS) and 
quorum sensing (QS). Members of Burkholderia species contain amongst the highest 
number of two-component systems of any bacterial species (Alan Brown, personal 
communication). None of these have been looked at in detail, and little is known 
about Buritholderia virulence regulation. However, QS has been shown to play a role 
in the virulence and versatility of the Bee and is involved in onion pathogenicity of B. 
cepacia ATCC25416 (Venturi et at, 2004), and swarming motility, siderophore 
production and biofilm formation of B. cenocepacia clinical isolates (Huber et at, 
2001; Lewenza et al., 1999; Lewenza & Sokol, 2001)). Interestingly, Bee have been 
-\ 
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shown to respond to P. aeruginosa quorum sensing molecules, and the two can co-
exist in biofilms in vitro (Riedel et aL, 2001) 
Exopolysaccharide (BPS) production and biofilm formation have been shown to be 
important in P. aeruginosa infections, and a role for BPS in the Bee has been 
investigated recently. Bee BPS had been shown to be involved in persistence in the 
lung (Chung et aL, 2003; Conway et aL, 2004), interactions with antimicrobial 
peptides (Herasimenka et al., 2005) and the ability to scavenge reactive oxygen 
species and inhibit neutrophil chemotaxis (Bylund et aL, 2006). Bight different 
putative BPS gene cluster were found in the B. cenocepacia J2315 genome (Holden et 
aL, 2008), where of the best characterised is the conserved bce gene cluster (Moreira 
et aL, 2003). The bce genes encode enzymes for the biosynthesis of cepacian, which 
is a highly branched heptasaccharide repeating unit consisting of rhamnose, mannose, 
galactose, glucose and glucuronic acid (Fig. 2 (B) (Cescutti et al., 2000)). Cepacian is 
the main EPS produced by the Bee, although three additional EPSs have been isolated 
from some species (Cerantola et aL, 1996; Chiarini et aL, 2004). 
The Bee express a number of secreted virulence factors, for example haemolysins, 
proteases and lipases. In addition, four types of siderophores are produced: salicylic 
acid, ornibactin, pyochelin, and cepabactin (Mohr et al., 2001). The Bee have also 
been shown to have mucin-sulfatase activity, which enables them to degrade mucins 
for carbon sources to survive in the mucus (Schwab et al., 2002). 
The Bee have been shown to be able to adhere to mucins and cellular receptors via 
pili and adhesins. The CblA cable pilus and the 22 kDa adhesin have been the most 
studied to date. The CblA is mainly associated with epidemic strains, and is in fact 
one of the ET-12 epidemic strain markers together with the genomie island associated 
Burkholderia cepacia epidemic strain marker (BCESM) (Mahenthiralingam et aL, 
1997). 
There is increasing evidence that epithelial cell invasion plays an important role in 
Bee lung infections, which could explain the bacteraemia seen in association with the 
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capacia syndrome. Studies suggest that all members of the Bce are capable of cell 
invasion, although, interestingly, B. multivorans and B. cenocepacia have generally 
been shown to be more invasive than the other species of the complex (Keig et at, 
2002). 
Table 2: Putative virulence factors of the Bee 
Virulence trait Features References 
Two-component Burkholderia species contain amongst the (Alan Brown, 
regulatory systems (TCS) highest number of TCSs of any bacterial personal 
species communication) 
Quorum sensing (QS) CepIR is conserved within Bcc, and BviIR is (Lewenza flat, 
unique in B. vietnamiensis; 1999; Malott & 
Can respond to F. aeruginosa QS molecules Sokol, 2007; Riedel 
and co-exist in biofllms in vitro ci at, 2001) 
Flagella fiG mutants show reduced invasiveness and (Tomich et at, 2002; 
fiG mutants how increase survival in rat agar Urbane! at, 2004) 
lung infection model; immuno-stimulatory via 
TLR-5  
Adhesins and pili 22 kDa adhesin and (Cheung et at, 2007) 
CblA cable pilus  
Transmissibility Burkholderia cepacia epidemic strain marker (Mahenthiralingam 
(BCESM) and CbIA et al., 1997) 
Cell invasion and Can survive in macrophages and amoeba; (Holden et at, 2008; 
intracellular survival B. stabilis, B. multivorans and B. cenocepacia Lamothe et al., 2004; 
more invasive; survive using superoxide Lamothe et al., 2007; 
dismutase (SOD), peroxidases, catalases, Lefebre & Valvano, 
nitric oxide detoxification 2001; Moura et at, 
2008; Valvano ci at, 
2005) 
EPS cepacian biosynthesis and export cluster; 7 (Holden ci at, 2008; 
additional putative EPS gene cluster Moreira c/ at, 2003) 
LPS Unusual lipid A structure and inner core has (Isshiki et al., 1998; 
Ko-Kdo; constitutive L-Ara4N modification, Shaw ci at, 1995; 
very immuno-stimulatory and is not Shimomura et at, 
neutralised by antimicrobial peptides 2003; Silipo et al., 
2007) 
Antimicrobial resistance Inherently resistant to all classes of antibiotics (Holden ci at, 2008; 
and antimicrobial peptides Mahenthiralingam ci 
at, 2005) 
Secretion Type 1, H, III, IV, V and VI secretion systems (Holden c/ at, 2008) 
Haemolysin Induces degranulation and induces cell death (Hutchison et at, 
in phagocytes 1998) 
Zinc metalloproteases ZmpA is porteolytically active against type (Kooi et at, 2005) 
IV collagen, fibronectin, gamma interferon 
______________________ 
and neutrophil a-i protease inhibitor  
Siderophores Salicylic acid, ornbactin, pyochelin and (Mohr et at, 200 1) 
cepabactin  
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Members of the Bee have been shown to survive within epithelial cells and 
macrophages, as well as amoeba, suggesting a potential environmental reservoir 
(Lamothe et all, 2004; Valvano et all, 2005). The Bee can survive in macrophages 
despite the oxidative burst and they have been shown produce enzymes such as 
superoxide dismutase (SOD), catalase and catalase-peroxidase which contribute to 
resistance to reactive oxygen intermediates (Lefebre & Valvano, 2001). 
Flagella have also been shown to be involved in invasion of epithelial cells (Tomich 
et al., 2002) as afiiG mutant shows reduced invasiveness. However, a major role for 
flagella appears to be in the induction of the host immune response. AfliCII mutant 
of B. cenocepacia K56-2 survived a rat agar lung infection model whereas the wild 
type showed 40% mortality. Wild type flagella were also shown to directly stimulate 
interleukin-8 (IL-8) and NFicB through Toll-like receptor 5 (TLRS) (Urban et all, 
2004). 
The main Bee virulence factor proposed to induce immuno-stimulation is 
lipopolysaccharide (LPS). Bee LPS has been shown to be as inflammatory as 
Escherichia coil and Salmonella LPS, except in IL-113 induction (Shimomura et all, 
2001). However, a study by Shimumura et al showed that B. cepacia LPS has an 
unusual interaction with the cationic AMP Polymyxin B (PMB). It binds tightly but is 
not neutralised like Salmonella LPS, instead IL-10 induction is elevated (Shimomura 
et all, 2003). The LPS from the Bee has also been shown to be four to five times more 
endotoxic and induce nine times more tumour necrosis factor (TNF) than P. 
aeruginosa, and a similar pattern was observed for IL-8 induction (Reddi et all, 
2003; Shaw et all, 1995). The structure of B. cenocepacia J2315 LPS was recently 
determined (Fig. 1) and, together with studies of other Bee species, suggests the 
common lipid A structure is a 0-1-6-linked disaccharide of glucosamine, 
phosphorylated at position 1 and 4' with 4-amino-4-deoxy-J3-L-arabinose (L-Ara4N) 
attached to the 1-phosphate, and acylated at the 2, 3, 2', 3' positions, with a 
secondary myristate on the distal glucosamine (De Soyza et all, 2008; Silipo et al., 
2005; Silipo et all, 2007). The inner core consists of a Burkholderia species specific 
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trisaccharide of L-Ara4N-(1 —*8)-D-glycero-cz-D-talo-oct-2-ulosonic acid-(2—*4)-3-
deoxy-D-manno-oct-2-ulosonic acid (Ko-Kdo) which is linked to the distal 
glucosamine (Kdo-(1-6)-GlcpN) (Fig 4, (Gronow et aL, 2003; Isshiki et all, 1998; 
Silipo et all, 2007). The rest of the core is similar to that found in enterobacteria and 
contains L-a-DHepp-(1—*7)-L-cL-D-Hepp-(1--*3)- [0-D-Glcp- (1—*4)]-L-a-D-Hepp 
linked to the Kdo (1—*5) (Isshiki et all, 2003; Silipo et all, 2007)). 
C16 
Fig. 1: The structure of the LPS from B. cenocepacia J2315 (Silipo et al., 2007). 
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The 0-antigen repeat of Burkholderia cepacia strain ASP B 2D was shown to be 
—*2)-3-D-Ribf-(1—*6)-cz-D-Glcp-(1—* (Leone et at, 2006), however, at least 16 
different serotypes have been observed for the Bcc (Mahenthiralingam et at, 2005) 
but with no correlation with genomovar status (Kenna et at, 2003). The immuno-
stimulatory abilities of the different genomovars have been compared by various 
groups, and although all species induce a similar response, some variations between 
and within the genomovars have been observed (De Soyza et al., 2004; Moura et at, 
2008). Although many studies hint at clinical epidemic strains having higher 
endotoxicity than environmental strains, it has never been confirmed. The role of LPS 
of the Bcc is not only as an endotoxin, but also for membrane integrity and resistance 
mechanisms, in particular to AMPs, which will be discussed in detail below. 
In addition to AMPs, the Bcc are resistant to practically all classes of clinically useful 
antibiotics. A striking illustration of this is B. multivorans ("eater of everything") 
which can to utilize Penicillin G as a sole nutrient (Beckman & Lessie, 1979). 
Resistance is species specific, with clinical isolates generally exhibiting broader 
resistance than environmental isolates. The genome of J2315 contains at least 4 I-
lactamases and six different types of efflux systems (Holden et al., 2008). 
In summary, Bcc infection of the CF lung involves a complicated mixture of a variety 
of virulence factors and adaptation mechanisms. All virulence factors appear to some 
extent to be strain specific which makes it difficult to generalise for a species, 
nevertheless for the complex. The outcome of disease can differ enormously 
depending on what strain of Bcc is involved, but is also influenced by host factors. 
However, the main problem of Bcc infections is without question the virtually 
untreatable chronic inflammatory airway infection which leads to the fatal 
deterioration of the lung, and two likely virulence factors responsible for this are EPS 
for persistence and LPS for inflammation. 
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1.3. Exopolysaccharides 
1.3.1 Role of bacterial exopolysacch arid es 
BPSs are produced by both Gram-positive and Gram-negative bacteria and generally 
exist in the form of capsules or slime, often associated with biofilms. Many bacterial 
species are believed to exist naturally in biofilms. Biofilms are often associated with 
nosoconiial infections, for example, by biofilms forming on catheters and artificial 
hips (Mah & O'Toole, 2001). Many pathogenic bacteria use biofilm formation as a 
virulence factor, for example, Streptococcus inutans biofilms form dental plaque 
which eventually results in dental caries, and Pseudomonas aeruginosa exists as 
biofilms in the CF lung (see below). EPS capsules also contribute to virulence, and 
some examples of encapsulated bacteria are Haemophilus influenzae type B, 
Streptococcus pneumoniae, Kiebsiella pneumoniae, Neisseria meningitides and 
Burkholderia sp. The main role of EPS during a bacterial infection is in protection 
against phagocytosis and antimicrobial agents, making it hard to treat bacteria once 
they convert to a mucoid phenotype. 
However, there are also many industrial applications for extracted bacterial BPS, for 
example, as gelling agents, emulsifiers, heavy metal removers, or in enhanced oil 
recovery (Kumar et al., 2007). As well as theses beneficial properties, there are also 
medicinal uses for EPS in anti-tumour, antiviral and arthritis treatments (Kumar et al., 
2007). 
1.3.1 Pseudomonas aeruginosa alginate 
It is well established that production of the BPS alginate is a main virulence factor of 
P. aeruginosa. In the CF lung, alginate forms complex biofilms in association with 
human mucin and neutrophil DNA, which reduce bacterial growth rate and act as a 
direct barrier against phagocytosis and opsonisation, and are involved in immuno-
stimulation, adhesion and resistance to AMPs and reactive oxygen species (Govan & 
Deretic, 1996). Once P. aeruginosa converts to this mucoid phenotype it is associated 
15 
Chapter 1: introduction 
with repeated pulmonary exacerbations and decreased life expectancy, and is virtually 
impossible to eradicate. Alginate is a linear co-polymer of (1—*4) linked I3-D-
mannuronic acid and a-L-guluronic acid ((Govan & Deretic, 1996) Fig. 2 (A)). Its 
biosynthesis overlaps with LPS biosynthesis, and this may explain why a loss of 0-
antigen is observed in mucoid isolates (Govan & Deretic, 1996). Alginate production 
can be induced in the CF lung but, with the exception of chronic bronchiectasis, is not 
generally observed during other P. aeruginosa infections (Govan & Deretic, 1996). 
Interestingly, variations in mucoidy are observed when bacteria are cultured on 
different media. For example, a strain can be mucoid on Pseudomonas Isolation Agar 
(PTA; Difco) but revert when grown on nutrient agar (Columbia Based agar, Oxoid), 
hence the media commonly used to identify P. aeruginosa is PTA (Govan & Deretic, 
1996; Pugashetti et all, 1982). Recently, Marvin Whitely and colleagues analysed 
sputum samples from CF patients and have developed a synthetic CF sputum medium 
(SCFM; (Palmer et all, 2007)). They compared growth on SUM with growth in 
sputum and found no significant differences in phenotype. This highlights the 
importance of the choice of virulence models and different media. The ability to use 
"host based" media should provide a more informative tool in understanding the 
mechanisms of CF lung disease. 
1.3.2 Burkholderia exopolysacharides 
BPS production is so far only a putative virulence factor for the Bcc. Bcc BPS in the 
form of mucoid colonial morphotypes is rarely seen in laboratory cultures, and no 
correlation has been observed between mucoidy and deterioration of the lung. 
However, Bcc BPS has been associated with altered clearance in a mouse model of 
infection (Chung et al., 2003; Conway et all, 2004), and BPS-deficient Bcc mutants 
displayed reduced mortality within a COD mouse model (Sousa et al., 2007). 
Similarly, a role for BPS in persistence in human airways is suggested by its capacity 
to scavenge reactive oxygen species and inhibit neutrophil chemotaxis (Bylund et all, 
2006). Bcc EPS has also been involved in interactions with antimicrobial peptides, 
although not as efficiently as P. aeruginosa alginate (Herasimenka et al., 2005), and 
the formation of thick biofilms (Cunha et all, 2004). Peeters et al. showed that Bcc 
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grown in bioflims are more resistant to antimicrobial compounds than planktonic 
bacteria (Peeters et al., 2008). Recent studies (Richau et all, 2000; Ziosnik et al., 
2008) have also challenged the previous belief that mucoid, EPS-producing colonial 



















Fig. 2: Exopolysaccharides of the Bee and P. aeruginosa. (A) P. aeruginosa alginate (Ilerasimenka et 
at, 2005). (B) Bcc EPS: (i) cepacian (PSII) (Cerantola at at, 1999; Cescutti et at, 2000); (ii) 
homologous to main capsular polysaccharide of B. pseudomallei (Masoud et at, 1997); (iii) B. 
pseudomallei and B. mallei 
Studies have shown that mucoid Bee isolates mostly synthesize one type of EPS in 
the form of a highly branched heptasaccharide repeating unit consisting of rhamnose, 
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mannose, galactose, glucose and glucuronic acid 1:1:3:1:1 (Fig. 2 (B); (Cescutti et at, 
2000). This EPS, now referred to as cepacian, was the second Bee BPS whose 
structure was determined and was originally named PSII (Cerantola et at, 1999). PSI 
was the first Bee BPS structure with a repeating unit of equal amounts of glucose and 
galactose with pyruvate as a substituent (Fig. 2 (B) (Cerantola et at, 1996)). The 
cepacian biosynthetic enzymes are encoded by the conserved bee gene cluster, and 
the biosynthetic pathway, as well as many of the enzymes have been well 
characterised (Ferreira et at, 2007; Moreira et at, 2003; Sousa, 2007; Videira et at, 
2005). In addition to cepacian and PSI, two other EPS have been isolated from the 
Bee. One of these has previously been found in B. pseudoinallei, which produces 
capsular BPS that have been shown to be involved in persistence and resistance to the 
host immune system (Reckseidler-Zenteno et at, 2005; Reckseidler et at, 2001). The 
main BPS produced by B. pseudoinallei is a linear unbranched polymer of repeating 
units of galactose (KDO) and 0-acetyl 3:1:1 (Fig. 2 (B) (Masoud et al., 1997)). In 
addition, a gene cluster, web, was discovered in B. mallei that encodes the capsular 
BPS referred to as Type I 0-PS (Fig. 2 (B) (DeShazer et at, 2001)), also produced by 
B. pseudomallei, and was previously believed to be part of the 0-antigen (Reckseidler 
et at, 2001). The web gene cluster was recently found in B. cenocepacia J2315, but 
contained an insertion sequence in wcbO, encoding a putative BPS 
biosynthesis/export protein (Parsons et at, 2003). This gene cluster was found on a 
genomic island on some, but not all, species of the Bee. In addition to these BPSs, the 
common bacterial BPS levan has been found in members of the Bee (Fig. 2 (B); 
(Chiarini et at, 2004; Reckseidler et at, 2001)). Finally, there are an additional 3 
putative BPS gene clusters in the B. cenocepacia J2315 genome that have not been 
investigated (Holden et at, 2008). 
Although a potentially important virulence factor, the prevalence, exact role and 
contribution of Bee BPS to CF lung disease is still not clear. Many different media 
have been used to enhance BPS production in vitro. The addition of glycerol or 
mannitol has been shown to increase BPS production of the Bcc in the laboratory 
(Sage et at, 1990; Zlosnik et at, 2008), but it is not clear if this reflects what occurs 
in vivo. 
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1.4. Lipopolysaccharides 
1.4.1 Role of Iipopotysaccharides in Gram-negative bacteria 
LPS, or endotoxins, are major components of the outer membrane of most Gram-
negative bacteria (Fig. 3), and are required for an intact cell envelope, resistance 
mechanisms and interactions with the host immune-system. The term "endotoxin" 
was coined by Richard Pfeiffer, who described a heat stable non-protein, non-secreted 
toxin of Vibrio cholerae that was still active in killed bacterial suspensions used for 
immunisation (Pfeiffer, 1892). 
LPS consist of a hydrophobic anchor, lipid A, a non-repeating core oligosaccharide 
and often a distal 0-antigen polysaccharide (Fig. 3). A strain containing 0-antigen is 
referred to as "smooth", whereas a strain without 0-antigen is "rough", originally 
based on their phenotypic appearance on agar plates. Mutants have been created that 
display LPS without both 0-antigen and the outer core and these are referred to as 
"deep-rough" strains. These deep-rough strains contain the minimal required LPS for 
growth in most Gram-negative bacteria (Belunis et al., 1995), although hypersensitive 
mutants lacking all core sugars have been isolated in E. coli (Meredith et al., 2006). 
The lipid A structure is highly conserved among Gram-negative bacteria, whereas the 
outer core and 0-antigen are variable. It is thought that 0-antigen is not required for 
growth but has a protective role involved in complement neutralisation, phage 
interaction and serum resistance. Lipid A, on the other hand, is essential for survival 
and is an important structural component of the outer membrane. It is also important 
for inmiuno-stimulation and resistance to detergents and AMPs. 
LPS is responsible for the fever symptoms during a Gram-negative bacterial 
infection. This is due its very potent inimuno-stimulatory properties, which can lead 
to a dramatic induction of an inflammatory response that, if not regulated, will lead to 
toxic shock and sepsis. By preparing synthetic lipid A, Shiba and colleagues proved 
that the lipid A was the main immuno-stimulatory component of the LPS (Tanamoto 
et al., 1984). This synthetic lipid A was shown to have identical endotoxic activities 
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to natural E. coil lipid A, and activity was shown to depend on phosphate groups and 
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Lipid A generally interacts with the host immune system via TLR-4 receptors on 
innate immune cells, although B. pseudomallei, Porphyromonas gingivalis and 
Leptospira interrogans LPS have been associated with TLR-2 (Hirschfeld et at, 
2001; Werts et at, 2001; Wiersinga et al., 2007). The exact molecular details of the 
recognition of LPS and its mechanism of stimulation are not known, but a working 
model has been postulated: a LPS binding protein (LPB) in serum delivers LPS to 
CD 14, which inserts the LPS into the TLR-4/MD-2 receptor complex. The LPS can 
then induce dimerisation of TLR-4 which activates the complex. This leads to 
activation of signalling cascades, such as the MAP kinase and NFicB-inducing 
cascades, via myeloid differentiation factor 88 (MyD88) and IL-1 receptor associated 
kinase (IRAK), which results in the production of an array of inflammatory cytokines 
and chemokines (Beutler, 2009; Erridge et at, 2002). 
An optimum core LPS structure for TLR-4 activation is a hexa-acylated 
diphosphorylated glucosamine disaccharide with fatty acyl chain lengths of C12-14, 
as illustrated by E. coli Kd02dipid A (Fig. 6). The length and number of fatty acyl 
chains, as well as the presence or absence of phosphate groups, affect endotoxicity of 
the LPS isolated from other organisms. Some lipid A analogues, usually with fewer 
acyl chains, are in fact potent TLR4/MD2 antagonists. A study by Schromm et al. 
showed that a hexa-acylated lipid A with two phosphates was a better agonist than 
with one phosphate, and that penta or tetra acylated lipid A was antagonistic 
(Schromm et at, 2000). Interestingly, the lipid A of the species that have been 
associated with TLR-2, for example B. pseudomallei and Leptospira interrogans, 
have less agonistic structures which may not be recognised by TLR-4 (Que-Gewirth 
et at, 2004; Wiersinga et at, 2007). 
LPS also plays a major role in AMP resistance. Production of AMPs is part of the 
innate immune response in most plants and animals (Zasloff, 2002). Humans produce 
various different types, for example: defensins, cathelicidins and thrombocidins. 
These have been shown to recognize and inactivate microbial pathogens, as well as 
recruiting leukocytes and other cell types (by chemotaxis) to the site of infection and 
activating the adaptive immune response (Dun & Peschel, 2002). 
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In addition, many AMPs can bind and neutralize LP S during infection, hence 
inhibiting the cytokine response and the risk of endotoxic shock (Rosenfeld et at, 
2006). Their cationic and hydrophobic properties enable these peptides to disrupt the 
bacterial membrane by creating pores or leaks, leading to cell lysis (Brogden, 2005; 
McPhee & Hancock, 2005). Although, some pathogens can acquire resistance or are 
inherently resistant to AMPs, resistance is uncommon amongst pathogenic organisms, 
but is seen to some extent in commensal organisms. It has been proposed that these 
organisms provide protection by chronically stimulating the epithelia to express 
AMPs at levels that kill pathogens (Boman, 2000). 
With increasing evidence of bacterial resistance, the natural product cationic AMP 
polymyxin (produced by Paenibacilluspolymyxa) and its synthetic derivative colistin, 
have been useful clinically despite being toxic. Polymyxin is the main AMP used in 
research as it is a good model for AMPs and cheap to produce. However, to isolate 
and overproduce human, non-toxic AMPs would be ideal, and although it is 
technically difficult and expensive at the moment (Vargue, Morrison et al. in press) 
improvement in synthetic recombinant techniques should allow access to a range of 
novel peptides for future analysis. For example, one of the most cationic AMPs, 
human D-defensin 3 (HBD-3), has been shown to kill a broad spectrum of pathogens 
at micromolar concentrations including P. aeruginosa, multi-resistant Staph. aureus 
(MRSA) and vancomycin-resistant Enterococcusfaecium (VRE) (Garcia et at, 2001; 
Harder et al., 2001). Garcia and colleagues claimed HBD-3 was active against the 
Bee, but a conflicting, in-depth study was published using 23 different Bee strains, all 
of which were highly resistant to HBD-3 (Sahly et at, 2003). Importantly, all 
members of the Bee remain uniquely resistant to all classes of AMPs. 
A large number of studies have shown that AMP resistance occurs due to various 
chemical modifications of the lipid A that, in most cases, lead to neutralisation of the 
normally negatively-charged outer membrane. The different modifications are 
discussed in section 1.4.3. 
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1.4.2 Lipid A biosynthesis and transport 
The E. coil lipid A is the best studied to date and provides an excellent model to 
understand molecular details involved in the conversion of a basic glucose precursor 
into the lipid core. The core LPS, Kd02-lipid A, is synthesised by 9 constitutively-
expressed enzymes found in the cytoplasm and on the cytoplasmic face of the inner 
membrane (Fig. 4). This is referred to as "the Raetz pathway" (after Professor 
Christian Raetz, Duke University, North Carolina, USA, who has led this field for 
over 30 years) and homologues of most of these enzymes are found in all LPS-
containing bacteria (Raetz & Whitfield, 2002; Raetz et at, 2007). 
Lipid A biosynthesis begins in the( cytoplasm with the acylation of UDP-N-
acetylglucosamine (UDP-GlcNAc) with R-3-hydroxymyristate by LpxA (Anderson et 
at, 1993), followed by deacetylation of UDP-3 -O-(acyl)-GlcNAc by LpxC (Young et 
at, 1995) and a second fatty acyl chain is added by LpxD to form UDP-2,3- diacyl-
GlcN (Kelly et al., 1993). The peripheral membrane protein LpxH cleaves the 
pyrophosphate linkage of the UDP moiety to form 2,3-(diacyl)-GlcN-1-phosphate, 
also known as lipid X (Babinski et at, 2002a; Babinski et at, 2002b). LpxB then 
condenses lipid X with UDP-2,3- diacyl-GlcN, releasing UDP and creating the 3,1'-
6-linked disaccharide backbone (Radika & Raetz, 1988). The inner membrane protein 
LpxK adds a 4' phosphate generating the lipid A antagonist precursor lipid IVA 
(Garrett et at, 1997) Next the bifunctional enzyme KdtA adds two Kdo molecules 
(Belunis & Raetz, 1992; Clementz & Raetz, 1991), and LpxL and LpxM add 
secondary lauroyl and myrositoyl residues to the distal glucosamine unit (Clementz et 
at, 1996; Clementz et at, 1997). The complete product is referred to as Kdo2-lipidA. 
Though the overall pathway and the enzymes catalysing each step are generally 
conserved, there are slight variations between bacterial species. For example, the 
length of fatty acyl chains incorporated by LpxA can vary between CIO and C14 in 
different organisms Anderson et at, 1993; Odegaard et at, 1997; Wyckoff et at, 
1998), and some bacteria lack LpxM and/or LpxL. Lack of LpxL can be compensated 
by the expression of an additional homologue LpxP, which incorporates palmitate 
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(C16) instead of laurate (C12) (Carty et al., 1999; Montminy et al., 2006). There are 
also differences in the Kdo incorporation, as some bacteria, for example, 
Helicobacter pylon, Haemophiius infiuenzae and Vibnio cholerae incorporate a single 
Kdo sugar (White et al., 1997), and the LPS from other species contain a Ko 
molecule instead of a second Kdo, such as Acinetobacter, Raistonia and members of 
the Burkhoideria species (Vinogradov et al., 1997; Zdorovenko et al., 2008). 
Because lipid A is an essential component of the outer membrane, the lipid A 
biosynthetic enzymes have been suggested as valid antibacterial drug targets. 
Interestingly, an LpxC inhibitor, CHIR-090, has shown potency against LpxC 
orthologues in N. men ingitidis, H pylon, P. aeruginosa and E. coil at nanomolar 
concentrations (Barb et al., 2007). 
Once synthesis of the Kd02-lipidA is complete, it is then transported across the inner 
membrane by the ABC transporter MsbA (Fig. 5). This transporter is essential and 
msbA knockouts in E. coil are lethal (Karow & Georgopoulos, 1993). Its essentiality 
and role as an LPS "flippase" was shown by Raetz and co-workers by creating a 
temperature sensitive point-mutant of the E. coli msbA, WD2, which is rapidly 
inactivated at 44 °C (Doerrler et al., 2001). This mutant showed -90% inhibition of 
lipid transport to the outer membrane by pulse-labelling and inner-membrane 
invaginations were observed by electron microscopy. Interestingly, lipid A 
modifications, believed to occur on the periplasmic face of the inner membrane, were 
also inhibited and these results further supported the role of MsbA as an inner 
membrane transporter. In addition, over-expression of MsbA can overcome LPS 
defects, such as Kdo-deficiency or under-acylation (Meredith et al., 2006; Zhou et al., 
1998). 
Once flipped to the periplasmic side of the inner membrane, the core and 0-antigen 
are ligated to the lipid A and various species specific modifications can occur. These 
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Fig. 5: Lipopolysaccharide transport in E. coil 
It is still not fully understood how the hydrophobic lipid A is transported across the 
periplasm to the outer membrane. It was believed that so called Bayer bridges would 
form, providing contact sites between the inner and outer membrane (Bayer, 1968), 
however, these structures observed by electron microscopy could have been due to 
cell fixation method. A study by Sperandeo and co-workers described an ABC 
transporter system in E. cob, involving LptA and LptB (Sperandeo et al., 2007), 
which showed similarity to the Lol system that transports lipoproteins across the 
periplasm (Tokuda & Matsuyama, 2004). iptA and B are co-transcribed in an operon 
which also contains kdsC and D, involved in Kdo biosynthesis (Sperandeo et al., 
2007). Conditional mutants, using an arabinose inducible promoter, showed growth 
depletion after 6 generations, and electron micrographs showed accumulation of 
membranous materials. This was confirmed by isopycnic sucrose density gradient 
centrifugation, after growing the mutants in N-acetyl  [3  H]glucosamine, which revealed 
that the LPS did not reach the outer membrane, and accumulated in the periplasm 
(Sperandeo et al., 2007). Raetz and co-workers recently showed that a temperature 
sensitive iptA mutant is completely defective in LPS export (Ma et aL, 2008). These 
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results indicate that LptA and B are both essential for E. cob. Another recent study 
showed that LptA is a periplasmie lipid A-specific binding protein (Tran et at, 2008). 
Tran and co-workers suggest that to transport the lipid A to the outer membrane LptA 
and B work together with LptC, F and U as an "ATP-transporter" (Fig. 5). It is 
believed that LptB provides energy by hydrolysing ATP and LptB/F/G and possibly 
LptC release the LPS molecule from the inner membrane. Thereafter LptA binds lipid 
A and functions as a chaperone to transfer the LPS across the periplasm. Outer 
membrane proteins LptD and LptE then flip the LPS to the outer leaflet of the 
bacteria. 
1.4.3 Lipopolysaccharide modification systems 
Microbes have evolved various ways to evade the mammalian immune system as well 
as escape the pressure of antibiotic therapy. These avoidance/resistance strategies 
have been shown to be directly linked to their ability to covalently modify their lipid 
A core and outer structure. In most Gram-negative bacteria, for example E. coil and 
Salmonella typhimurium, a majority of these modifications are controlled by the 
TCSs PhoP/Q and PmrAIB. 
A TCS consists of an inner membrane bound histidine kinase (PhoQ or PmrB) with 
an external loop to sense the periplasm, and a cytoplasmic response regulator (PhoP 
or pmrA) (Gunn, 2008). PmrA/B can be activated by PhoP/Q, but can also induce 
modifications independently (Soncini, 1996). Interestingly, Francisella tularensis 
pmrA exists as an orphan gene without a co-transcribed pmrB locus, but is still able to 
control modifications (Mohapatra et at, 2007). These systems can be activated by 
growth of the bacteria in, for example, high Fe3t low Mg2 and acidic pH (Groisman 
et at, 1997; Wosten et at, 2000). 
Under repressed conditions, for example high Mg  2+  and neutral pH, the acidic 
residues of the histidine kinase periplasmic sensor domain are bound to Mg2 or other 
divalent cations. However, under acidic conditions or under Mg 2+  limited conditions, 
it is thought that the lack of divalent cations bound to the sensor domain triggers a 
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conformational change where a conserved histidine is autophosphorylated and the 
phosphate is transferred to a conserved aspartate in the N-terminus of the response 
regulator, which then binds to specific recognition sites at promoters of regulated 
genes (Bader et a)'., 2005; Gunn, 2008). These genes can modify the lipid A by 
adding positively charged L-Ara4N, phosphoethanolamine (PET) and/or 
adding/removing fatty acyl (FA) chains depending on growth conditions. 
Acidic pH and a Mg 2+  limiting environment are thought to be present inside 
macrophages, and it has been speculated that Salmonella have evolved to modify its 
LPS to be able to reside within macrophages. It has recently been shown that S. 
typhimurium grown inside RAW264.7 macrophages in the presence of 32P, produced 
labelled lipid A that was extensively modified with L-Ara4N, PET, 2-
hydroxymyristate and/or palmetate moieties (Gibbons et al., 2005). 
Bader and colleagues recently provided evidence that PhoQ can be directly activated 
by AMPs (Bader et al., 2005). They propose that AMPs bind to the phosphate groups 
of the lipid A by displacing divalent cations to interact with the acidic residues of 
PhoQ. Bader et al showed that AMPs can displace divalent cations at low and 
intermediate Mg 2+  levels, but not at high concentrations, suggesting that AMPs have 
evolved to compete with the divalent cations of the bacterial outer membrane. 
However, when the phosphate groups of lipid A are modified with, for example, 
positively charged L-Ara4N or PET, AMPs can no longer interact with PhoQ, 
rendering the bacteria resistant. 
These modifications may also help control the electrostatic interactions of the outer 
membrane that would be disrupted upon depletion of divalent cations, that would 
normally bridge neighbouring negatively charged molecules (Bader et al., 2005) 
Under Mg  2+ conditions, modifications of the outer membrane allow the 
normally LPS-bound Mg 2+  to be used for other cellular needs. 
In contrast to enteric bacteria, it is possible that environmental non-pathogenic, or 
opportunistic bacteria, that would not have encountered AMPs of the immune system, 
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have evolved to adapt to low Mg  2+  in aquatic environments, or high Fe 3+  and 
aluminium concentrations in the soil, and are therefore able to resist AMPs. In 
addition, Paenibacillus polymyxa, the producer of the cyclic AMP PMB (Paulus & 
Gray, 1964), is a soil bacterium suggesting a need for other soil organisms to develop 
resistance to harmful secreted natural products. 
Different bacteria have evolved to modify their lipid A in different ways, some of 
which are shown in Fig. 6. 
The addition to positively charged L-Ara4N residues to the 1 or 4' phosphate position 
of the lipid A glucosamine disaccharide is associated with AMP resistance in many 
Gram-negative bacteria. In contrast, PET addition only appears to play a role in 
resistance in some pathogens, particularly those unable to synthesise L-Ara4N, for 
example N meningitides (Tzeng et at, 2005). Modification by PET is most probably 
involved in membrane stability, but does contribute to AMP resistance to some 
extent. 
There are 6 different putative PET transferases encoded in E. coli (Raetz & Whitfield, 
2002), and three of these have been identified. These catalyse the transfer of PET to 
the 1 and 4' phosphates (by EptA), the distal Kdo molecule (EptB) and on heptose 
sugars (CptA) of the core (Kanipes et at, 2001; Lee et al., 2004; Reynolds et at, 
2005; Tamayo et at, 2005; Trent & Raetz, 2002). EptA has been shown to be 
regulated by PhoP/Q, however, EptB is induced by high Ca2 concentrations, and 
cptA is constitutively expressed. Knocking out eptA has no significant effect on AMP 
resistance in Salmonella, but that could be because L-Ara4N is still produced in these 
mutants. Knocking eptB out in a deep-rough E. coli strain WBB06 results in 
hypersensitivity to Ca2t which could be suppressed by excess Mg2 (Reyno1ds et at, 
2005). This shows-that modification of the Kdo by PET is protective in a heptose 
deficient mutant, and that PET modifications in E. coli and Salmonella could play a 
major role in membrane permeability and serum resistance, as serum contains around 
1 mM Ca2t 
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Fig. 6: Lipid A modifications in various Gram-negative bacteria. Blue structures can be added, and green structures 
removed, by various modification enzymes, shown in orange. The Ko of Burkholderia cenocepacia is shown in red. 
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Many species-specific peculiarities have been observed. For example, N. meningitidis 
lipid A is heavily modified with PET and is intrinsically resistant to AMPs even 
though it is unable to produce L-Ara4N, indicating a role for PET in AMP resistance 
in this organism (Tzeng et at, 2005). It is unclear how these PET modifications are 
regulated. 
Rhizobium leguminosarum, F. tularensis and H. pylori can remove a phosphate group 
instead of modifying it with positively charged groups (Karbarz et at, 2003; Price et 
at, 1995; Tran et at, 2006; Vinogradov et all, 2002). LpxE removes the 1 phosphate 
and LpxF the 4' phosphate. In H pylon, removal of the 1 phosphate is followed by 
the addition of PET directly to the C-i of the glucosamine (Tran et at, 2004). 
Knocking LpxE out resulted in complete sensitivity to PMB indicating the need for 
dephosphorylation before PET addition (Tran et al., 2006). 
Some organisms can modify their lipid A with molecules other than PET and L-
Ara4N. For example Leptospira interrogans methylates the I phosphate using S-
adenosyl methionine (SAM) (Boon Hinckley et at, 2005), and F. tularensis adds a 
galactosamine on the 1 phosphate and can add mannose directly to the 4'-C 
(Kanistanon et al., 2008). R. leguminosarum lacks both phosphate groups and 
sometimes adds galacturonic acid on the 4'-C and the distal Kdo (Kanjilal-Kolar et 
at, 2006; Kanjilal-Kolar & Raetz, 2006). 
Many Gram-negative bacteria also modify their lipid A by adding or removing fatty 
acyl chains. The number and length of FA chains are important for both membrane 
stability and immuno-stimulation. For example, an increase in amide-linked acyl 
chains could provide further stability to the outer membrane under harsh conditions. 
Salmonella and E. coli will normally add palmitate (C16) by the PhoP/Q-induced 
palmitoyl-transferase PagP (Bishop et all, 2000). Salmonella can also induce the 
esterase PagL which removes the 3-0-acyl chain (Kawasaki et at, 2004), and under 
conditions of high Ca2 , induce the deacylase LpxR which hydrolyses off the 3'-0-
acyloxoacyl residue of lipid A (Reynolds et at, 2006), possibly to evade recognition 
by the immune system. Many organisms have evolved to produce under-acylated LPS 
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to evade an immune response. For example, H. pylori and F. tularensis mostly have 
tetra-acylated LPS (Shaffer et al., 2007; Stead et al., 2008). 
Interestingly, Pseudomonas aeruginosa has been shown to change its PA 
modification of its lipid A during CF infection (Ernst et al., 2006). Environmental 
strains or strains from early/mild infection have penta or hexa-acylated LPS. Under 
these conditions PagL removes the 3-OH C10. However, this deacylase activity is lost 
during severe CF infection and hexa or hepta-acylated LPS is produced, increasing 
the inflammatory properties and causing more damage to the lung. This hepta-
acylated CF LPS can be re-produced outside the CF lung by culturing the bacteria 
under Mg  2+  limiting conditions (Ernst et at, 2006). 
A contradictory example to the theory that lipid A with fewer FAs are less immuno-
stimulatory is Bcc LPS. Only penta or tetra-acylated Bcc LPS has ever been isolated, 
which is still highly immuno-stimulatory (De Soyza et at, 2008; lerano et at, 2008; 
Silipo et al., 2005; Silipo et al., 2007). 
Lipid A modifications are important for the bacteria to survive, but additional core 
and 0-antigen modification can also contribute. Deep-rough mutants of E. coil are 
hyper-sensitive to AMPs and detergents, and a heptose-less B. cenocepacia mutant 
SAL-1 is not sensitive, but significantly less resistant to PMB (Loutet et al., 2006), 
indicating a protective role for the core. In E. coil these heptose sugars of the core can 
be further phosphorylated by WaaP and WaaY (Yethon et at, 1998). Addition of 
these negative charges on the inner core allows bridging of neighbouring LPS 
molecules by divalent cations, resulting in less fluid and more stable membrane. 
PnnA has also been shown to regulate resistance to complement killing by increasing 
0-antigen (Delgado et at, 2006). 
Interestingly, members of the Bcc and Raistonia sp. do not phosphorylate their core 
(Zdorovenko et at, 2008). Instead, the Bcc are extensively decorated with L-Ara4N 
(De Soyza ci' at, 2008; Gronow et at, 2003; Silipo et at, 2007) which has been 
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shown to be not only essential for resistance but uniquely also for survival (Ortega et 
at, 2007). 
1.4.4 Aminoarabinose biosynthesis 
L-Ara4N modification is an important resistance mechanism in many Gram-negative 
bacteria, and is directly associated with protection from AMP killing. In the majority 
of bacteria, for example E. coil and Salmonella, this resistance mechanism is 
regulated by PmrAB and can be switched on or off by various stimuli; however, some 
bacterial species, such as members of the Bee, are constitutively modified with L-
Ara4N and inherently resistant to AMPs. 
In E. coli and Salmonella, the genes encoding the L-Ara4N biosynthetic enzymes are, 
with the exception of Ugd, found in an operon divided into two transcriptional units: 
arnBCAD/arnTFE (Fig. 7; (Breazeale et al., 2002; Gunn et al., 1998)). This locus 
was originally named the pmr locus because of its link to PMB resistance, but is now 
referred to as the arn locus due to its role in L-Ara4N biosynthesis. Homologues of 
these genes have been identified in the B. cenocepacia J2315 genome, however, the 
genetic organisation of the main locus is different, with the genes transcribed: 
amnTG/amnBCAjA2D (Fig. 7; (Ortega et at, 2007)). 
In E. coli and Salmonella, L-Ara4N biosynthesis (Fig. 7; (Raetz et at, 2007; Yan et 
at, 2007)) begins with the oxidation of UDP-glucose to UDP—glucuronic acid by 
UDP-glucose dehydrogenase (Ugd). The C-terminal domain of AmA then catalyses 
the oxidative carboxylation of UDP-glucuronic acid to UDP-4-ketopenose (Breazeale 
et al., 2002), which is converted to UDP-13-L-Ara4N by the transaminase ArnB 
(Breazeale et at, 2003). Then the N-terminal domain of AmA uses N-b-
formylterahydrofolate to N-formylate UDP-13-L-Ara4N, which is selectively 
transferred to undecaprenyl phosphate (Upp) by ArnC (Breazeale et at, 2005). The 
Upp-L-Ara4-formyl-N is deformylated by ArnD, and the product Upp-L-Ara4N is 
then flipped across the inner membrane by the heterodimeric flippase ArnE/F (Yan et 
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all, 2007), and the L-Ara4N is finally transferred from the Upp-L-Ara4N to lipid A 
by the L-Ara4N transferase AmT(Trent et all, 2001). 
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Fig. 7: Aminoarabinose biosynthesis (Yam et al., 2007; Ortega et aL, 2007). (A) Proposed 
aminoarabinose biosynthetic pathway of E. co/i (blue/black) vs. Bce (red/black): (B) genetic 
organisation of the am locus of non-Burkholderia species vs. Burkholderia species. 
None of these enzymes have been characterised in Burkholderia, although in slilco 
analysis suggests a similar pathway, but with some differences (Fig. 7). For example, 
AmA, which is a bifunctional enzyme in E. coil, appears to be two separate enzymes 
in B. cenocepacia, ArnAl and 2. In addition, it is likely that the flippase, which is a 
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Fig. 8: Effect of conditional mutagenesis of the arn gene cluster (Ortega et aL, 2007). (A) Conditional 
lethal phenotype of strains XOAI 1 and X0Al2 on M9 agar plates supplemented with 0.5% (w/v) 
rhamnose or 0.5% (w/v) glucose; (B) Transmission electron microscopy of strains K56-2, XOAI I, and 
XOAI2 after 8 h under non-permissive conditions. 
In E. coli and Salmonella, knock outs of any of the above genes results in loss of 
resistance to PMB (Gunn et at, 1998; Yan et at, 2007). To prove the involvement of 
the arn locus in B. cenocepacia in AMP resistance, insertional inactivation attempts 
were carried out but none of the knock out strains survived (Ortega et at, 2007). To 
investigate this further, Ortega and colleagues (in a collaboration between the 
Valvano, Govan and Campopiano laboratories) created conditional mutants of B. 
cenocepacia K56-2 by inserting a rhamnose inducible promoter upstream of AmT 
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(XOA1 1) and ArnB (X0Al2). Under permissive conditions (in presence of 
rhamnose), where the promoter is induced to transcribe the gene, the mutants behaved 
like wild type, but under non-permissive conditions (in presence of glucose), where 
the gene is not expressed, the conditional mutants displayed a significant loss in 
viability along with visible cell envelope defects (Fig. 8). Uniquely, this indicates that 
L-Ara4N synthesis is essential for viability of B. cenocepacia and provides an 
important potential Achilles heel for improved treatment of Bce infections. 
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1.5. Aims 
1.5.1 Exopolysaccharide investigation 
Since the first description of pathogenicity of the Bee was based on sour skin rot of 
onion bulbs, initial studies focused on growth on onion tissue extracts to investigate 
the "natural phenotype" of these organisms. Many strains of the different Bee species 
are capable of infecting onions, some causing a stinky brown rot whereas others 
produce a colourless, slimy pathophysiology. To investigate the ability to grow on 
onions, "onion agar" was created by adding a homogenised, filtered onion extract to 
bacteriological agar. Interestingly, all strains tested were able to grow when this plant 
substrate was provided as the sole nutrient; in addition, many Bee isolates, previously 
classified as nonmucoid, produced copious amounts of EPS. 
The aim of this section was to investigate EPS production in all species of the Bee in 
response to the onion substrate; to identify the onion component that induced the 
mucoid phenotype; and investigate the involvement of putative EPS gene clusters. 
1.5.2 Lipopolysaccharides and AMP Resistance 
1.5.2.1 Lipopolysaccharide extraction and analysis 
The LPS from the Bee is chemically and biologically unusual. It has a tetra or penta 
acylated lipid A which has Kdo-Ko attached at position 6 of the distal glucosamine, 
and Ara4N attached to one or both phosphates and to the Ko. In addition, it has a non-
phosphorylated core. Its structure would suggest that Burkholderia LPS should not be 
immuno-stimulatory; however, LPS from members of the Bee have been shown to be 
as immuno-stimulatory as E. coli LPS (De Soyza et al., 2004; Zughaier et al., 1999). 
Since the chronic inflammation in the airways is a main problem in CF infections, 
understanding the unique character of Bee LPS is important. 
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Our overall goals of this thesis were to characterise the unusual chemical and 
biological properties of the LPS from the Bee. The aim in this section was to isolate 
smooth, rough and deep-rough LP S of B. cenocepacia ET-12 strains and analyse 
them by gel electrophoresis and different staining methods. 
1.5.2.2 UDP-glucose dehydrogenase 
Uniquely, amongst Gram-negative bacteria, the enzymes of the L-Ara4N biosynthetic 
pathway are essential for B. cenocepacia viability, which suggests these enzymes 
could be potential targets for specific antimicrobial agents 
The synthesis of UDP-L-Ara4N begins with the conversion of UDP-glucose to UDP-
glucuronic acid catalysed by the enzyme UDP-glucose dehydrogenase (Ugd). Two P. 
aeruginosa Ugd enzymes were recently characterised and shown to be involved in L-
Ara4N and EPS biosynthesis (Hung et al., 2007). The authors suggest Ugd as a 
potential drug target which will decrease the organism's impermeability and hence 
provide access to other drugs. 
The genome of B. cenocepacia J2315 contains three predicted ugd genes: ugdncAL2946, 
ugdBcAMo855 and ugdBcAM2034. In collaboration with Slade Loutet (University of 
Western Ontario, London, Canada) these three ugd genes were each insertionally 
inactivated to generate independent mutant strains. Only inactivation of ugdBcAL2946 
resulted in increased sensitivity to polymyxin B. This sensitivity could be overcome 
when either ugdBcAL2946 or ugdBcAMosss but not ugdBcAM2034 were expressed from 
plasmids. A conditional ugdBcAL2946 mutant was created in a z1ugdBcAMo855 
background, and under repressive conditions, growth of the conditional mutant was 
significantly impaired; however, growth could be rescued by either ugdBcAL2946 or 
ugdncAMo855, but not ugdBcAM2034, expressed in trans (Loutet et aL, 2009). 
The aim of this section was to purify and biochemically characterise the three 
- 
putative Ugd enzymes and investigate their Ugd activity in vitro. 
- 
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1.5.2.3 Aminoarabinose transferase 
The last enzyme of the L-Ara4N biosynthetic pathway is the inner membrane protein 
aminoarabinose transferase, ArnT, which catalyses the transfer of L-Ara4N from 
undecaprenyl phosphate to the lipid A. There is only one clear putative ArnT in the B. 
cenocepacia J2315 genome rendering this enzyme a good drug target. 
In this part of the work, the aim was to clone, express and purify recombinant B. 
cenocepacia ArnT. In addition, it was hoped to biochemically characterise this 
important Bcc enzyme. 
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2.1. Materials 
2.1.1 Solutions and Buffers 
Polymyxin B stock (10 mg ml'): one hundred mg polymyxin B sulfate (Calbiochem) 
was dissolved in 10 ml dH20 and filter-sterilised through a 0.2 j.xm filter (Micropore). 
Final Polymyxin B concentrations are specified in different methods. 
Trimethoprim stock (50 mg ml'): one hundred mg trimethoprim (Sigma) was 
dissolved in 2 ml DM50 and filter-sterilised through a 0.2 gm filter. Trimethoprim 
was used at a final concentration of 50 jig unless otherwise stated. 
Tetracycline stock (5 mg ml'): 50 mg tetracycline (Sigma) dissolved in 10 ml 70% 
(vlv) ethanol and filter-sterilised through a 0.2 jim filter. Tetracycline was used at a 
final concentration of 25 jig ml' unless otherwise stated. 
Gentamycin stock (50 mg ml'): 500 mg gentamycin (Sigma) dissolved in 10 ml 
dH20 and filter-sterilised through a 0.2 jim filter. Gentamycin was used at a final 
concentration of 50 jig ml' unless otherwise stated. 
Kanamycin stock (30 mg ml"): 300 mg kanamycin (Sigma-Aldrich) dissolved in 10 
ml dH20 and filter-sterilised through a 0.2 jim filter. Kanamycin was used at a final 
concentration of 30 jig ml' unless otherwise stated. 
Ampicillin stock (100 mg ml'): one gram ampicillin sodium salt (Fluka-
BioChemika) dissolved in 10 ml dH20 and filter-sterilised through a 0.2 jim filter. 
Ampicillin was used at a'f,nal concentration of 100 jig ml' unles otherwise stated. 
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IPTG (isopropyl-P, D-thiogalactopyranoside; Apollo Scientific LTD): a 100 mM 
stock solution was prepared and filter-sterilised through a 0.2 jim filter. It was stored 
at 2-8 °C and used at a final concentration of 1 mM unless otherwise stated. 
SDS (sodium dodecyl sulfate) sample buffer (2x): one ml of 1.5 M Tris (Trizma 
Base, Sigma), pH 8.0, 2 ml 100% (v/v) glycerol (Fisher Scientific), 2 ml 0.05% (w/v) 
bromophenol Blue (Sigma), 1.6 ml 10% (w/v) SDS (Sigma) and 0.4 ml fi-
mercaptoethanol (Sigma) were mixed and stored at room temperature. 
SDS running buffer: 1xTGS buffer was made up in dH20 (10 x stock, Bio-Rad) 
containing 25 mM Tris, pH 8.3, 192 mM glycine and 1% (w/v) SDS. 
SDS stain: one gram Brilliant Blue R250 (Sigma), 400 ml methanol (Fisher 
Scientific), 100 ml acetic acid (Fisher Scientific) and 500 ml dH20 were mixed and 
stored at room temperature. 
SDS destain: 400 ml methanol, 100 ml acetic acid and 500 ml dH20 were mixed and 
stored at room temperature. 
TAE (Tris-Acetic acid-EDTA): 1xTAE buffer was made up in dH20 (50 x stock, 
Bio-Rad) containing 40 mM Tris-HC1, 20 mM acetic acid and 1.0 M EDTA, adjusted 
to pH 8.3. 
Ethidium Bromide (Sigma): a stock solution of 10 mg ml-1 was made up in dH20, 
and used at a final concentration of 5 jig m1 1. The solution was stored at 2-8CC. 
Saline: eight and a half grams of NaCl was dissolved in I litre dH20 and sterilised by 
autoclaving at 121 ,C for 15 minutes. 
Transfer buffer (Western Blot): 25 mM Tris (Sigma), 150 mM glycine (Fisher 
Scientific), 10% (vlv) methanol (Fisher Scientific) in dH20 
41 
Chapter 2: General Materials and Methods 
PBS (phosphate buffered saline): One phosphate buffered saline tablet (Dubelco A, 
Oxoid) was dissolved in 100 ml dH20 and autoclaved at 121 'C for 15-20 minutes. 
Binding buffer: 20 mM Tris (Sigma), 500 mM NaCi (Fischer Scientific), 5 mM 
Imidazole (Sigma), pH 7.5 in dH20. 
Blution buffer: 20 mM Tris, 500 mM NaCl, 500 mM Imidazole, pH 7.5 in dH20. 
2.1.2 Media 
All liquid media and solid agars were autoclaved at 121 'C for 15-20 minutes. 
Nutrient agar (NA): 15.6 g Columbia based agar (Oxoid) was dissolved in 1 L dH20. 
Nutrient broth (NB): 25 g Nutrient Broth No2 (Oxoid) and 5 g yeast extract (DIFCO 
Laboratories) was dissolved in 1 L dH20. 
Pseudomonas isolation agar (PTA): 45 g of Pseudomonas isolation agar (Difco) was 
dissolved in 1 L of dH20 containing 20 ml of glycerol. 
Isosensitest agar (ISA): 31.4 g Isosensitest agar (Oxoid) was dissolved in I L dH20. 
Isosensitest broth (ISB): 23.4 g Isosensitest broth (Oxoid) was dissolved in I L 
d1120. 
Luria Bertani (LB) agar: 35 g LB agar (Sigma) was dissolved in 1 L dH20. 
LB broth: 10  Bacto tryptone (Biogene), 5 g yeast extract (Fluka-BioChemika), 10 g 
NaCl (Fisher Scientific) was dissolved in 1 L dH20 and adjusted to pH 7.5. 
2YT broth: 16 g peptone, 10 g yeast extract and 5 g NaCl was dissolved in 1 L dH20 
and adjusted pH to 7.5. 
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S-Gal/LB/Amp plates: a pack of SGalTM/LB  Agar Blend (Sigma) was dissolved in 
500 ml dH20. After autoclaving, ampicillin was added just before pouring the plates. 
SOB (super optimal broth) medium: 20 g Bacto Tryptone (Biogene), 5 g Bacto 
Yeast Extract (Fluka-BioChemika) and 0.5 g NaCl (Fisher Scientific) was dissolved 
in 1 L dH20, adjusted to pH 7.5. After autoclaving, 2.5 mM KC1, 10 mM MgC12 and 
10 MM MgSO4 was added. 
SOB agar: 20 g Bacto Tryptone (Biogene), 5 g Bacto Yeast Extract (Fluka-
BioChemika) and 0.5 g NaCl (Fisher Scientific) was dissolved in 1 L dfl20, adjusted 
to pH 7.5, then Bacteriological Agar (Oxoid) was added at 1.5% (w/v). After 
autoclaving, 2.5 mM KC1, 10 MM MgCl2 and 10 mM MgSO4 was added. 
SOC (SOB with catabolite repression) medium: 20 g Bacto tryptone, 5 g yeast 
extract, 2 ml SM NaCl, 2.5 ml 1M KC1 (Fisher Scientific), 10 ml 1 M MgCl2 (Fisher 
Scientific), 10 Jul 1M MgSO4 (Fisher Scientific), 20 ml 1 M glucose (Fisher 
Scientific), in 1 L dl-I20, adjusted to pH 7.5. 
2.1.3 Instruments 
DNA thermal cyclers for PCR amplification (Techne/Techgene, Applied Biosystems 
or Perkin Elmer), gel tanks for SDS-PAGE and DNA gel electrophoresis (Bio-Rad, 
Flowgen, Anaehem), centrifuges (DuPont Instruments, Denley), FPLC: Akta 
Basicl0O (Amersham Biosciences), Cary 50 UV-Vis spectrophotometer (Varian), 
multipoint inoculator (Denley), sonicator (Soniprep 150) and electroporator 
(EasyjecT Plus, EQUIBJO, Flowgen), freeze drier (Edwards), rotary evaporator 
(BUchi B-480), heating block (Grant Instruments Ltd), sonicator bath (Sonicor). 
2.1.4 Bacterial Strains and plasmids 
All E. coli strains and plasmids used in this study are specified in Table 3. 
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Table 3: E. coil strains and plasmids. 
Strain name Relevant characteristics Source/Reference 
JM109 endAl, recAl, gyrA96, th4 hsdRl7 (rk, mk*), re/Al, Promega 
supE44, A( lac-proAB), [F' traD36,proAB, 
lagPZAM151  
ToploTM F- mcrA A(mrr-hsdRMS-mcrBC) cp80lacZaM15 Invitrogen 
AlacX74 recA 1 araD 139 tx(araleu) 7697 galE galK 
rpsL (StrR) endAl nupG  
DH5u F- p80/acZAM 15 L\(/acZYA-argF)U 169 recA 1 endA 1 Jnvitrogen 
hsdRl7(rk-, mk+) phoA supE44 tin-i 8yrA96 relAl A-  
F1MS174 DE3) K-12 derivative, V recAl hsdR(rxj/ mKI2) (DE3) Novagen 
(Rif)  
BL21 (DE3) B834 derivative, F ompThsdS8(r5 mj7 gal dcm Novagen 
(DE3)  
BLR (DE3) 8L2 I derivative F ompT hsdS(rj in11 ) gal dcm (DE3) Novagen 
a(srl-recA)306: Tn] 0 (TetR)  
Rosetta (DE3), BL2 1 derivative , F ompT hsdS(r m0 ) gal dcm (DE3) Novagen 
pRARE (CamR)  
C41 (DE3) BL2 1(DE3) derivative F ompT hsdS8 (rB ma) gal dcm (Miroux & Walker, 
(DE3) 1996) 
C43 (DE3) C41 (DE3) derivative, expressing F-ATPase gene (Miroux & Walker, 
1996) 
GillS rmcrA A(mrr-hsdRMS-mcrBC) 801acThM15 InvivoGen 
ó.1acK74 recAl endAi Ac/cm, uiad(Mlul)::pir-1]6, 
sbcC-s beD  
MG 1655 K-12 wild type, F, lambda-, rph-1 Coli Genetics Stock 
Centre 
W8806 W3 110 K-12 derivative ö(rfaCF)::teta (Brabetz et al., 1997) 
A 10 W3110,pmrAC,  AarnT::kan, (Kan) (Yan et al, 2007) 
Plasmid name Relevant characteristics Source/Reference 
pGEM T-Easy Cloning vector; Apr Promega 
pET28a Expression vector, Kan K Novagen 
pET22b Expression vector, Amp' Novagen 
pTrc99a treP vector, lacP, pUC 18 .EcoRI-Hindlll polylinker 
region, Amp"  
(Amann et al, 1988) 
pRK2013 RK2 derivative, Kmr  mob tra ColE 1 (Figurski & llelinski, 
1979) 
pDA-17 orzpBBR1, Tet"', mob+, Pdhfr, FLAG epitope (Flannagan et aL, 
2007) 
pSCRhaB3 or4anR, rhaR rhaS P haB TpT mob (Cardona & Valvano, 
2005) 
pGPQTp oriR6K, cTpr cassette, mob (Ortega et aL, 2007) 
All Bee isolates are from the Edinburgh CF Microbiology Laboratory strain 
repository, unless otherwise specified. Strain names and sources are specified further 
for each method below. 
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2.2. Molecular biology: Competent cells 
2.2.1 chemically competent cells prepared by the cad 2 method 
One hundred ml of LB broth, supplemented with appropriate antibiotics, was 
inoculated with 1 ml of overnight culture and grown at appropriate temperatures to 
an 0D600 of 0.6. They were then cooled down quickly on ice, and transferred to a 
pre-cooled falcon tube and pelleted at 6000 x g for 10 minutes at 4 °C. The pellet 
was resuspended in ice cold 10 mM Tris (pH 8.0) with 50 mM NaCl and pelleted 
again. The pellet was resuspended in half the original volume of 30 mM CaCl2 and 
incubated on ice for 20 minutes. The cells were pelleted and finally resuspended in 
one twentieth of the original volume of 30 mM Cad 2. The cells were prepared in 
200 p,l aliquots and frozen in liquid nitrogen to be stored at -80 °C. 
2.2.2 Electro-competent cells 
Two hundred ml of 2YT broth, supplemented with 5 mM CaCl2 and appropriate 
antibiotics, was inoculated with 2 ml of overnight culture. The cells were grown at 
appropriate temperatures until an 0D500 of 0.6. They were then cooled down quickly 
on ice, and transferred to a pre-cooled falcon tube and pelleted at 6000 x g for 10 
minutes at 4 °C. The pellet was washed 3 times in ice cold sterile dH20. The pellet 
was transferred to a 10 ml falcon tube and washed with sterile dH20 containing 10 % 
(v/v) glycerol. Finally, the pellet was resuspended in an equal volume of sterile dFI20 
containing 10 % (v/v) glycerol. Aliquots of 200 p1 were prepared and frozen in liquid 
nitrogen to be stored at -80 CC. 
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2.3. Molecular biology: DNA manipulation 
2.3.1 Alkaline lysis extraction of bacterial chromosomal DNA 
Two to three bacterial colonies were scraped from a plate and mixed into 20 p1 lysis 
buffer (2.5 ml 10% (wlv) SDS (Sigma), 5 ml 1 M NaOH (Fisher Scientific), 92.5 ml 
MilliQ H20) in an Eppendorf tube, then heated to 95 C for 15 minutes. After a quick 
spin in a centrifuge, 180 p1 milliQ water was added. It was centrifuged for 5 minutes 
at 10 000 x g, then stored at —20 °C. 
2.3.2 Polymerase chain reaction (PCR) amplification 
All primers used in these studies were purchased from SigmaGenosys and are listed 
in Table 4. PCR reagents, programmes and the instruments used are described in the 
relevant methods. 
Table 4: Primers used in this study. 
General Primers Primer Sequence 5'-3' 
BCR1 TGACCGCCGAGAAGAGCAA 
BCR2 CTCTTCTTCGTCCATCGCCTC 
BCRG3A 1 GCTCGACOTTCAATATGCC 
BCRG3A2 TCGAGACGCACCGACGAG 
BCESM 1 CCACGGACGTGACTAACA 
BCESM 2 CGTCCATCCGAACACGAT 
eblA 1 CCAAAGGACTAACCCA 
cblA 2 ACOCGATGTCCATCACA 
Sequencing pCR2. 1 For CAGCAAACAGCTATGAC 
Sequencing pCR2. I Rev GTAAAACGACGGCCAG 
Sequencing pGEM For TAATACGACTCACTATAGGG 
Sequencing pOEM Rev ATTTAGGTGACACTATAGAA 
Sequencing pET For TTAATACGACTCACTATA000 
Sequencing pET Rev CTAGTTATTGCTCAGCGGT 
1112.  
Chapter 2: General Materials and Methods 
Table 4 continued... 
Chapter 3 Primers Primer Sequence 5' - 
Bamb 5549 For CGCAGCCAGAAGATACAGGT 
Bamb5 549 Rev TCGAGCGTGTAGAGCTTGC 
Bamb 3621 For TCGTCGCACAGCAOCATT 
Bamb 3621 Rev CACTTCGCCGTCCAGATAGA 
bceB Al lbp For TGAAGGCGGTSGCGATCGTC 
bceB Al lbp Rev TCOATSCGCACGTCGTCGAG 
bceB short For (Ndel) AGCCA TA TGTTGAGCGTGCTGGCGAGAGTCATGAT 
bceB long For (Ndel) CA TA TGCGGCACGGGCTGCACAAGGAGCTGTTCGG 
bceB no stop Rev (fbI) TAATGCTCGAGGTACGCGTTGCTGCCGGTGAAGC 
bceB 6 His Rev (Xbal) TCTAGACAACTCAGCTTCCTTTCGGGCTTTGTTAGC 
KO bceB For (xbal) TCTAGAGTTCGGCAAACGCCTGTTCAAAGA 
KO bceB Rev (EeoRJ) GAATTCCCGACTGOTGAAAGCTGAAACTCATC 
RSF 1300 TAACGGTTGTGGACAACAAGCCAGGG 
webO For ATGAGTCGTTCTTTCCTTGC 
wcbO Rev ACATGCTTGCOTTGOTCG 
Chapter 4 Primers Primer Sequence 5'-3' 
arnT For C-term His (Neol) GGCTC3AAAACCCATGGACGATACGCCGTCG 
arnT Rev C-term His (fbI) UGOAOGCGCTCGAGCGATTGCGGTTTCTCG 
arnT For N-term His (Ndel) ACAACCAACAGGCTGAAAACATATGAACGA 
arnT Rev N-term His (fol) GGGTTCATGCTCGAGGCQTCCTTACGATTG 
arnT Ntermó His Forl (Neol) AGAAGGAGATATACCA TGGGCAGCAGCCAT 
arnT Nterm6 His For2 (EcoRI) ACTTTAAGAAGGAGAA TTCCCATGGGCAGCAG 
arnT Nterm6 His Rev (Hindlll) CTCGAGGCAAGCTTACGATTGCGGTTTCT 
arnT Cterm6llis Rev (Hindlll) AAGCTTITGTTAGCAGCCGGATCT 
pmrK For CTGACGTTCGCGTGGTTC 
pmrK Rev GGCCCATCAGGTTCCAGT 
ugd bca12946 For (Ndel) AGTACCGGAACACA TATGAAAATCACCATC 
ugd bca12946 Rev (BamHI) TCGCGAAGAGGATCCATCGTAGGTTCAGCC 
ugd bcam0855 For (Ndel) AGGGGTCCGACACA TATGAATCTGACTATC 
ugd bcam0855 Rev (fol) CTCGAGTGACGGAAAACGGGTTACGCGCTG 
ugd bcam2034 For (Ndel) GTCACAAGCCACCCAGGGGAACACATATGA 
ugd bcam2034 Rev (BamHI) TCAAGGTCGGA TCCFCAGTGCTGAAGCAG 
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2.3.3 Gel electrophoresis of DNA 
To prepare a 1% (wlv) agarose gel, I g agarose (Fisher Scientific) was added to 100 
ml 1xTAE buffer and heated in a microwave until totally dissolved. The solution was 
cooled to ca 60 °C before the addition of ethidium bromide. The gel was poured into 
a casting mould and allowed to set at room temperature. Alternatively, precast 1.2 or 
4 % E-gels (Invitrogen) were used. 
The PCR products were prepared by adding 5x loading buffer (Bioline) and were 
then added to the wells, alongside either a I kb Plus DNA ladder (Invitrogen), 50 kb 
DNA ladder (Invitrogen) or Hyperladder I (Bioline). The gel was run at 100 V until 
markers showed sufficient separation, or according to manufacturers' instructions for 
the E-gels. The bands were visualised using a UV lamp (Uvitec) or a Gel Doc (Bio-
rad). 
DNA purification from the agarose gel was carried out following a QlAprep® Gel 
Extraction kit from Qiagen. 
2.3.4 Cloning 
Three p1 gel purified PCR product was ligated with 1 p1 pGEM® T-Easy in 5 p1 2x 
ligation buffer and 1 p1 T4 DNA ligase (Promega). It was left overnight at 4 °C or for 
3 hours at room temperature. 
Two utl of the ligated product was then transformed into 50 p1 E. coli JM109 cells. 
After the cells had defrosted on ice, the ligation product was added and incubated on 
ice for 30 minutes. The mix was then heat shocked at 42 ,C for 30 s, then put back on 
ice for 2 mm. To this, 250 p1 SOC media was added and the cells were grown for 1 
hour at 37 C with shaking at 200 rpm. The cells were spread on S-Gal/LB/Amp 
plates and incubated at 37 °C over night. 
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Viable (white) colonies were picked, based on blue/white screening, into LB/Amp 
broth and grown overnight at 37 at 200 rpm. 
Plasmid DNA purification from the overnight cultures was carried out using a 
QlAprep® Spin Mini-Prep kit from Qaigen according to the manufacturer's 
instructions. 
2.3.5 Restriction Digests 
The restriction enzymes used in this study were: EcoRT, Ncol, Ndel, flaT, Hindlll, 
BamHI, Haelll and Xhol (all purchased from New England Biolabs, NEB). 
For a small scale restriction digest, 8 jil DNA was mixed with 0.5 R' of each 
restriction enzyme required and 1 R1  10 x buffer relevant to the restriction enzymes 
used. The mixture was incubated at 37 t for 3 hours, then analysed by agarose gel 
electrophoresis. 
For a large scale restriction digest, 43 Al of plasmid DNA was mixed with 1 jfl of 
each restriction enzyme required and 5 p1 10 x buffer relevant to the restriction 
enzymes used. After incubation at 37 °C for 3 hours the samples were analysed by 
agarose gel electrophoresis followed by a gel extraction. 
2.3.6 DNA Sequencing 
The DNA sequencing of clones was carried out by a PCR-based method using 
BigDye®Terminator v3.1 (Applied Biosystems). Samples were prepared in a 0.5 ml 
PCR tube: 5 p1 plasmid DNA, 1 j.tl forward or reverse primer, 2 p1 BigDye and 2 jil 
5x sequencing buffer. The reaction was cycled 30 times at 94°C for 30 s, 45°C for 15 
s and 60°C for 4 minutes. The reaction was then submitted to the ICMB (Institute for 
Cell and Molecular Biology, University of Edinburgh) service for sequencing 
analysis. Fluorescent DNA sequence chromoatograms were analysed using 
VectorNTl software (Invitrogen). 
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2.3.7 Electroporation 
Aliquots of electro-competent cells and plasmid DNA were thawed on ice. Two j.il 
DNA was placed in a 0.2cm cuvette (Sigma-Aldrich), and then -100 p1 cells were 
added. The cuvette was dried and placed in the electroporator and the cells were 
subjected to electroporation (2500V, 25p.F, 99 (2). Five hundred p1 SOC was added 
immediately and the mixture was transferred to a sterile Eppendorf tube. The mixture 
was left shaking at 30 °C for 1 hour, then spread onto antibiotic containing LB agar 
plates and incubated overnight at 300C. 
2.3.8 Tr-parental mating 
The recipient strain was grown on an LB plate overnight at optimal temperature. An 
E. coli DH5a helper strain carrying pRK2013 and the E. coli donor strain carrying 
the plasmid to be conjugated were streaked onto SOB agar plates with appropriate 
antibiotic selection and incubated at 37°C overnight. The recipient strain was then 
grown overnight in LB broth, and the donor and helper strains were grown in SOB 
media with antibiotics. 
The cells were pelleted at 6000 x g for 15 minutes. The donor and helper strains were 
each resuspended in 3 ml PBS, and 1 ml of each was used to resuspend the recipient 
strain. The cells were pelleted together and washed in 2 ml PBS and then 
resuspended in 2 ml LB broth. A sterile 2 gm filter was placed on an SOB plate and 
left for 10 minutes. 100 il of the neat bacterial mixture was added to the filter paper, 
and the plate was incubated upright overnight at optimum temperature. The filter 
paper was then placed in a sterile universal tube containing 10 ml LB broth. After 
quickly vortexing, 100 tl  of the eluted bacterial mixture was spread onto LB plates 
containing antibiotics to select for the recipient containing the donor plasmid. 
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2.3.9 Insertional inactivation of Bcc genes. 
Insertional inactivation of B. cenocepacia K56-2 genes was performed using suicide 
vector pGPQTp, as described previously by Flannagan et al. (Flannagan et aT, 
2007). A 300 bp PCR-amplified internal fragment from the target gene, flanked by 
Xbal and EcoRJ sites, was cloned into pGPQTp. E. coli GT1 15 cells were 
transformed with the resulting mutagenesis plasmid, and were used to conjugate the 
plasmid into a wild-type strain of the Dcc by triparental mating. Colonies were 
verified by PCR using the forward primer for the insert and the reverse plasmid 
specific primer RSFI300. 
2.4. Molecular biology: Protein Expression and purification 
2.4.1 Protein expression 
Six p1 DNA product from 2.3.4 was ligated with 2 p1 of an expression vector, such as 
pET28a or pET22b (which had been digested by the same restriction enzymes), in 1 
p1 10 x buffer (NEB) and 1 p1 T4 DNA ligase (NEB). It was left overnight at 4 C. 
The ligation product was transformed into TOP  1OTM  cells or DH5a cells as described 
in Method 2.2.4. The cells were plated on LB antibiotic selection plates overnight at 
37 °C. Colonies were picked and grown overnight in LB broth, containing 
appropriate antibiotics, and plasmid DNA was prepared by Miniprep (Qiagen). A 
small-scale restriction digest was carried out to assess the success of the ligation. 
For expression, the plasmid DNA was used to transform E. coli (DE3) cells (Table 
1). They were plated on LB antibiotic selection plates, and then grown in LB broth, 
containing appropriate antibiotics, until 0D600 of 0.5 - 1.0. Approximately 1 ml broth 
was enough for a small-scale induction. Half of the cells were induced with IPTG 
and left for 3 hours, the other half were used as un-induced controls. The cells (500 
r.tl) were pelleted by centrifugation at 5000 x g and used for analysis by SDS-PAGE 
(see 2.4.4). Large-scale inductions required 6 litres of broth. Cells were induced with 
4,  
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IPTG for 3 hours and pelleted by centrifugation at 5000 x g. The pellet was kept at - 
20 C until needed for purification. 
2.4.2 Protein purification: immobilised metal affinity chromatography 
(IMAC) 
The E. coli cell pellet was resuspended in binding buffer containing a tablet of 
protease inhibitor cocktail (Roche). The cells were sonicated on ice, 30 seconds 
onl30 seconds off, for 10 minutes, followed by centrifugation at 25000 x g for 30 
minutes at 4 °C. The supernatant was filtered through a 0.45 jim filter. An AKTA 
Basic instrument fitted with a 5 ml I-IisTrapTM (Nickel resin, GE Healthcare) column 
was used to isolate the enzymes from the filtered cell free extract following 
manufacturer's instructions. The enzymes were eluted in 10 ml fractions using an 
increasing gradient of elution buffer, and the fractions of interest were analysed by 
SDS-PAGE. 
2.4.3 Protein purification: size exclusion chromatography 
The enzymes were further purified by size exclusion chromatography using a HiPrep 
26/60 Sephacryl S-200 column (GE Healthcare) following manufacturer's 
instructions. The calibrated column was equilibrated with 150 mM NaCl and 20 mM 
Tris, pH7.5, then 5 ml of concentrated protein sample was injected and eluted at 2 ml 
per minute. The molecular weights of the enzymes were estimated from their column 
elusion volumes and by non-denaturing gel electrophoresis (10% Novex® Tris-
Glycine Pre-Cast Gels, Invitrogen), following the manufacturer's instructions. 
The protein concentration was determined by a BCA assay (Pierce) following the 
manufacturer's instructions. - 
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2.4.4 Calibration of Sephacryl S-200 column 
Calibration was carried out using high molecular weight (11MW) and low molecular 
weight (LMW) calibration kits from GE Healthcare, following manufacturer's 
instructions. Briefly, the column was equilibrated with 150 mM NaCl and 20 mM 
Tris, pH7.5. First, 1 mg ml-1 Blue Dextran 2000 was run alone, and its elution 
volume was noted as the void volume, V0. Second, a mixture of high molecular 
weight standards (5 - 20 mg ml-1 each) were run and the elution volumes, V6, noted. 
Finally, the low molecular weight standards (5 - 20 mg ml-1 each) were run. The Kay 
was caculated as V - Vo/V —V0, where Vt is the total volume of the column (320 
ml). Kay was plotted against log(molecular weight) of each standard. The molecular 
weights of unknown samples were read from the graph. 
2.4.5 SDS-PAGE 
SDS-PAGE mini gels (15% (v/v) acrylamide) were made, using the Mini-Protean 3 
system (Bio-Rad), as follows; 5 ml 30% (v/v) acrylamide (Bio-Rad), 2.185 ml d1120, 
2.5 ml 1.5 M Trizma (Sigma), pH 8.8, 100 p110% SDS, 15 p1 N,N,N,N-tetramethyl-
ethane- 1 ,2-diamine (TEMED) (Fluka-BioChemika) and 200 p1 ammonium persulfate 
(APS) (100 mg mU1, Fluka-BioChemika) were mixed to make the running gel. After 
the running gel had set, the 4% (v/v) acrylamide stacking gel was made by mixing 
1.35 ml 30% (v/v) acrylamide, 5.8 ml dH20, 2.5 ml 0.5 M Trizma, pH 6.8, 100 xl 
10% (w/v) SDS, 15 p1 TEMED and 200 p1 APS (100 mg ml-1). 
Protein samples were denatured by the addition of 2 x SDS sample buffer and water 
to the cell pellets and boiling for 10 minutes. They were then loaded onto the gel 
along side either LMW marker (GE Healthcare), ColourPlus pre-stained marker 
(NEB) or SeeBlue8Plus2 pre-stained marker (Invitrogen) and run in SDS running 
buffer at 200V and 180 mA for 1 hour. 
Gels were stained using SDS stain for one hour whilst gently shaking at 37 'C. The 
bands were visualised by destaining the gel in SDS destain for one hour at 37 °C. 
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2.4.6 Western Blot 
After SDS-PAGE, the gel was cut so that only the lanes of interest were present. A 
piece of nitrocellulose membrane (Hybond-ECL, Amersham) was cut 0.5 cm 
longer and wider than the gel. Both the gel and the membrane were put in transfer 
buffer for 10 minutes at room temperature whilst agitated. Six pieces of filter paper 
(Whatman) were cut 0.5 cm longer and wider than the membrane. Three pieces were 
soaked in transfer buffer and placed on top of each other in the Trans-Blot®SD 
Semi-Dry Transfer Cell (Bio-Rad), the membrane was placed on top of the filter 
papers followed by the gel. The remaining 3 filter pieces were soaked and placed on 
top of the gel. The gel was blotted for 30 minutes at 15 V and 5.5 x width x length of 
the gel in mA. The membrane was placed in blocking solution (25 ml 1 x PBS, 
0.01% (v/v) tween 20, 5 % (wlv) dried skimmed milk) over night at 4 °C whilst 
agitated. 
The blocking solution was poured off and the membrane was covered in washing 
solution (PBS, 0.01% tween 20) and washed 3 x 5 mm, followed by 2 x 10 mm 
whilst agitated. After that, an anti-His antibody solution [30 ml PBS, 0.01% (v/v) 
tween 20, 5% (wlv) dried skimmed milk, 2.5 j.xl anti-His antibody (GE Healthcare)] 
was added and left for 1 hour at room temperature whilst agitated. The membrane 
was washed again 3 x 5 mm, 2 x 10 mm, followed by incubation of the anti-IgG 
antibody solution [30 ml PBS, 0.01% (v/v) tween 20, 5% (wlv) dried skimmed milk, 
2.5 pA anti-mouse IgG-Hrp-linked antibody (Cell Signalling Technology, Inc)], then 
washed again 3 x 5 mm, 2 x 10 mm, then dried on filter paper (Whatman) before it 
was basted with ECL Plus Western Blotting Detection System (GE Healthcare). It 
was dried again then covered in cling film before it was developed using KODAK 
BioMax XAR film in a HypercassetteTM (Amersham) for 30 s, 2 mm, 5 min and 10 
mm. 
The above method, with a few modifications, was also used detect biotinylation 
Superbiock (Pierce) was used instead of blocking solution for overnight incubation. 
Instead of the antibody solutions, 0.5 j.xl streptavidin-Hrp (BD Biosciences) was 
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added to 25 ml Superbiock. The washing steps were extended to 2 x 5 mm, 2 x 10 
mm, 1 x 30 mm. 
2.4.7 Protein assays 
Cary 50 UV visible spectrophotometers (Varian) were used to assay protein 
concentrations and activities, the concentration and kinetics programmes were used 
respectively. Origin 6.1 software was used to analyse any activity data. 
2.4.8 Liquid chromatography-electrospray ionisation mass spectrometry (LC-
ESI-MS) of proteins 
Molecular weight of purified proteins was determined by LC-ESI-MS, carried out by 
David Clarke and Gareth Morrison, School of Chemistry, University of Edinburgh 
Mass spectrometry was performed on a MicroMass Platform equipped with an 
electrospray ion source. The spectrometer cone voltage was ramped from 40 to 70 
volts and source temperature set to 140 °C. Protein samples were separated with a 
Waters HPLC 2690 with a Jupiter CS reverse phase column (5 gm, 250 x 4.6 mm, 
Phenomenex) directly connected to the spectrophotometer. Proteins were eluted from 
the column with a 5-95% acetonitrile gradient using an acetonitrile/water/0.01% 
(v/v) trifluoroacetic acid (TFA) solvent system (flow rate 0.4 ml/min). The total ion 
count in the range 500 to 2000 mlz was scanned at 0.1 s intervals. The scans were 
accumulated, the spectra combined and the molecular mass was determined by the 
MaxEnt and Transform algorithms of the Mass Lynx software (MicroMass). 
2.5. Molecular biology: RNA manipulation 
2.5.1 RT-PCR 
RNA was extracted from mid-log phase cultures (RNeasy® Protect Bacteria Mini 
Kit; Qiagen) and DNase I-treated (RNase-free DNase set; Qiagen), prior to reverse 
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transcription with 1.5 jig RNA template, random primers and SuperScript III Reverse 
Transcriptase (RT; Invitrogen). cDNAs and corresponding non-RT controls were 
used as template in PCR reactions. 
2.6. Minimum Inhibition Concentration (MIC) assay 
The method used follows that of Andrews, 2001 (Andrews, 2001): Bacterial strains 
of interest, and control stains' Pseudoinonas aeruginosa NTCTC 10662, Escherichia 
coli NTCTC 10418 and Staphylococcus aureus NTCTC 6571, were grown over 
night on a nutrient agar plate at 37 °C, followed by overnight subcultures in nutrient 
broth at 37 C. The bacterial cultures were diluted in saline: Gram-negative bacteria 
1:500 and Gram-positive bacteria 1:100. Two p1 (approximately 10 cfu) of each 
strain was spotted onto antibiotic plates using a multipoint inoculator. The plates 
were prepared according to Table 5. For example, for a plate with a final 
concentration of 64 jig mU', 0.128 ml of a 10 mg ml-1 antibiotic stock ws added to 
20 ml ISA. 
Table 5: Concentration of antibiotic stock; Amount of antibiotic added; Concentration in 20m1 ISA 
10 gg mY' 100 gg mY 1 mg mY' 10 mg ml" 
0.12 ml 0.25 0.5 0.1 0.2 0.4 0.8 0.16 0.32 0.64 0.128 0.256 0.512 1.024 
0.06 pig mY' 0.12 0.25 0.5 1 2 4 8 16 32 64 128 256 512 
The inoculated plates were incubated overnight at 37 °C. The MIC value is 
interpreted as the lowest concentration of an antibiotic where all visible growth is 
inhibited. 
'Kindly donated by Ahmed Hamouda, Molecular Chemotherapy, University of Edinburgh 
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3.1. Materials and methods 
3.1.1 Bacterial strains and culture conditions 
Bcc isolates used in this study are described in Table 6, and include 16 isolates from 
the two published Bcc strains panels (Coenye et aL, 2003; Mahenthiralingam et all, 
2000b). Additional Bcc strains investigated included B. pyrrocinia BTS7, B. 
cenocepacia BTS2, as well as 19 B. inultivorans, 14 B. cenocepacia lilA and 11 B. 
cenocepacia IlIB isolates from the Edinburgh CF Microbiology Laboratory 
(ECFML) collection. Isolates were recovered from storage at -80 °C by subculture on 
nutrient agar (NA; Columbia base agar, Oxoid) and subsequently grown on media 
composed of 1.5% (wlv) bacteriological agar (Oxoid) containing 2% (wlv) sugars 
and fractions from various isolation methods below. All clinical P. aeruginosa 
strains used were from the ECFML collection, and were sub-cultured onto 
Pseudomonas isolation agar (PIA; Difco) or NA before grown on sugar media. 
Sugars and other related chemicals were purchased from: Sigma-Aldrich, BDH 
AnalaR, MP Biochemicals, Fluka BioChemika, or Acros Organics. 
3.1.2 Onion maceration 
Peeled white onion (Sainsbury's, Edinburgh, UK) slices were placed in Petri dishes 
and inoculated with stationary phase Bcc cultures (106  efu) that had been cultured 
overnight in 2.5% (w/v) nutrient broth No 2 (Oxoid) with 0.5% (wlv) yeast extract. 
The onions were incubated at 30 °C for 5 days. The results were assessed by eye, and 
onion maceration recorded as positive or negative. 
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3.1.3 Onion extract agar 
Peeled white onions (1 kg) were chopped, homogenised in a blender at room 
temperature, and filtered through muslin. The filtrate was filter-sterilized through a 
0.22 pin filter and lyophilised to give a yellow sticky powder (typical yield 62 g). 
Twenty grams of lyophilised onion extract and 15 g bacteriological agar were made 
up to 1 litre distilled 1120, and then autoclaved at 121 °C for 15 mm. Strains were 
subcultured onto onion agar and incubated for 72 hours at 30 °C. Mucoidy was 
recorded on a scale ranging from nonmucoid (-) to very mucoid (+++). 
Concentration effects were investigated by incorporating onion extract into agar at 
final concentrations ranging from 0.25 j.tg ml-1 to 5 mg ml-1. 
3.1.4 Sugar agar 
Sugar agar contained 20 g of the sugar of interest, 2 g yeast extract, and 15 g 
bacteriological agar dissolved in 1 litre distilled H20 (Sage et at, 1990). The sugars 
used were as follows: D-fructose, D-galactose, D-mannitol, D-glucose, glycerol, 
lactose, L-rhamnose, D-mannose, maltose, sucrose, myo-inositol, ribitol (adonitol), 
and D-glucitol (sorbitol). The fructan polysaccharide inulin was also tested. 
As a control isolates were grown on bacteriological agar containing 0.2% (w/v) yeast 
extract alone. 
3.1.5 Reverse-phase chromatography 
Twenty millilitres of onion extract, 2% (w/v) in distilled 1120, was loaded onto a pre-
packed C8 column (10 g/60.0 ml, Varian, Anachem) and bound material was eluted 
stepwise using 3 concentrations of methanol (20% (v/v), 50% (v/v) and 80% (v/v); 
Fisher Scientific). Each fraction was lyophilised, dissolved in distilled H20 and 
incorporated into 1.5% (w/v) bacteriological agar. 
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3.1.6 Ethyl acetate partitioning 
To separate any lipids, non-polar, non-acidic and polar compounds, the resolubilised 
onion extract was brought to pH 7.0 using NaOH and partitioned against ethyl 
acetate (Fisher Scientific) at 1:1 (v/v). The phases were separated, and the aqueous 
phase was brought to pH 2.0 using HC1 and the extraction was repeated. Following 
both extractions, the organic and aqueous layers were evaporated or lyophilised 
respectively, and then redissolved in distilled 1120, pH adjusted to 7.0, and 
incorporated into 1.5% (w/v) bacteriological agar. 
3.1.7 Acid hydrolysis. 
The aqueous phase residue of the ethyl acetate partitioned onion extract was 
redissolved in distilled 1120 (50 mg ml') and was hydrolysed in 2 M TFA (Sigma) at 
60 °C or 120 °C for I h. 
3.1.8 Paper electrophoresis 
To fractionate the extract based on the presence or absence of functional groups, the 
freeze-dried aqueous phase of the onion extract was weighed and resuspended in 
distilled 1120 to a final concentration of 50 mg ml'. One millilitre was loaded at a 
centre origin of a Whatman No.1 paper (57x42 cm). The following standards were 
added in the margins of the paper: glucose 6-phosphate, glucose, glucosamine, 
methyl green (Sigma) and orange U (BDH). Electrophoresis was conducted at 1 kV 
for 20 mm, in volatile buffers at pH 2.0 or 6.5 with white spirit or toluene as coolant 
(Fry, 2000). The chromatograms were left to dry overnight in a fume cupboard. 
3.1.9 Paper chromatography 
One millilitre aliquots of each of the redissolved aqueous phase of the onion extract 
and the TFA hydrolysed samples (50 mg ml-1) were chromatographed on Whatman 
Nol paper alongside markers [ferulic acid, rhanmose, glucose, lactose, mannose, 
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galactose, fructose, mannitol, and glycerol] in butan-1-ol:acetic acid:water (12:3:5) 
for up to 60 h. The chromatograms were left to dry overnight in a fume cupboard. 
3.1.10 Staining and elution methods 
Electrophoretograms and chromatograms were stained with silver nitrate to reveal 
monosaccharides, oligosaccharides, alditols, saccharinic acids and phenols (Fry, 
2000). Briefly, the chromotograms were dipped in solution 1 (prepared by dissolving 
0.2 g AgNO3 (Sigma) in 0.4 ml dH20, which was added to 26 ml acetone (Fisher 
Scientific) whilst rapidly stirring) and air dried for 15 minutes, then covered in 
solution 2 (1.25 ml 10 M NaOH mixed with 100 ml ethanol) and air dried for 15 
minutes, this process was repeated a second time. The chromatograms were then 
placed in a water bath and washed with running water for 2 hours. Stained sugars 
appear brown. 
To reveal monosaccharides and reducing disaccharides, the chromatograms were 
stained with aniline hydrogen phthalate (Fry, 2000). Briefly, a stock solution was 
prepared by mixing 16 g phthalic acid (Sigma) in 490 ml acetone, 490 ml 
diethylether (Fisher Scientific) and 20 ml dFI20. One hundred ml of the stock 
solution was mixed with 0.5 ml aniline (Fisons), and used to cover the 
chromatograms. The chromatograms were left to dry, and then placed in an oven at 
105 'C for 5 minutes. Uronic acids stain orange, hexoses brown, pentoses dull-red, 
and reducing disaccharides are stained in various colours. 
The paper strips of interest from both methods were eluted by a syringe method with 
distilled H20 (Eshdat & Mireman, 1972). Briefly, 2 cm wide strips were cut along 
the chromatogram, and rolled up tightly to fit into a 5 ml syringe, which was placed 
in a 15 ml Falcon tube. Five hundred i.tl dE120 was added at the time (2 ml in total) 
and the sugars were eluted by centrifugation at 2600 rpm. The eluted material was 
incorporated into 1.5% (wlv) bacteriological agar with 0.2% (w/v) yeast extract. 
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3.1.11 High-performance anion-exchange chromatography with pulsed 
amperometric detection (HPAE—PAD). 
The HPAE-PAD was carried out by Ben R. Mewbum (Edinburgh Cell Wall Group, 
Institute of Molecular Plant Sciences, University of Edinburgh) 
Twenty microlitres each of the aqueous phase of the onion extract and the TFA-
hydrolysed samples (0.1 mg ml-1) were analysed by HPAE—PAD (Dionex). The 
system consisted of an AS3500 autosampler, GP40 gradient pump, ED40 
electrochemical detector, and PC 10 pneumatic controller. The amperometry detector 
cell contained a gold electrode and a pH-AgAgCl combination reference electrode. 
CarboPac MA-1, PA-1, and PA-100 columns and guard columns were used for the 
separation of alditols, monosaccharides, and oligosaccharides respectively. Eluents, 
degassed by bubbling with helium, were as follows. MA-1: 600 mM NaOH at 0.4 
ml min 1 (isocratic); PA-1: 20 mM NaOH for 3 mm, then H20 for 32 mm, then a 
0—*200 mM NaOH gradient over 10 mm (all at 1.0 ml min-' with post-column 
addition of base); PA-100: 100 mM NaOH throughout, supplemented with a 0—>200 
mM NaOAc gradient over 30 mm, then 200—*800 mM NaOAc over 10 mm (all at 
1.0 ml min-'). Analytes were identified by comparison of retention times to those of 
standards (D-glucose, D-fructose, D-galactose, D-mannose, L-rhamnose, arabinose, 
xylose, fticose, D-ribose; lactose, sucrose, cellobiose, mix: maltose, maltotriose, 
maltotetraose, maitopentaose, maitohexose, maltoheptaose; D-glucitol, perseitol, 
xylitol, D-mannitol, D-galactitol, ribitol, arabinitoi, myo-inositol, erythritoi) and 
quantified by integration of peak area with Chromeieon software (Dionex). 
3.1.12 Investigation of conserved EPS gene clusters in 6cc species. 
The genome analysis was carried out by Alan R. Brown (CF Group, Centre for 
Infectious Diseases, University of Edinburgh). 
Genome sequences representing five Bcc species were examined to determine if two 
previously published EPS gene clusters within B. cenocepacia J2315, the bce gene 
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cluster (Moreira et aL, 2003) and the wcb gene cluster (Parsons et aL, 2003), are 
conserved across the Bce. The amino acid sequences for every open-reading frame 
(ORF) within each of the two gene clusters within B. cenocepacia J2315 (genome 
sequence available at the Wellcome Trust Sanger Institute; http://www.sanger.ac.ukl) 
were used to search by TBLASTN the following Bce genome sequences: B. 
ambfaria AMMD, B. vietnamiensis G4, B. multivorans ATCC176I6, Burkholderia 
sp. 383. (all sequences are available at the US Department of Energy Joint Genome 
Institute; http://www.jgi.doe.gov/) and B. dolosa AU0158 (available at The Broad 
Institute; http://www.broad.mit.edu/). TBLASTN searches were performed using 
default parameters (BLOSUM 62, Word size 3). 
3.1.13 RT-PCR analysis of EPS biosynthetic gene clusters 
The RT-PCR analysis was carried out by Alan R. Brown and Roseanna Hennessey 
(CF Group, Centre for Infectious Diseases, University of Edinburgh). 
The EPS-producing strain, B. ambfaria AMMD, was cultured in 0.2 % (w/v) yeast 
extract with or without supplementation with 2 % (w/v) mannitol. RNA was 
extracted from mid-log phase cultures (RNeasy Protect Bacteria Mini Kit; Qiagen) 
and DNase I-treated (RNase-free DNase set; Qiagen), prior to reverse transcription 
with 1.5 jig RNA template, random primers and SuperScript III Reverse 
Transcriptase (Invitrogen). cDNAs and corresponding non-RT controls were used as 
template in PCR reactions specific for two distinct wza homologues (Bamb_5549 
and Bamb 362 1) located within two separate putative EPS biosynthetic gene 
clusters. 
3.1.14 PCR analysis of wcbO gene. 
The wcbO gene is found in the wcb gene cluster, previously described by Parsons et 
al. (Parsons et aL, 2003). Parsons and colleagues report an IS407—like insertion 
sequence within the B. cenocepacia J2315 wcbO and they suggest it may be the 
reason B. cenocepacia J2315 is unable to produce EPS. A PCR assay was set up 
using the previously published wcbO primers (Parsons et aL, 2003). Genomic DNA 
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from strains to be tested was prepared as described in 2.3.1. PCR reactions were 
performed in a 25 j.tl volume containing 2 .tl genomic DNA, 300 nM forward and 
reverse primer (wcbO For, Rev), 260 j.tM of each dNTP, 4% (vlv) DMSO, I U Gold 
Taq polymerase (Biogene) and appropriate manufacturer's reaction buffer. Thermal 
cycling was performed using the following parameters: 94 °C 3 mm; 30 cycles of 95 
°C (1 mm), 50 °C (1 mm) and 72 °C (10 mm); 72 °C 10 mm. PCR products were 
electrophoresed on a 1.2 % E-Gel alongside a 1 kb Plus DNA ladder and visualised 
by UV illumination. The B. cenocepacia J2315 wcbO gene sequence harbouring the 
IS407—like insertion yields a PCR product of 1.65 kb, compared to 400 bp for wild 
type wcbO. 
3.1.15 PCR analysis of bceB gene. 
The bceB PCR assay was developed by Alan R. Brown (CF Group, Centre for 
Infectious Diseases, University of Edinburgh). 
Using the beeR gene sequence of B. cenocepacia J2315, bceB homologues were 
identified within the publicly-available genome sequences of B. ambfaria AMMD, 
B. cepacia sp. 383, B. cenocepacia AU1054, B. cenocepacia H12424, B. cenocepacia 
PC 184, B. vietnamiensis G4 and B. dolosa AU0158. The eight gene sequences were 
aligned, and PCR primers flanking the location of the previously described 11-bp 
deletion in B. cenocepacia J2315 (Moreira et at, 2003) were designed based on 
conserved regions across the eight aligned sequences (beeR Al lbp For and Rev). 
Genomic DNA from strains to be tested was prepared as described in 2.3.1. Two 
microlitres of supernatant containing genomic DNA was used as template in PCR 
assays. PCR reactions were performed in a 50 R1  volume containing 300 nM forward 
and reverse primer, 1.5 MM  MgCl2, 260 jiM of each dNTP, 4% (vlv) DMSO 
(Sigma), 1 U Taq polymerase (Invitrogen) and appropriate manufacturer's reaction 
buffer. Thermal cycling was performed using the following parameters: 94 °C 3 mm; 
40 cycles of 94°C (30 s), 60°C (30 s) and 72°C (30 s); 72°C 10 min. PCR products 
were electrophoresed on a 4 % B-Gel alongside a 1 kb Plus DNA ladder and 
visualised by UV illumination. The B. cenocepacia J2315 bceB gene sequence 
harbouring the ll-bp deletion yields a PCR product of 140 bp, compared to 151 bp 
from the wildtype sequence found in B. cenocepacia 1ST 432 (Videira et at, 2005). 
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3.1.16 PCR analysis of BCESM and chiA gene 
Isolates of the B. cenocepacia ET12 lineage uniquely harbour both of the putative 
epidemic strain markers BCESM and the cblA gene. PCRs were performed as 
described previously (Mahenthiralingam et all, 1997; Sajjan et al., 1995). Briefly, 
two microlitres of genomic DNA was used as template in PCR assays. PCR reactions 
were performed in a 25 p1 volume containing 300 nM forward and reverse primer 
(cblA 1 and 2, BCESM 1 and 2), 260 jiM of each dNTP, 4% (vlv) DM50, I U Gold 
Taq polymerase (Biogene) and appropriate manufacturer's reaction buffer. Thermal 
cycling was performed using the following parameters: BCESM, 30 cycles of 94 °C 
(1 mm), 63 °C (1 mm) and 72 °C (2 mm) followed by a final extension at 72 °C for 
10 mm; cblA, 3 min 95, then 30 cycles of 94 °C (1 mm), 55 °C (1 mm), 72 °C (1 
mm), followed by a 10 min extension at 72 °C. PCR products were electrophoresed 
on a 1.2 % E-Gel alongside a 1 kb Plus DNA ladder and visualised by UV 
illumination. 
3.1.17 Expression of recombinant BceB in E. colt 
Genomic DNA from B. cenocepacia PC 184, containing a wild type bceB gene, was 
prepared as described in 2.3.1. A long (1440 bp) and a short (1380 bp) version of the 
bceB gene, both flanked by Ndel and Xhol sites and no stop codon, was PCR-
amplified, using 2 puReTaqTM Ready-To-Go PCR beads (Amersham), 5 Ld of each 
primer (bceB short For or bceB long For, with bceB no stop Rev), 1 p1 genomic DNA 
and 39 p1 dl-I20. Samples were amplified for 30 cycles: 95 °C 1 mm, 60 °C 1 mm, 
and 72 °C 2 mm; with a final 10-min extension at 72°C. The genes were 
electrophoresed on a 1% agarose gel, and gel extracted using QlAprep® Gel 
Extraction kit from Qiagen. The bceB long and bceB short genes were cloned into 
pGEM as described in 2.3.4. After restriction digests and sequencing analysis, the 
genes were cloned into pET28a (to use as a template for PCR in 3.1.17) and pET22b 
vectors, yielding C-terminal 61-lis tags (see 2.4.1.). 
rwii 
Chapter 3: Exopolysaccharide Investigation 
Expression in E. coli C41 (DE3) was carried out as in 2.4.1. using the plasmids 
pET22b/bceB long and short, selected on ampicillin, and visualised by Western Blot 
(see 2.4.6). BceB long is 55041.55 Da and BceB short is 52486.44 Da. 
Two PCR reactions were set up using pET28aIbceB long and short as templates, 
using 2 puReTaqTM  Ready-To-Go PCR beads (Amersham), 5 jil of each primer 
(bceB short For or bceB long For, with bceB 6 His Rev), 1 jil genomic DNA and 39 
p.1 dH20. Samples were amplified for 30 cycles: 95 °C 1 mm, 60 'C I mm, and 72 'C 
2 mm; with a final 10-min extension at 72°C. The bceB long (1506 bp) and short 
(1446 bp) genes, flanked by Ndel and Xbal, were now amplified with the 6 His tag. 
The genes were electrophoresed on a 1% agarose gel, and gel extracted using 
QlAprep® Gel Extraction kit from Qiagen. The bceB long 61-lis and bceB short 6His 
genes were again cloned into pGEM as described in 2.3.4. After restriction digests 
and sequencing analysis, the genes were cloned into pSCRhaB3 (as described in see 
2.4.1.) and selected on trimethoprim. 
Expression in E. coli DH5cz was carried out using pSCRhaB3/bceB long 6His and 
bceB short 6His, and visualised by SDS-PAGE (see 2.4.5.) and Western Blot. 
3.1.18 Complementation of AbceB. 
Complementation was attempted using the rhamnose-inducible pSCRhaB3 vector as 
described previously by Ortega and colleagues (Ortega et at, 2005). E. coli DH5a 
was transformed with pSCRhaB3/ bceB long 6His or bceB short 6His and selected on 
trimethoprim plates to become donors for triparental mating. In addition, the helper 
strain was prepared by transforming E. coli DH5cz with helper plasmid pRK2013, 
selected on kanamycin plates, and the recipient strains B. cenocepacia K56-2 and 
BC7 were streaked onto a gentamycin plate. Triparental mating was carried out as 
described in 2.3.8, and B. cenocepacia K56-2 and BC7 containing a wild type bceB 
on pSCRhaB3 were selected on trimethoprim and gentainycin. Complementation 
was investigated by streaking successful colonies on onion and mannitol agar plates. 
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B. cenocepacia species determination was carried out by B. cenocepacia ITT-A recA 
PCR (see 3.1.19). 
3.1.19 RT-PCR analysis of bceB expression 
Overnight cultures of E. coli ToplO cells transformed with either empty pSCRhaB3 
or with pSCRhaB3/bceB and overnight cultures of B. cenocepacia K56-2, with either 
pSC1ThaB3, pSCRhaB3/bceB or without plasmid, was sub-cultured into fresh LB 
media containing either 1 % (wlv) glucose or rhamnose. RNA was extracted from 
mid-log phase cultures (RNeasy Protect Bacteria Mini Kit; Qiagen) and DNase I-
treated (RNase-free DNase set; Qiagen), prior to reverse transcription with 1.5 g 
RNA template, random primers and SuperScript ITT Reverse Transcriptase 
(Invitrogen). cDNAs and corresponding non-RT controls were used as template in 
PCR reaction amplifying bceB following the protocol in 3.1.15 using bceB All bp 
For and Rev primers. 
3.1.20 Insertional inactivation of bceB in B. ambifaria AMMD 
The insertional inactivation was carried out in collaboration with Alan R. Brown (CF 
Group, Centre for Infectious Diseases, University of Edinburgh). 
Insertional inactivation of bceB was performed using the pGPQTp suicide vector, 
essentially as described previously (Flannagan et all, 2007). In brief, a 300-bp 
fragment internal to the bceB ORF of B. ambfaria AMMD and flanked by Xbal and 
EcoRI sites was PCR-amplified (using KO bceB For and Rev primers) and ligated 
into the corresponding sites in pGPQTp following appropriate restriction. The 
resulting plasmids were transformed into E. coli GT1 15 competent cells (InvivoGen, 
San Diego USA) and subsequently introduced into B. ambfaria AMMD by 
triparental mating. Any resulting exconjugants were selected using gentamicin (50 
mg ml') and trimethoprim (100 mg ml'), and mutants identified by PCR using a 
chromosomal-specific primer in conjunction with the vector-specific primer 
RSF1300 (Flannagan et all, 2007). B. ambfaria  species determination was carried 
out by recA PCR and RFLP analysis (see 3.1.21). 
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3.1.21 Species determination by recA PCR and RFLP 
recA PCR and restriction fragment length polymorphism (RFLP) are routinely used 
in reference laboratories to identify, and also distinguish between, Bee isolates 
(Mahenthiralingam et aL, 2000a). The BCR1 and 2 primers amplify a Bee specific 
region of the recA gene, whereas BCRG3AI and 2 are specific to the B. cenocepacia 
ITT-A recA gene. PCR reactions were performed in a 25 jil volume containing 300 
nM forward and reverse primer, 260 j.xM of each dNTP, 1 U Taq DNA polymerase 
(Qiagen) with Q solution and appropriate manufacturer's reaction buffer. Thermal 
cycling was performed using the following parameters: 30 cycles of 94 °C (30 s), 58 
°C (BCR)/62 °C (BCRG3A) (45 s), 72 °C (1 mm), followed by a 10 min extension at 
72 °C. PCR products were analysed by electrophoresis on a 1.2 % B-Gel alongside a 
1 kb Plus DNA ladder and visualised by UV illumination. BCR 1 and 2 amplifed a I 
kb product, whereas BCRG3A 1 and 2 amplifed a 278 bp product. 
RFLP was carried out using 10 p1 recA PCR product, 7 dH20, 1 p1 buffer 2 (NEB), 
and I p1 Haelll (NEB). The mixture was incubated overnight or for 3 hours at 37 °C, 
after which it was run on a 4% B-gel alongside a 50 kb DNA ladder and visualised 
by UV illumination. 
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3.2. Results 
3.2.1 Exopolysaccharide production on onion agar 
When a lyophilised onion extract was incorporated into agar at 2% (wlv) as the sole 
nutrient, members of the Bee were not only able to grow, but the majority of isolates 
also produced copious amounts of exopolysaccharide, as typified by B. ambfaria 
AMMD (Fig. 9). This "mucoid" phenotype is not observed when the Bee are 
cultured on Burkholderia cepacia media (Mast Diagnostics), nutrient agar and other 
common laboratory media. Different concentrations of onion extract, ranging from 
0.25 j.tg ml-1 to 5 mg m1 1, were tested, and EPS production was observed in all cases. 
Induction of EPS biosynthesis on onion agar was observed in all Bee species 
investigated, but was not observed in all strains within a species (Tables 6-9). The 
exception was the single strain of B. stabilis available for testing. Of particular 
interest was the failure of the virulent B. cenocepacia ET12 representatives J2315, 
K56-2 and BC7 to produce EPS on any media tested. 
IE 
Fig. 9: Growth of Burkholderia ambfaria AMMD on (A) nutrient agar (nonmucoid); (B) onion agar 
(mucoid), and (C) comparison of AMMD bceB mutant (left) and AMMD wild type (right) on 
mannitol agar. 
Interestingly, there was no correlation between induction of Bee EPS on onion agar 
and the ability of individual Bee strains to cause maceration of onion bulbs (Table 6). 
Maceration by B. cepacia ATCC25416 is illustrated in Figure 10. 
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Table 6: Exopolysaccharide biosynthesis of Bw-kholderia cepacia complex species when grown on agar supplemented with various substrates. 
Species Strain Source Maceration YE Onion Glucose Sucrose Fructose 
of Onions  
Inulin Glycerol Mannitol Glucitol Ribitol Inositol Mannose 
B. cepacia - ATCC25416 Onion Yes brown - ++ - -H- -3-3-4- - -4-HI- -*-H- -f-H- +-H- 4+3- + 
B. cepacia CEP509 CF No - - + -1-4- + -3-f- -f--f- + + + - 
B. mulilvo,-ans C1576 CF No -H- - + 4-H + 
B,multivorans ATCCI766 Soil § - -i-i- - + -4-4-4- + -4-4- -4-H- -3+3- -4--H- -H--f- - 
B. cenocepacia J2315 CF Yes brown - - - - - - - - - - 
B.cenocepacia I(56.2 CF No 
B.cenocepacia BC7 CF § - 
B. canocepacia PCI84 CF § - -H- . + -H- + + 4+ + + + - 
B.cenocepacs BTS2 CF § - 4+ - + -4-1- + + 4-4- -4-4- + -H- - 
B.stobilis LM014294 CF § - - - - + - - + - - - - 
B. v,elnamiensis LMG10929 Rice No -f-H- - -H- -H-I- + -f-H- 4-H- + - 4--f--f -4-4- 
B.vefflamiensLc PC259 CF No - -H- - + 4-H- + -H- -4-H- + - - - 
B. dalosa E12 CF Yes green -f-i- - - 4-H- - -H- -H- - + 4-H- - 
B. amb?[aria AMM1) Soil No -f-H- - + 4-H- + 
B. anihina W92' Soil No -f-H- - - 4-H- +3- 
B.an!hina C1765 CF No - * - - -4-4-4- - -f-f-f- *-H- . -f-H- + + 
H. pyrrocinia BTS7 CF § - -*-+- - + -4-4--I- -4-4-+ -h-f-f- 4--H- -f-H- -f-H- -f-H- + 
B. pyrrocinia C1469 CF Yes Shiny - -H- - -H- -f-I- +  
All strains tested are from the two published Bee panels (Coenye et al., 2003; Mahenthiralingam et al., 2000) except BTS2 and BTS7 that were donated by Paola 
Cescutti, University of Trieste, Italy. EPS production was scored on a scale from - (no EPS) to +++ (very mucoid). Mucoid growth described as -i—H- is shown in 
Figure lb. *ET12  isolates. § Not tested for maceration. YE, yeast extract agar. 
Table 7: EPS production and bceB, BCESM & cblA PCR results for clinical isolates of B. cenocepacia 111k 
EPS PRODUCTION IN RESPONSE TO GROWTH ON ONION EXTRACT AND ALCOHOL SUGARS PCR RESULTS 
Strain Onion Sucrose Fructose Inulin Glycerol Mannitol Glucitol Ribitol Inositol Mannose bceB BCESM cblA 
E3097 - - - - - - - - - - Allbp + + 
E3051 - - - - - - - - - - wt - - 
E3046 -H- + -H- - -I-I- -4-4-4- -4-4-4- -1-f-I- ±4- - wt - - 
E3042 + + - - + + + + - - wt - - 
E1913 - - - - - - - - - - Allbp + + 
E1217 ++ + -I-H- - + -H- -H- *4-4- -H- - wt - - 
E1197 - - - - - - - - - - A!lbp- + + 
E1189 - - - - - - - - - - Allbp + + 
E1150 -1±1- - -I-H- - - -H- -H- -4-H- -H- - wt - - 
111073 - - - - - - - - - - Allbp + + 
EIOOI -H* + ++ - + *4- -H- ++ +1- - wt + - 
E946 -I-H- + -H- - - -4--I- ++ ±4- + - wt - - 
11938 - - - - - - - - - - A!lbp + + 
E937 +++ -I-H- -I-H- - -H- -I-H- -I-H- -4-H- -I-H- - wt - - 
EPS production was scored on a scale from - (no EPS) to ++-l- (highly mucoid). bceB PCR: 'A llbp' denotes the presence of an 11 bp 
deletion as judged by size of the observed PCR product compared to wildtype (wt) sequence. With the exception of isolate E3051, all non-
EPS producing B. cenocepacia lilA isolates studied appear to harbour the 11 bp deletion. B. cenocepacia lilA isolates were also assessed 
for the presence of the epidemic strain markers, BCESM and cblA. These analyses revealed the 11 bp deletion within bceB to be a 
conserved feature of isolates of the El 12 lineage (positive for both epidemic markers). 
Table 8: EPS production and boeB PCR results for clinical isolates of B. multivorans. 
EPS PRODUCTION IN RESPONSE TO GROWTH ON ONION EXTRACT AND ALCOHOL SUGARS 
Strain Onion Sucrose Fructose Inulin Glycerol Mannitol Glucitol Ribitol Inositol Mannose bceB PCR 
£3221 + - - - - - + -I-H- -H- - wt 
£3218 + - - - - - - - - - wt 
£3215 -H- - - - + - - - - - wt 
£3187 ++ - - - - + + -I-H- -H- - wt 
£3155 + - + - - H -4-4- -H- - wt 
£3142 - - - - - - - - - - wt 
£3103 -H- - + - + -H- +-H- -4-4-4- +4* - wt 
E2989 + - + - - + -H- -H- -H- - wt 
£2964 - - - - - - +-H- -4-H- +4-4- - wt 
£2972 + - 4* - + -H- +-4- -4±4- +-l-+ - wt 
£2858 + - - - - - - -4-H- + - wt 
£2785 - - - - - - - - - - wt 
E2779 -H- - + - - -4-4- -H- + -H- - Wt 
E2739 + - - - - + + - - - wt 
£2633 ±f - + - - -H- -H- -H- -H- - wt 
£2608 - - - - - - - - - - wi 
£2525 - - - - - - - - - - wt 
£2228 + - - - - + + + + - wt 
£2499 + - - - - - - - + - wt 
EPS production was scored on a scale from - (no EPS) to +-H- (highly mucoid). All B. inultivorans isolates studied 
harboured a beeR PCR product consistent with the wildtype (wt) sequence, irrespective of their EPS status. 
Table 9: EPS production and bceB PCR results for clinical isolates of B. cenocepacia IlIB. 
EPS PRODUCTION IN RESPONSE TO GROWTH ON ONION EXTRACT AND ALCOHOL SUGARS 
Strain Onion Sucrose Fructose Inulin Glycerol Mannitol Glucitol Ribitol Inositol Mannose bceB PCR 
E3043 +-H- - - - + -H- +-4- + - - - wt 
E2854 ++ - ++ + + -4-4- *4- -4-H- + - wt 
E2836 -I-H- + tH- + -I-H- +-H- -4-H- -4-H- - wt 
E2685 -H- - + - + -H- ++ +-H- + - wt 
E2398 -H-+ - -H-I- -H- *H- -H-I- +++ -I-H- -4±4- - wt 
E2101 -I-H- + -H-I- + + -4-H- +++ -4-4* -I -H- - wt 
E1974 - - - - - - - - - - wt 
E1673 +++ + +-H- + -I-H- -4-4* -1-4* -I-H-  wt 
E1601 - - - - - - + - - - wt 
E1123 - -H- - - - - - - - - Wt 
E1003 -I-H- -H- -I-H- + -4±4- +-H- -4-H- -4--H- -H-+ - wt 
EPS production was scored on a scale from - (no EPS) to +-I* (highly mucoid). All B. cenocepacia lllB isolates 
studied harboured a bceB PCR product consistent with the wildtype (wt) sequence, irrespective of their EPS status. 
(A) 
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(B) 
Fig. 10: Onion maceration by B. cepacia ATCC25416. (A) control onion and (B) onion infected 
by B. cepacia ATCC25416. 
For comparison, clinical P. aeruginosa strains, either mucoid on both PIA and 
nutrient agar or non-mucoid, were grown on onion and mannitol agars. However, the 
choice of agar had no significant effect on phenotype (Table 10). 







E14 (+) + (+) (+) 
E15 + + + + 
E16 + +++ ±++ +++ 
E24 + ++ ++ ++ 
E25 (+) + + (+) 
E29 + +++ +++ +++ 
E36 (+) ++ +++ + 
E48 (+) +++ ++ + 
E55 + + ++ + 
E64 + +++ +++ +++ 
E81 +++ +++ +++ 
E9 - - - - 
E22 - - - - 
E23 - - - - 
E32 - - - - 
E37 - - - - 
E39 - - - - 
E49 - - - - 
E56 - - - - 
E60 - - - - 
Clinical isolates of P. aeruginosa were grown on NA, PIA, marmitol and onion 
agars. EPS production was scored on a scale from - (no EPS) to ++± (highly 
mucoid). 
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3.2.2 Investigating the onion factor 
Attempts were made to identify the "onion factor" responsible for EPS biosynthesis 
by use of standard biochemical methods for extracting and fractionating 
phytochemicals. The causative factor was retained on drying in vacuo, and remained 
in the aqueous phase after partition with ethyl acetate at pH 7.0 and p1-I 2.0 
discounting the role of lipids. Reverse-phase chromatography was carried out but 
only the flow through was biologically active suggesting the active component is not 
hydrophobic. A proteinaceous factor was also ruled out by the fact that there were no 
bands by SDS-PAGE analysis (data not shown) and the extract was still active after 
incubation at 70 C for 15 minutes, which would have denatured most polypeptides. 
Attention was then turned to the carbohydrate content of onion extract. After 
preparative paper electrophoresis in buffers at pH 2.0 and 6.5 (Fig. 11), the only 
biological active material recovered from paper strips co-migrated with the glucose 
standard, indicating the absence of ionisable functional groups such as phosphate, 
acid or amine. Based on staining methods and paper elution, analytical paper 
chromatogography revealed the likely causative agent to be glucose, fructose, 









4— Glucose —* 
1 Glucosamme 
Fig. 11: Paper clectrophoretograms of onion extract. (A) pH 2.0 in white spirit; and (B) pH 6.5 in toluene. Edges have 
been silver nitrate stained to illustrate the migration of the extract. Methyl Green and Orange G were used as markers 
to see how far the solvent front had migrated. 
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Fig. 12: Paper chromatograms run in butan-1-ol:acetic acid:water (12:3:5) for 50 hours, (A) silver 
stained, (B) aniline hydrogen phthalate stained. Order of samples on both chromatograms: glucose, 
fructose, sucrose, galactose, mannose, lactose, mannitol, sorbitol, glycerol, inulin, onion, TFA 60°C, 
TFA 120°C, TFA 120°C, TFA 60°C, onion, hiulin, glycerol, sorbitol, mannitol, galactose, sucrose, 
fructose, glucose. The green box indicates the mucoid inducing area. 
Further analysis using HPAE-PAD chromatography (Fig. 13) confirmed the major 
carbohydrate components to be sucrose, glucose, fructose and fructans. The HPAE-
PAD chromatograms in Fig. 13 show characteristic peaks of glucose, fructose and 
sucrose. Sucrose breaks down to fructose and glucose upon mild hydrolysis, as do 
the fructans to fructose. Fructose breaks down under complete hydrolysis whilst 
glucose remains stable. The ability of these and related compounds to stimulate EPS 
biosynthesis in Bcc was then investigated (Table 6). Glycerol and mannitol were 
also included as these sugar alcohols have previously been noted to enhance BPS 
biosynthesis in Pseudomonas aeruginosa (Whitchurch et al., 1996) and the Bcc 
(Sage et al., 1990). Glucitol was included because of its close degradative 
relationship with fructose and mannitol (Allenza et al., 1982). These experiments 
showed that within a particular Bcc species, EPS biosynthesis was strain-specific and 
that the most potent inducers of EPS were fructose and all the alditols tested, most 
significantly mannitol and glucitol, as well as the cyclitol myo-inositol. Importantly, 
the profile of EPS biosynthesis production with these sugars was similar to that 
observed with onion extract (Table 6). EPS biosynthesis was not observed on agar 
containing yeast extract alone, nor in the presence of glucose (Table 6), galactose, 
lactose or maltose (data not shown) with any Bcc strains tested. 
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Fig. 13: HPAE-PAD chromatograms. Carbopac PA-100 column separation of sugars in onion extract. 
(A) crude onion extract; (B) onion extract hydrolysed by 2 M TFA 60'C 1 h; and (C) onion extract 
hydrolysed by 2 M TFA 120'C 1 h. Glucose, fructose and sucrose peaks were clearly identified based 
on standards (not shown), and hydrolysis pattern. Peaks with retention times between 12.0 to 36.0 mm 
appear to be oligosaccharides of fructose based on theft degradation to fructose under mild hydrolysis. 
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3.2.3 Molecular basis for lack of EPS biosynthesis in Bcc 
With the exception of the single B. stabilis strain tested, all Bcc species were shown 
to be capable of producing EPS when grown on onion agar (Tables 6-9), suggesting 
the presence of a conserved BPS biosynthetic gene cluster. Consequently, genome 
sequences representing five Bcc species (B. amb(faria,  B. multivorans, B. 
vietnamiensis, B. dolosa and Burkholderia sp. 383) were examined to determine if 
two putative BPS gene clusters within B. cenocepacia J2315, the bce gene cluster 
(Moreira et aL, 2003) and the wcb gene cluster (Parsons et aL, 2003), are conserved 
across the Bcc. The wcb gene cluster was found to be poorly conserved, with 
between one-third and one-half of J2315 ORFs having no direct homologues within 
the species examined (data not shown). Notably, within the EPS-producing B. 
ambfaria AMMD strain, over half of the J2315 wcb-associated ORFs have no 
homologues, and the remaining homologous ORFs are not organised within a gene 
cluster. In contrast, the bce gene cluster was conserved across all species examined, 
both in terms of sequence homology and organization of ORFs (Fig. 14). 
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Fig. 14: Comparison of homology within bce gene cluster of representative 8cc species. Genetic 
organization of the bce gene cluster within B. cenocepacia J2315 is shown (Moreira et at, 2003). The 
homologous genes from other Bcc genomes are present in the same order and orientation as observed 
within B. cenocepacia 32315, indicating a conserved gene cluster. The only exception is the bce gene 
cluster of B. dolosa AIJO 158, which lacks a homologue of BceL, a putative transporter protein. 
Numbers indicate the percentage identity to the B. cenocepacia J2315 proteins. 
In the course of these genome comparisons, a third putative polysaccharide 
biosynthetic gene cluster was identified on chromosome 2 of B. cenocepacia J2315. 
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This cluster encodes two putative EPS transporter proteins (BCAM1330 and 
BCAM 1331), an acyltransferase (BCAM 1333), several glycosyltransferases 
(BCAM1335, BCAM1337, BCAM1338), a polysaccharide biosynthesis protein 
(BCAM1336) and a mannose-6-phosphate isomerase (BCAM1340). This cluster is 
conserved amongst several Bcc species, albeit to a lesser extent than the bce gene 
cluster (data not shown). In the EPS-producing B. ambfaria AMMD, this gene 
cluster maps to ORFs Bamb_3621 through to Bamb_3629. 
To investigate which polysaccharide gene cluster is induced by growth on mannitol, 
the expression of representative genes from two distinct EPS gene clusters was 
assessed in B. ambfaria  AMMD grown in the presence and absence of mannitol. 
The genes studied each encode homologues of the Wza EPS export protein: 
Bamb_5549 of the bce gene cluster (equivalent to bceE, BCAM0858 of B. 
cenocepacia J2315), and Bamb_3621 of the novel putative polysaccharide gene 
cluster described above (BCAM1330 of B. cenocepacia J2315). As shown in Figure 
15, expression of Bamb_3621 was not observed under either growth condition. In 
contrast, expression of the bceE homologue (Bamb_5 549) was clearly induced by the 
presence of mannitol. Consequently, we focused on the bee gene cluster to 
investigate why some Bce isolates, most notably those of the B. cenocepacia ET12 
lineage, failed to produce BPS under any growth conditions. 
bceE 
YE YE+Ma  
RT + - + - 
Barnb 3621 , 
. . 
+ + 
YE YE+Ma LU 
+ - +  
Fig. 15: Induction of the bce gene cluster by mannitol. RT-PCR analysis was performed to assess the 
expression of two distinct wza homologues (bceE and Bamb_3621) of B. ambfaria AMMD in the 
absence and presence of mannitol. Expression was assessed in yeast extract (YE) and yeast extract 
supplemented with 2% (w/v) mannitol. Only bceE expression was strongly induced by growth in 
YE+Mannitol. RI and non-RI reactions (+ / -) are shown alongside each other. Genomic DNA 
positive controls are shown for each gene (bceE +ve, 3621 +ve). 
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To confirm that the IS40 7-like insertion sequence in wcbO, described by Parsons et 
al., is not the reason for lack of EPS production, a screen was set up using the PCR 
assay described by Parsons and colleagues (Parsons et al., 2003). No correlation was 
found between the presence of the IS407-like insertion sequence within wcbO and 
lack of mucoidy, even within the ET-12 lineage (Fig. 16). In fact, most mucoid 
isolates tested did not appear to possess a wcbO gene at all. 
1 2 3 4 5 6 7 8 9 10 11 12 
1.65 kb 
0.4 kb 
Fig. 16: PCR for the presence of wcbO and screen for the IS407-like sequence in wcbO in B. 
cenocepacia lilA representatives. Lane 1, J2315; lane 2, E1189, lane 3, E3051; lane 4, E1073; lane 5, 
E1197; lane 6, 1 kb Plus ladder; lane 7, E1001; lane 8, E946; lane 9, E938; lane 10, E937; lane 11, 
K56-2; lane 12, J2315. The presence of the IS 407-like sequence in wcbO is seen in lane 1, 2 and 12 
with a product of 1.65 kb, whereas a wild type wcbO yields a product at 0.4 kb (lane 4, 5 and 11). 
Note, some do not contain a wcbO gene (lane 3, 7, 8, 9, 10). 
A PCR assay was then designed to screen isolates for an 11-bp deletion in the bceB 
gene which has been suggested to be responsible for loss of EPS production in the 
CF isolate B. cenocepacia J2315 (Moreira et al., 2003). Of the panel of strains shown 
in Table 6, only the B. cenocepacia ET12 isolates J2315, K56-2 and BC7 were found 
to harbour the 11-bp deletion. This result prompted an examination of a panel of B. 
cenocepacia recA lineage lilA strains containing both ET12 and non-ET12 isolates. 
There was a clear correlation between the 11-bp deletion and the presence of both 
cblA (cable pilus) and BCESM (B. cepacia epidemic strain marker), confirming this 
deletion is a conserved feature within the ET12 lineage (Fig. 17). In our study, with 
the exception of strain E305 1, the presence of the deletion correlated with the lack of 
EPS production in all B. cenocepacia lilA isolates examined (Fig. 17; Table 7). 
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Furthermore, the 11-bp deletion in the bceB gene was not observed in any B. 
cenocepacia IlIB or B. multivorans isolates studied (Tables 8 and 9). 
NM NM NM NM NM M M NM M EPS 
200 bp - 
— - •_-. — — — bceB 
100bp - -... 
: 1.65 kb -
QUO %W 400 400 BCESM 
1 kb - 
650bp- cb1A 
Fig. 17: bceB PCR analysis of representative B. cenocepacia lilA isolates. For each isolate, EPS 
production is indicated as mucoid (M) or nonmucoid (NM) alongside PCR analysis of bceB, and the 
epidemic strain markers cblA and BCESM. All PCR products are pictured alongside the 1 Kb Plus 
DNA Ladder (Invitrogen). NTC - no template control. The bceB PCR assay yields a 151 bp product 
from wild-type sequence and a 140 bp product from sequence harbouring an 11-bp deletion (as 
previously reported within J2315). With one exception (E3051), lack of EPS production within B. 
cenocepacia lilA isolates correlated with the 11-bp deletion within bceB. This deletion was only 
observed within strains that were positive for both cblA and BCESM, indicating it to be a conserved 
feature of the ETI2 lineage. 
To confirm the involvement of BceB in onion-induced EPS production, attempts 
were made to complement BceB function within B. cenocepacia K56-2 by 
introducing a wildtype bceB amplified from B. cenocepacia PCi 84 on a pSCRhaB3 
plasmid, previously used for complementation of gene function in B. cenocepacia 
(Ortega ci' al., 2005). Weak expression of 6 His-tagged B. cenocepacia Pci 84 BceB 
on a pET22b plasmid was detected in E. coli C41(DE3) cells (Fig. 18) by Western 
blot. These E. coli cells have previously been shown to support expression of 
membrane-bound proteins (Miroux & Walker, 1996). In addition, wild type bceB 
mRNA was being expressed in the B. cenocepacia K56-2 recipient containing 
pScRhaB3/bceB (Fig. 19), however, we were unable to detect protein expression 
within B. cenocepacia K56-2 nor see a change in phenotype on sugar and onion agar. 
Consequently, we chose to disrupt the bceB ORF of an EPS-producer. Insertional 
inactivation of the bceB gene resulted in loss of EPS production in B. ambfaria 










12 3 4 5 6 
1i 
Chapter 3: Exopolysaccharide Investigation 
1 2 3 4 5 6 
48 kDa 
,J 
1 1J  
Fig. 18: Weak B. cenocepacia PC 184 BceB expression in E. coil C41 (DE3). The order on both gels 
is as follows: lane 1, SeeBlue®P1us2 pre-stained marker; lane 2, BceB/C41 uninduced; lane 3, 
BceB/C41 induced; lane 4, BceB/C43 uninduced; lane 5, BceB/C43 induced; lane 6, SPT 6His +ve 
control. BceB appears at 48-kDa, the gene sequence predicted a 52-kDa protein but BceB has a 
cleavable signal peptide at the N-terminal site resulting in a 48 Da product (Videira et al 2005). 
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Fig. 19: RT-PCR expression of pSCRhaB3IbceB in B. cenocepacia K56-2. Lane 1, 1kb plus DNA 
marker showing only between 100 bp and 200 bp; lane 2 and 3, B. cenocepacia 1(56-2, RT + and -; 
lane 4 and 5, K56-2/pSCRhaB3 control rhamnose, RT +1-; lane 6 and 7, K56-2/pSCRhaB3 control 
glucose, RT +1-; lane 8 and 9, K56-2/pSCRhaB3/bceB rhamnose, RT +/-; lane 10 and 11, K56-
2/pSCRhaB/ bceB glucose, RT +1-; lane 12 and 13, B. cenocepacia J2315, RT +1-; lane 14, J2315 
DNA control. The bceB wild type yields a 151 bp product and bceB with an li-hp deletion a 140 bp 
product. 
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3.3. Discussion 
This study returned to the original Bee host and found that Bee isolates previously 
considered non-mucoid produce copious amounts of BPS when onion tissue is 
provided as the sole nutrient. This surprising observation not only highlights the 
metabolic potential of this group of organisms, but also revealed a putative virulence 
factor that would be missed on routine laboratory culture. Onion-induced BPS 
biosynthesis is not species-specific, and is exhibited by isolates of both clinical and 
environmental origin. Interestingly, mucoidy on onion agar does not correlate with 
onion maceration. 
The onion components responsible for EPS induction are primarily the carbohydrates 
sucrose, fructose and fructans. Additionally, all alcohol sugars tested are able to 
induce EPS production, in particular mannitol and glucitol. The reasons why EPS 
biosynthesis is readily induced by onion extracts and, in particular, by fructose and 
the hexitol sugars mannitol and glucitol require further investigation. However, the 
similar profile of BPS induction shown by growth on fructose and alcohol sugars 
may be explained by consideration of the results of a previous study that investigated 
the initial steps of utilization of these sugars by the Bee (Allenza et aL, 1982). It was 
found that growth of Bee on fructose involves active transport into the cell followed 
by fructokinase conversion to fructose 6-phosphate then degradation via the Entner—
Doudoroff pathway. Growth on mannitol and glucitol also requires this pathway 
following active uptake and intracellular oxidation to fructose. An ability to respond 
to inulin was confined to certain strains, all of which responded well to fructose. This 
suggests that the fructan polysaccharide was only active in bacteria that can 
hydrolyse it to fructose. 
The ability of hexoses and hexitols, in particular mannitol, to enhance BPS 
biosynthesis in the Bee has disturbing clinical implications for therapeutic 
intervention in CF. Recent attempts to improve airway clearance with hypertonic 
saline 5% (wlv) have been handicapped by the problem of salty taste and reservation 
concerning the salt-sensitive nature of most natural antimicrobial peptides, including 
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human defensins. Thus, attention has turned to the use of non-ionic osmolytes, 
including inhaled mannitol (Daviskas et all, 2005; Robinson et al., 1999; Wills, 
2007), which is marketed as BronchitolTM by Pharmaxis. In their study of the clinical 
use of BronchitolTM, Robinson and colleagues acknowledged that the majority of P. 
aeruginosa and Bee isolates are able to utilize mannitol as a carbon and energy 
source. However, they felt that the nutritional influence of mannitol as a therapeutic 
osmolyte would be minimal given the abundance of other nutrients already present in 
CF respiratory secretions. In contrast, our study highlights the potential induction of 
virulence determinants during osmolyte therapy, and provides further justification for 
the continued exclusion of CF individuals known to be infected with Bee from 
ongoing trials of inhaled mannitol (http://clinicaltrials.gov; identifier NCT00117208 
and NCT00251056). Additionally, fructose and sugar alcohol levels are elevated in 
the serum, and possibly the airway secretions, of patients with CF related diabetes, 
indicating that the lung environment of these patients may enhance bacterial 
virulence (Reid & Bell, 2009). 
Intriguingly, none of the B. cenocepacia ET12 lineage tested was able to produce 
BPS on any media tested. This was surprising as the lineage is considered to be the 
most virulent of the Bee and BPS had been suggested as a putative virulence factor 
analogous to the characteristic transition to an alginate producing mucoid phenotype 
in P. aeruginosa (Govan & Deretic, 1996). Two previous studies proposed reasons 
for the lack of BPS production in B. cenocepacia J2315. Parsons and colleagues 
described an IS407-like insertion sequence within wcbO, encoding a putative 
polysaccharide biosynthesis/export protein, found in the web gene cluster (Parsons et 
al., 2003); and Moreira and colleagues found an 11 bp deletion in bceB, encoding a 
glycosyltransferase, in the bee gene cluster (Moreira et al., 2003). In silico analysis 
comparing available Bee genome sequences, revealed that the web gene cluster is 
poorly conserved, and is in fact only present in some strains on a genomic island. Its 
role in onion-induced BPS biosynthesis can be further discounted by the lack of 
correlation between the presence or absence of the IS407-like insertion sequence and 
mucoidy. In contrast, the bee gene cluster is highly conserved among all Bee species. 
Several of the encoded proteins in this particular cluster have been characterised 
F:] 
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(Ferreira et at, 2007; Sousa et at, 2008; Sousa, 2007; Videira et al., 2005), and it is 
thought to be involved in the biosynthesis of cepacian, the major and the best 
characterised EPS of the Bcc. In the present study, we obtained evidence for the role 
of this BPS in the onion-induced mucoid phenotype by demonstrating induction of 
the bce gene cluster by mannitol. We also found a clear correlation between the 
inability of representatives of the B. cenocepacia BT12 lineage to produce EPS and 
the presence of an 11 bp deletion within the bceB gene. Consistent with this 
correlation, insertional inactivation of bceB resulted in the loss of EPS production by 
B. ambfaria  AMMD when grown on onion and mannitol media. However, 
mutations elsewhere within the bce gene cluster, or in other BPS-related gene 
clusters, must be responsible for the lack of EPS biosynthesis in B. cenocepacia 
strain E3051, and in other BPS-negative Bcc strains in our study which contain a 
wild type bceB. This could also explain our inability to generate an BPS producer by 
simple expression of a plasmid-encoded, wild-type bceB in a non-producer that 
contained the 11 bp deletion. Taken together, these interesting observations highlight 
the pivotal role of the bce gene cluster in onion-induced BPS biosynthesis, and 
suggest that the observed EPS is cepacian. 
The role of Bcc BPS as a putative virulence factor is unclear. The influence of 
mannitol and other alcohol sugars on EPS production suggests that the prevalence of 
BPS in the Bcc may have been underestimated. In addition, given the variety of 
human, animal, plant and other models studied, the role of BPS may be influenced by 
the host involved and the route of inoculation. BPS has been associated with altered 
Bcc clearance in a mouse model of infection (Conway et at, 2004), and BPS-
deficient Bcc mutants displayed reduced mortality within a COD mouse model 
(Sousa et at, 2007). Similarly, a role for BPS in resistance of Bcc in human airways 
is suggested by its capacity to scavenge reactive oxygen species and inhibit 
neutrophil chemotaxis (Bylund et at, 2006). hi our study, BPS biosynthesis did not 
correlate with the ability to cause onion rot, which is perhaps to be expected since 
pectinases rather than EPS are likely to play the major role in the maceration of plant 
tissue. Cunha et al. did not observe a clear correlation between EPS biosynthesis in 
vitro and the ability of Bcc strains to establish chronic infections within the CF lung 
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(Cunha et at, 2004). Recent evidence, however, suggests a possible and unexpected 
role for Bee EPS in CF lung infection. Consistent with the findings of our study, 
Zlosnik et aL reported that isolates of B. cenocepacia, the most virulent Bee species, 
are most frequently non-mucoid (Zlosnik et at, 2008). They also observed a mucoid 
to non-mucoid conversion in sequential isolates of Bee from chronically-infected CF 
patients. This loss of mucoidy in vivo, and its absence in the virulent B. cenocepacia 
ET1 2 lineage, provides an intriguing contrast with the characteristic non-mucoid to 
mucoid conversion observed with alginate-producing P. aeruginosa. The 
observations made by Zlosnik and colleagues suggest that Bee EPS could be 
responsible for the persistence of Bee in CF airways whilst loss of EPS leads to 
increased disease severity. Clearly, further analyses are required to explore the role 
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4.1. Lipopolysaccharide methods 
4.1.1 Bacterial strains and culture conditions 
B. cenocepacia K56-2, J2315 and SAL-i and E. coli WBB06 were recovered from 
storage at -80 'C by subculture on nutrient agar and grown at 37 °C; SAL-i was 
selected on trimethoprim and WBB06 on tetracycline agar. The E. coil AarnT strain 
AY103 (Yan et aL, 2007), was recovered from storage at -80 'C by subculture on LB 
with kanamycin agar and grown at 30 °C. 
E. coil WBB06 and AY 103 were made electrocompetent as described in 2.2.2. 
E. coil TOPi0, E. coil BL21 (DE3), HSM174 (DE3), Rosetta (DE3), C41 (DE3) or 
C43 (DE3) were used for cloning and expression of recombinant proteins. 
Kd02.lipid A, purified from E. coil WBB06 (Raetz et aL, 2006), was purchased from 
Avanti Polar Lipids. 
4.1.2 Small-scale lipopolysaccharide extraction 
Bacteria were grown overnight in nutrient broth at 37 'C. Five ml were centrifuged 
for 10 minutes at 13000 rpm. The pellet was resuspended in 0.75 ml dH20. 0.5 ml 
90% phenol (Fisher Scientific) was added. The mixture was vortexed then heated to 
65 °C for 15 minutes, vortexing every 5 minutes. It was then cooled on ice after 
which the layers were separated by centrifugation. Both layers were dialysed against 
water in 6000 - 8000 Dalton (Da) molecular weight cut off dialysis tubing 
(Spectra/Por, Spectrum) for 48 hours, with running water. The samples were then 
freeze dried, and resuspended in 100 p1 DOC sample buffer (4m1 of stock solution C 
(7.69 g Tris base (Sigma); 75 ml dH20; pH 6.8, made up to 100 ml with dH20); 5 mg 
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Bromophenol blue, 2 ml glycerol (Fisher Scientific), made up to 20 ml with dF120) 
and analysed by DOG-PAGE (see 4.1.4.). 
4.1.3 Large-scale lipopolysaccharide extraction 
Bacteria were grown in 4 L nutrient broth at 37 C for 48 hours; the cells were 
harvested by centrifugation at 9000 g for 20 minutes. The pellet was resuspended in 
70 ml chilled EDTA solution (0.05 M Na2HPO4 (Sigma), 0.005 M EDTA (Fisher 
Scientific), pH adjusted to 7.0). The mixture was sonicated (amplitude 10 microns) 
on ice for 30 seconds with a 1 minute pause, repeating 10 times. Then 15 mg 
lysozyme (Sigma) was added and stirred at 4 °C over night. The mixture was then 
heated to 37 °C for 20 minutes with frequent stirring. 4 mg DNase (Roche), 20 mg 
RNase (Roche) and 25 ml of 0.04 M MgCl2 (Fisher Scientific) was added. The 
solution was then incubated at 37 °C for 10 minutes followed by incubation at 60 °C 
for 10 minutes. The mixture and 100 ml phenol were both heated to 65 °C; they were 
then added together in a fume hood and heated at 65 °C for 15 minutes with stirring. 
The mixture was then incubated on ice for 15 minutes and then centrifuged at 9000 x 
g for 20 minutes at 4 °C in new polypropylene centrifuge tubes. The water and 
phenol layers were each pipetted into a new centrifuge tube. 30 cm lengths of 3000-
6000 Da molecular weight cut off dialysis tubing (Spectra/Por, Spectrum) were 
rinsed in dH20 and then filled with each of the layers and dialysed against running 
*120 for 4 days. The dialysed samples were then centrifuged again at 9000 g, and 
then freeze-dried. Samples were then stored at - 20 °G until analysed by DOG-PAGE 
(see 4.1.4.). 
4.1.4 DOC-PAGE 
The DOG (deoxycholate) gels were made up using three solutions: Solution A, 30% 
Bis/Acrylamide (Bio-Rad); solution B, 1.5 M Trizma (Sigma), pH 8.8; and solution 
G, 500 m Trizma, pH 6.8. 
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The running gel was prepared as follows: 6 ml Solution A, 2 ml Solution B, 2 ml 
dH20, 17.5 p1 APS (Fluka) and 8.75 p1 TEMED (Sigma) were mixed and loaded into 
glass plates. The stacking gel was made up of 0.66 ml Solution A, 1 ml Solution C, 
3.34 ml dH20, 12.5 j.xl APS and 6.25 p1 TEMED. 
A running buffer was made up of 10.85 g glycine (Fisher Scientific), 2.25 g Tris 
base, 1.25g sodium deoxycholate (BDH), 500 ml dH20. 
The gels were pre-run for 10 minutes at 30mA, then after loading run for 1 hour at 
30mA. Gels were left in fixative (40% w/v ethanol, 5% acetic acid) overnight, or in 
fixative with 0.05% (w/v) alcian blue (Sigma). 
4.1.5 Sodium-m-periodate silver staining 
The gel was covered in 50 ml oxidiser (0.7% w/v sodium-m-periodate (Fisons) in 
fixative) for 10 minutes on shaker, then washed in water 5 x 5 minutes. It was then 
covered with stain solution (140 ml water, 280 r.xl 10.0 M NaOH (Fisher Scientific), 
2 ml 28-30% ammonium hydroxide (Sigma), 1 g silver nitrate (Sigma) semi-
dissolved in 5 ml water added drop wise) for no more than 10 minutes, and washed 
again 5 x 5 minutes. Developer (100 ml water, 50 id formaldehyde (Sigma), 50 j.tl 
citric acid (Fisher Scientific)) was added until bands were visible, then a stop 
solution (100 ml water, 500 j21 acetic acid) was added for exactly 1 minute. The gel 
was washed, and stored, in water. 
Staining by alcian blue follows the protocol above, but without the initial oxidising 
step by sodium-m-periodate. 
4.1.6 Negative staining 
Negative staining was carried out as described previously (Castellanos-Serra & 
Hardy, 2006), with some modifications. After gel electrophoresis, the gel was 
washed 3 x 15 minutes in 30% (v/v) acetonitrile (Fisher Scientific). Then the gel was 
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incubated in 10 mM zinc sulfate (Sigma) for 15 minutes, after which the gel was 
washed in excess dH20 for 30 seconds before adding a 0.2 M imidazole (Sigma) 
solution for 1-3 minutes. The gel was washed, and kept, in dH20. The bands were 
visualised by scanning the gel with a black cardboard background. 
The bands of interest were excised and incubated in PBS, pH7.4, containing 100 mM 
EDTA di-sodium salt or 0.3 M glycine (Fisher Scientific) for 1-2 minutes, then 
washed in dH20 for 2 x 5 minutes. The gel was crushed through a metal sieve and 
incubated in twice the crushed gel volume of 5% (vlv) triethylamine (Sigma-Aldrich) 
for 20 minutes. The eluted material was lyophilised. 
4.1.7 Sulfo-NHS-biotinylation 
LPS (100 jig) was solubilised in 1 ml sterile PBS using a heated sonicator bath for 10 
minutes. 500 tl was kept as control, and 500 p1 was incubated with 100 p.1 10 mM 
N-hydroxysulfosuccinimide-biotin (Sulfo-NHS-biotin; Pierce) for 30 minutes at 
room temperature. Both the control LPS and the biotinylated LPS was lyophilised 
overnight, then resuspended in 100 p1 DOC-sample buffer. Each sample (10 p1) was 
analysed on duplicate DOC gels (see 4.1.4.), one was silver stained as described in 
4.1.5. and the other was used for streptavidin western blot (see 2.4.7). 
4.2 Cationic antimicrobial peptide resistance 
4.2.1 In siico analysis of UDP-glucose dehydrogenase (Ugd) and 
Aminoarabinose transferase (ArnT) 
The Ugd PA2022 DNA and protein sequences from P. aeruginosa PA01, and the 
ArnT DNA and protein sequences from E. coil K12 strain MG1655 were used to 
BLAST the B. cenocepacia J2315 genome sequence available at the Wellcome Trust 
Sanger Institute (http://www.sanger.ac.ukl) and the NCBI genomic BLAST service 
(http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi) using TBLASTN and 
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TBLASTP. Protein sequence alignments were created using Vector NTI AdvanceTM 
Explorer and ClustaiW software. 
4.2.2 Cloning and expression of UDP-glucose dehydrogenases, 
ugdBcAL2946, ugdBcAM2O34 and U9dBCAM0855 
The B. cenocepacia J2315 UgdBCAL2946, ugdBcAM2034 and ugdBcAM0855 genes were 
amplified using 2 puReTaqTM Ready-To-Go PCR beads (Amersham), 5 p1 of each 
primer (ugd bca12946 For and Rev, ugd bcam2034 For and Rev, ugd bcam0855 For 
and Rev), 1 p1 B. cenocepacia J2315 genomic DNA (prepared as in 2.3.1.) and 39 p1 
dH20. Samples were PCR-amplified for 30 cycles at 94 °C 1 mm, 54 °C I mm, and 
72 °C 2 mm, with a final 10 min extension at 72 °C. The amplified ugd PCR products 
(1398 bp for ugdbca,2946, 1413 bp for ugdbcam2946 and 1436 bp for ugdbcamosss) were 
isolated from a preparative 1 % agarose gel and cloned using the pGEM®-T Easy 
vector system (see 2.3.4.). Positive clones were isolated and sequenced to confirm 
the fidelity of the PCR reaction. Restrictions enzymes Mel and BamHI were used to 
cut ugdscAL2946 and ugdBcAM2034, and Ndel and Xhol to cut UgdBCAMO855 to ligate with 
pET28a (cut with identical enzymes). The ligation mixtures were used to transform 
E. coli Top 10 cells, and selected by kanamycin resistance. Plasmids were isolated 
and inserts of the correct size were confirmed by restriction digest analysis. 
The resulting plasmids, pET-28aIugdBCAL2946, pET-28a!ugdBcAM2034 and pET-
28aIugdBcAMo855, were expressed in E. coli BL21 (DE3) or HSM174 (DE3) (see 
2.4.1), each with an N-terminal 6His tag. 
4.2.3 Purification of recombinant UgdBcAL2946 and UgdBcAMo855 
To prepare recombinant Ugd proteins for biochemical analysis a large-scale culture 
(4 liters of LB supplemented with kanamycin) was performed with E. coli HMS 174 
(DE3) transformed with pET-28aIugdBcAL2946 or pET-28a1ugdBcAuo855. Each batch 
was grown to an 0D600 of 0.6, and induced by addition of 0.5 mM IPTG (final 
concentration) for 3 h at 37 °C with shaking. Both Ugd8cpI2945 and UgdBc0855 
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were highly over-expressed in soluble forms and cell-free extracts were prepared as 
described in 2.4.2. 
An AKTA Basic instrument fitted with a 5 ml HisTrapTM (GE Healthcare) column 
was used to isolate the enzymes from the ultra-filtered cell free extracts. The buffers 
used were as follows: 500 ml binding buffer 20 mM Tris, 500 mM NaCl, 5 mM 
Imidazole, pH 7.5; 500 ml elution buffer: 20 mM Tris, 500 mM NaCl, 500 mM 
Imidazole, pH 7.5. The eluted His-tagged Ugd proteins were judged >90% pure by 
SDS-PAGE analysis after this step. 
The enzymes were further purified by size exclusion chromatography, as described 
in 2.4.3., using a HiPrep 26/60 Sephacryl S-200 column (GE Healthcare). The 
calibrated column was equilibrated with 150 mM NaCl and 20 mM Tris, pH7.5. The 
molecular weights of the enzymes were estimated from their column elution volumes 
and by non-denaturing gel electrophoresis (10% Novex® Tris-Glycine Pre-Cast 
Gels, Invitrogen), following the manufacturer's instructions. 
The subunit molecular weights were confirmed by LC-ESI-MS and were within 0.1 
% of the theoretical values (see 2.4.8.). 
The protein concentration was determined by a BCA assay (Pierce) and a typical 
yield was -3 mg Ugd per litre of E. coil culture. 
4.2.4 Purification of recombinant UgdBcAM2034 
To prepare recombinant UgdBcAJ41034 a large-scale culture (4 liters of LB 
supplemented with kanamycin) was performed with E. coil BL2 1 (DE3) transformed 
with pET-28aJugdBcAM2034. Each batch was grown to an 0D600 of 0.6, and induced by 
addition of 0.2 mlvi IPTG final concentration for 16 hat 15 °C with shaking. 
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A 5 ml HisTrapTM column was attempted as described in 4.2.2. and some protein was 
isolated; however, this was not possible to repeat due to problems of insolubility of 
the enzyme. 
To solubilise Ugdacl&.w034 for purification the pellet was resuspended and 
homogenized in 5m1 per g cell pellet in binding buffer containing 25 % (w/v) 
sucrose, 1 mM EDTA and a protease inhibitor tablet. Thirty mg lysozyme, 5 p1 
DNase and 5 mM MgCl2 was added and the cells were left to stir for 1 hour at 4 °C. 
The cells were sonicated in ice for 10 minutes, 30 s onl30s off. Then 1 % (w/v) n-
Dodecyl-13-maltoside (DDM) and 20 % glycerol was added and the cells were 
incubated with mixing at 4°C for 1 hour before centrifugation at 14 000 rpm for 45 
minutes. The supernatant was incubated with equilibrated nickel NTA agar beads for 
3 hour. The beads were washed in elution buffer (20 mM Tris, pH7.5, 500 mM NaCl, 
0.1 % (w/v) DDM, and 10 % glycerol) with 10 mM imidazole. Protein was eluted in 
elution buffer containing 20, 50, 100 or 200 mM imidazole. All fractions were 
analysed by SDS-PAGE, and fractions containing UgdBc2034 were concentrated to 
1 mg ml-1 and assayed for Ugd activity. The molecular weight of UgdBc&r..42034 was 
estimated from size-exclusion chromatography, LC-ESI-MS and non-denaturing gel 
electrophoresis (as above). 
4.2.5 In vitro Ugd activity assay 
Ugd oxidizes UDP-glucose to UDP-glucuronic acid, and in the process also reduces 
2 moles of NAD to 2 moles of NADH. The molar extinction co-efficient of NADH 
is 6.220 mM 1cm' at 340 run. A standard Ugd activity assay was set up using 200 j.xl 
H20, 100 p1 purified Ugd (1 mg ml-1), 200 R1  buffer (100 mM Tris, pH 7.5), 250 p1 
NAD (10 mM; Roche) at 25 °C. The reaction was initiated by the addition of 250 p1 
UDP-glucose (1 mM; Calbiochem) and the production of NADH was monitored at 
340 rim on a Cary 50 UV visible spectrophotometer (Varian). Initial velocities were 
determined for UDP-glucose using concentrations ranging from 0 to 0.25 mM, and 
NAD using concentrations ranging from 0 to 2.5 mM. To determine kinetic 
constants one substrate was held constant at the maximum concentration, while the 
92 
Chapter 4: Lipopolysaccha rides and AMP Resistance 
other was varied. The kinetic parameters (keat, ICm, Vmax) were determined by non-
linear regression from V = Vm [S]'/([S 1' + KnP) using 0rigin6. 1 software. 
Substrate specificity was investigated by replacing the substrate UDP-glucose with 
either: UDP-galactose, UDP-acetylglucosamine or GDP-mannose (Calbiochem), and 
performing the standard assay. 
4.2.6 Cloning and expression of aminoarabinose transferase, ArnT 
The B. cenocepacia J2315 arnT gene (BCAL 1929) was amplified twice; first arnT 
was amplified without a stop codon: 2.5 U Flerculase® Hotstart DNA Polymerase 
(Stratagene), 300 nM of each primer (arnT C-term His For and Rev,), 4 % DMSO, 
200 RM each dNTP and 1 jtl B. cenocepacia J2315 genomic DNA (prepared as in 
2.3.1.) with appropriate manufacturer's reaction buffer, made up in 50 fl reactions. 
The second reaction amplified arnT with a stop codon: 2.5 U Proofstart DNA 
polymerase (Qiagen), I p.M of each primer (arnT N-term His For and Rev), 300 p.M 
each dNTP and 1 p.1 B. cenocepacia J2315 genomic DNA (prepared as in 2.3.1.) with 
solution Q and appropriate manufacturer's reaction buffer, made up in 50 tl 
reactions. 
Both samples were PCR-amplified for 30 cycles at 95 °C 1 mm, 60 °C 1 mm, and 72 
°C 2 mm, then 1 puReTaqTM Ready-To-Go PCR bead was added for a final 10 mm 
extension at 72 °C. The amplified arnT PCR products (1680 bp for arnTc.te, 1692 
bp for arnTNte) were isolated from a 1% agarose gel and cloned using the pGEM®-
T Easy vector system (see 2.3.4.). Positive clones were isolated and sequenced to 
confirm the fidelity of the PCR reaction. Restrictions enzymes Ncol and Xhol were 
used to cut arnTcte and Ndel and fbI to cut arnTN.te to ligate with pET28a (cut 
with identical enzymes). The ligation mixtures were used to transform E. coli Top 10 
cells, and selected by kanamycin resistance. Plasmids were isolated and inserts of the 
correct size were confirmed by restriction digest analysis. 
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The resulting plasmids, pET-28aJarnTcte and arnTN-te, were expressed in E. coil 
HSM 174 (DE3), BLR (DE3), Rosetta (DE3), C41 (DE3) or C43 (DE3) (see 2.4.1). 
Expression was visualised by western blot using anti-His antibodies as described in 
2.4.6. (ArnTc.term at 63748.48 Da and ArnTN.term at 64845.64 Da). Large-scale 
inductions in E. coli C41 (DE3) or C43 (DE3) were set up using pET-28a1 arnTNte. 
To prepare the arnT genes for cloning into an alternative expression plasmid, 
pTrc99a, two PCR reactions were set up using pET-28aJarnTNC and arnTc.te as 
templates, using 2 puReTaqTM Ready-To-Go PCR beads (Amersham), 5 .xl of each 
primer (either arnT C-term and arnT C-term6 His Rev, or arnTNterm6 His Forl and 
arnTNterm6 His Rev), 1 i.tl genomic DNA and 39 p1 dH20. Samples were amplified 
for 30 cycles: 95 °C 1 mm, 60 'C 1 mm, and 72 'C 2 mm; with a final 10-mm 
extension at 72°C. The arnTc.tern-. (1698 bp) and arnTNt (1748 bp) genes, flanked 
by Ncol and Hindlll, were now amplified with the 6 His tag. The genes were 
electrophoresed on a 1% agarose gel, and gel extracted using QlAprep® Gel 
Extraction kit from Qiagen. The arnTcte and arnTN.te genes were again cloned 
into pGEM as described in 2.3.4. After restriction digests and sequencing analysis, 
the genes were cloned into pTrc99a (as described in see 2.4.1.) and selected on 
ampicillin. 
4.2.7 RT-PCR of C-terminal ArnT expression 
To double-check that arnTc.teim was being expressed, RT-PCR was performed. E. 
coil strain BLR (DE3) were transformed with pET-28aIarnTc.te; and E. coil TOP 10 
cells were transformed with pTrc99a/arnTc.te. B. cenocepacia J2315 was used as a 
positive control. Overnight cultures were sub-cultured into fresh LB media and 
grown until an 0D600 of 0.5, when half the E. coil cells were induced with IPTG 
(1mM final concentration). RNA was extracted from mid-log phase cultures (RNeasy 
Protect Bacteria Mini Kit; Qiagen) and DNase I-treated (RNase-free DNase set; 
Qiagen), prior to reverse transcription with 1.5 ig RNA template, random primers 
and SuperScript III Reverse Transcriptase (Invitrogen). cDNAs and corresponding 
non-RT controls were used as template in PCR reaction amplifying arnT. PCR 
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reactions were performed in a 25 p1 volume containing 300 nM forward and reverse 
primer (pmrK For and Rev), 260 j.tM of each dNTP, 1 U Taq DNA polymerase 
(Qiagen) with Q solution and appropriate manufacturer's reaction buffer. Thermal 
cycling was performed using the following parameters: 35 cycles of 95 °C (30 s), 58 
°C (30 s), 72 °C (1 mm), followed by a 10 min extension at 72 °C. 
4.2.8 Sulfo-NHS-biotinylation of E. coil WBBO6/pTrc99a/arnTc4erm LPS 
Deep-rough E. coli WBB06 were transformed by electroporation (as in 2.3.7.) with 
pTrc99a/arnTc.t= and clones were selected by tetracycline and ampicillin resistance. 
Overnight cultures were sub-cultured into fresh LB media and grown until an 0D600 
of 0.5 at 37°C, when half the E. coli cells were induced with IPTG (1mM final 
concentration). Small-scale LPS extractions of induced and uninduced cells were 
carried out (as in 4.1.2) followed by NHS-biotinylation and Western blot as 
described in 4.1.7. 
4.2.9 Purification of ArnT 
The E. coli C41 (DE3) or C43 (DE3) pellets expressing pET-28a/ arnTNte, were 
resuspended (5 ml per g cell pellet) in 25 mM Tris buffer (pH 8.0) and a tablet of 
protease inhibitor cocktail (Roche). The mixture was stirred briskly at 4°C for 30 
minutes. This mixture was sonicated for 15 minutes (30 seconds on and 30 seconds 
off) and then centrifuged at 25000 x g for 30 minutes at 4°C to remove insoluble 
debris. The opaque supernatant was decanted and ultra centrifuged at 120000xg for 2 
hours at 4°C. The resulting dense golden pellet was resuspended in a minimal 
amount of 25mM Tris buffer (pH 8.0) and frozen in 1 ml aliquots at -20°C. 
Aliquots of enriched inner membranes were solubilised in 25 mM Tris buffer (pH 
8.0) containing 500 mM NaCl, 1% (w/v) DDM and 20% (v/v) glycerol 
(resolubilisation buffer) at 4°C for 3 hours with gentle agitation. The extraction 
mixture was centrifuged for 30 minutes at 25000 x g and 4°C to remove any 
remaining unsolubilised material. TALON metal affinity resin (Clontech) was 
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washed three times in water and then three times in resolubilisation buffer. The 
extract supernatant was incubated with the equilibrated TALON resin for 1-2 hours 
at 4°C with gentle agitation. The resin was washed with 20 column volumes 10 mM 
imidazole. The protein was eluted with 25 mlvi Tris buffer with different 
concentrations of imidazole (20, 50, 100, 200 mM). All the fractions were collected 
for a SDS-PAGE and Western Blot. 
4.2.10 ArnT assay in E. co/i AY103 (arnT::kan) 
The E. coil arnT knock-out mutant strain AY103 was made electrocompetent as 
described in 2.2.2. Aliquots of the cells were transformed by electroporation (as in 
2.3.7.) with pTrc99a/arnTc.tern,, pTrc99a/arnTNte,, or pTrc99aJFbpA. As a positive 
control we used pTrc99a/FbpA which expresses a 33kDa ferric binding protein from 
Neisseria gonorrhoeae (cloned by Paul Bilton, School of Chemistry, University of 
Edinburgh). E. coil AY103, and E. coli AY103 containing pTrc99a/arnTcte, 
pTrc99a/arnTNte or pTrc99aJFbpA sub-cultured onto LB agar plates containing 
either kanamycin (30 p.g mY1), kanamycin and ampicillin (100 jig ml-1), or 
polymyxin (10 jig mU1), the same strains were used to inoculate 10 ml LB broth 
overnight at 30 °C. The overnight cultures were used for small-scale LPS extractions, 
followed by sulfo-NHS-bioltinylation and western blot. 
4.2.11 Complementation assay of B. cenocepacia XOAII (arnT 
conditional mutant) 
To clone the B. cenocepacia arnT gene into the pDA-17 plasmid suitable for 
expression in B. cenocepacia conditional arnT mutant XOA1 1 (Ortega et at, 2007) it was 
amplified as follows. A PCR reaction was set up using pET-28aIarnTNterm as 
template, using 2.5 U Proofstart DNA polymerase (Qiagen):, 1 jiM of each primer 
(arnT Nterm6 His For2 and arnT Nterm6 His Rev), 300 jiM each dNTP and I jil B. 
cenocepacia J2315 genomic DNA (prepared as in 2.3.1.) with solution Q and 
appropriate manufacturer's reaction buffer, made up in 50 jil reactions. Thermal 
cycling was performed using the following parameters: 40 cycles at 95 °C 1 mm, 55 
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°C 1 mm, and 72 °C 2 mm, then 1 puReTaqTM Ready-To-Go PCR bead was added 
for a final 10 min extension at 72 T. The arnTN.tCffl (1762 bp) gene, flanked by EcoRI 
and Hindlll, was now amplified with the N-terminal 6 His tag. The genes were 
electrophoresed on a 1% agarose gel, and gel extracted using QlAprep® Gel 
Extraction kit from Qiagen. The arnTN.te gene was again cloned into pGEM as 
described in 2.3.4. After restriction digests and sequencing analysis, the genes were 
cloned into pDA-17 (as described in see 2.4.1.) and clones were selected by 
tetracycline resistance. 
E. coil DH5cz was transformed with pDA-17IarnTNte and selected on tetracycline 
plates to become donors for triparental mating. In addition, the helper strain was prepared by 
transforming E. coil DH5a with helper plasmid pRK2013, selected on kanamycin plates, 
and the recipient strains B. cenocepacia conditional arnT mutant XOA1 1 was streaked onto 
a gentamycinitrimethoprim plate. Triparental mating was carried out as described in 2.3.8, 
and B. cenocepacia XOA1 1 containing a wild type arnT on pDA-17 was selected on 
tetracycline, trimethoprim and gentamycin, containing 0.5 % rhamnose. Complementation 
was investigated by streaking successful colonies on LB agar plates containing 0.5 % 
glucose. 
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4.3. Results 
4.3.1 LPS extraction and analysis 
Members of the B. cenocepacia ET-12 lineage have rough LPS with the exception of 
B. cenocepacia K56-2 which has smooth LPS. This was shown to be due to an 
insertion sequence in wbxE, encoding a glycosyl transferase involved in 0-antigen 
biosynthesis, found in all ET-12 strains except K56-2 (Ortega et al., 2005). Hence, 
the LPSs used in this section were isolated from the clonal ET-12 strains B. 
cenocepacia K56-2 and J2315. In addition, LPS from a deep-rough B. cenocepacia 
ET-12 mutant SAL-i was investigated. The SAL-I strain is heptose-less due to 
insertional inactivation of hidD and hidA genes, encoding a putative ADP-1-glycero-
D-maimo-heptose-6-epimerase and a putative D-beta-D-heptose 7-phosphate kinase, 
respectively (Loutet et all, 2006). The LPS from these smooth, rough and deep-rough 
B. cenocepacia ET-12 strains were extracted using the hot phenol-water method 
yielding an aqueous and a phenol phase. Both phases were analysed by DOC-PAGE. 
A commercial E. coil Kd02-lipid A preparation (Avanti), isolated from deep-rough E. 
coil strain W131306, was used as a control. E. coli WBB06 is also a heptose-less 
mutant, with mutations in heptosyltransferase genes rfaC and rfaF (Brabetz et al., 
1997), and its LPS has recently been fully characterised (Raetz et all, 2006), making 
it an excellent model for comparison. 
To visualise the LPS, the DOC gels were stained using different staining methods. 
Based on protein silver staining methods, sodium-m-periodate (smp) silver staining 
of LPS was developed by Tsai and Frasch in 1982 (Tsai & Frasch, 1982) and 
involves smp oxidation followed by ammoniacal silver nitrate incubation and citric 
acid/formaldehyde development. It is believed that the smp reacts with diol groups 
on polysaccharides to form reactive aldehydes with which the silver nitrate reacts to 
form a precipitate of silver (Fig. 20 (A)). Instead of using smp oxidation, the cationic 
dye alcian blue was added prior to silver staining. This combination is thought to 
reveal more negatively charged and hydrophilic residues (Fig. 20 (B)). However, 
based on the gels in Fig. 20, no significant differences were observed between the 
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two silver staining methods, although, smp silver staining produces a gel with a 
clearer background 
A) 1 2 3 4 
oil $ is 
Fig. 20: DOC-gels illustrating smp-silver staining (A) vs alcian blue silver staining (B). The sample 
order on both gels is as follows: lanel, B. cenocepacia J2315 aqueous phase; lane 2, B. cenocepacia 
K56-2 aqueous phase; lane 3, B. cenocepacia J2315 phenol phase; lane 4, B. cenocepacia K56-2 
phenol phase. 
Kropinski et al argued that smp silver staining does not stain polysaccharides but 
only lipid A and suggest possible Ag binding sites on the fatty acid chains 
(Kropinski et at., 1986). Corzo et at added that only pre-treating with alcian blue 
allowed the visualisation of polysaccharides that would be missed by smp silver 
staining (Corzo et al., 1991). It is likely that the lower (faster migrating) bands on a 
DOC-gel represent the lipid A and core, and, in smooth isolates, each rung up the 
characteristic ladder represents a lipid A-core molecule substituted with an increase 
of one additional 0 unit, and the spacing between rungs is determined by the size of 
the 0 unit. This gives rise to the characteristic, strain-specific 0-antigen ladder 
banding pattern observed in LPS gels. However, from gel analysis alone one cannot 
fully determine LPS modifications present in different isolates. Therefore, a method 
of isolating and analysing the chemistry of individual bands would be very useful. 
During literature research for this project a new staining method was found. This is 
called "negative", or "reverse", staining and is based on an interaction between zinc 
and LPS (Castellanos-Serra & Hardy, 2006; Hardy & Castellanos-Serra, 2004). The 
gel was incubated with zinc sulfate and the zinc bound to the biomolecules 
negatively charged residues, for example phosphate groups or polyhydroxyls, then 
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imidazole was added to interact with unbound zinc ions leading to form the insoluble 
zinc imidazolate (Znlm2) which stains the whole gel, except the biomolecule, white 
(Fig. 21). The LPS appears as a clear zone and is observed against a black 
background. In effect, the LPSs are not chemically modified and remain "unstained". 
In addition, this method appears to be more sensitive than silver staining (Fig. 21). 
(A)1 2 3 4 5 6 7 
•. U 
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(BI 1 2 3 4 5 6 7 
Fig. 21: DOC-gels illustrating smp-silver staining (A) vs negative (reverse) staining (B). The sample 
order on both gels is as follows: lane 1, B. cenocepacia K56-2 aqueous phase; lane 2, B. cenocepacia 
K56-2 phenol phase; lane 3, B. cenocepacia J2315 aqueous phase; lane 4, B. cenocepacia J2315 
phenol phase; lane 5, B. cenocepacia SAL-1 aqueous phase; lane 6, B. cenocepacia SAL-1 phenol 
phase; lane 7, E. coil Kd02-lipid A (Avanti). Two ig of each sample was loaded into the wells. 
The different LPS bands can then be excised and the biornolecules recovered by first 
reversing the zinc fixation by EDTA incubation and then eluting from the gel with 
triethylamine. This method should, when optimised, recover 80 % of the 
biomolecules, and the recovered material should still be intact and biologically active 
(Hardy & Castellanos-Serra, 2004). To optimise the recovery procedure in our hands 
we used Kd02-lipid A and SAL-1 LPS but we could only re-isolate a very small 
percentage of the initial material (data not shown). Time prevented a detailed study 
of the reverse-staining method but current work in the lab is aimed at optimising 
purification and analysis of Bcc LPS using this technique. With this method in hand, 
investigations into where AIvIPs bind to LPS can be carried out, as well as 
understanding which components and structures are immuno-stimulatory. 
A recent study by Raetz and co-workers used N-hydroxysuccinimide-biotin (NHS-
biotin; membrane permeable) and sulfo-NHS-biotin (membrane impermeable) to 
IEII, 
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show that Upp-L-Ara4N transport across the inner-membrane is defective in pinrL 
and pmrM mutants of pmrA' strain MST100 compared to wild type (Hung et al., 
2007). They treated cell cultures with NHS-biotin or sulfo-NHS-biotin, followed by 
lipid extraction, TLC and ESIIMS analysis of Upp-L-Ara4N modification. in this 
study, attempts were made to detect any LPS species modified with L-Ara4N by 
directly labelling isolated LPS with sulfo-NHS-biotin. The sulfo-NHS-biotin reacts 
with primary amine groups of L-Ara4N (Fig. 22), and the biotinylated LPS can be 
detected by streptavidin using Western blotting. When applied to B. cenocepacia 
J2315, SAL-1 and E. coil Kd02-lipid A, only J2315 and SAL-1 are visible after 
blotting (Fig. 23) as would be expected. However, the band observed from the SAL-
1 LPS is significantly higher (slower migrating) than the main band observed by smp 
silver staining, and suggests that the higher bands of the phenol phase of rough and 
deep-rough isolates observed mainly by alcian blue and negative staining may be 
important polysaccharide bands missed by some extraction and staining methods. 
This method may in future provide a useful tool for detecting L-Ara4N modified LPS 






sulfo-NI-IS-biotin biotinylated L-Ara4N-Iipid A 
Fig. 22: Sulfo-NHS-biotin reacting with L-Ara4N-lipid A. 
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(A)1 2 3 
Ei 
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Fig. 23: Biotinylation of LPS. (A) Srnp-silver stained DOC-gel: lane 1, B. cenocepacia J23 15; lane 2, 
B. cenocepacia SAL-1; lane 3, E, coil Kd02-lipid A (Avanti). (B) Western blot of biotinylated LPS 
using streptavidin: lane 1, biotinylated B. cenocepacia J2315; lane 2, control B. cenocepacia J2315; 
lane 3, biotinylated B. cenocepacia SAL- 1; lane 4, control B. cenocepacia SAL- 1; lane 5, biotinylated 
E. coil Kd02-iipid A; lane 6, control E. coil Kd02-lipid A. 
4.3.2 in silica genome analysis of B. cenocepacia ugd and arnT 
The synthesis of UDP-L-Ara4N begins with the conversion of UDP-glucose to UDP-
glucuronic acid catalysed by the enzyme UDP-glucose dehydrogenase (EJgd); and the 
last enzyme of the L-Ara4N biosynthetic pathway is the inner membrane protein 
aminoarabinose transferase, ArnT, which catalyses the transfer of L-Ara4N from 
Upp.-L-Ara4N to the lipid A. In order to identify any putative homologs of these two 
enzymes in the B. cenocepacia J2315 genome, the Ugd PA2022 DNA and protein 
sequences from P. aeruginosa PAO 1, and the ArnT DNA and protein sequences from 
E. coli K12 strain MG1655 were used to BLAST the B. cenocepacia J2315 genome 
sequence available at the Wellcome Trust Sanger Institute and the NCBI genomic 
BLAST service using TBLASTN and TBLASTP. 
Compared to E. coli MG1655 ArnT, there was no significant hit in the B. 
cenocepacia J2315 genome, but the three closest potential hits were BCAL1199, 
BCALI929 and BCAL2370, found on chromosome 1, with 8.2%, 22.3% and 14.8% 
amino acid identity respectively. BCALJ199 is found in a six gene-cluster containing 
phage-related proteins (Fig. 24) and is not very likely to be an L-Ara4N transferase. 
BCAL1929 and BCAL2370 are found in a seven and an eleven gene-cluster 
respectively (Fig. 25 and 26), both encoding putative gycosyl transfereases, however, 
102 
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amT bcalll99 
bcall198 b cal l200 b cal l2Ol b cal l2O2 b cal l2O3 
3889bp 
Fig. 24: Putative arnTBCALj 199  gene cluster. BCAL 1198, 1200, 1202 and 1203 encode hypothetical 
proteins; BCAL1199, a putative phage-related protein; and BCAL1201, a putative phage-related 
protein endonuclease-like protein. 
b cal 2364 
bca12363 
b cal 2362 
bca12361 





b cal 2366 
bca12367 
bca12368 
bca12369 arnT bca12370 
9488bp 
Fig. 25: Putative arnTBL2370 gene cluster. BCAL2360 and 2361, encode putative sigma factors; 
BCAL2362, hypothetical protein; BCAL2363, RDD domain-containing protein; BCAL2364, 
metallophosphoesterase; BCAL2365, putative glycosyltransferase; BCAL2366, putative 
glycosyltransferase or putative kinase; BCAL2367, TetR family regulatory protein or putative 
decarboxylase; BCAL2368, TetR family regulatory protein or putative decarboxylase; BCAL2369, 
putative dehydrogenase; BCAL2370, glycosyltransferase. 
am C 
Fig. 26: Putative L-Ara4N biosynthetic gene cluster in B. cenocepacia J2315. arnTBcAL 1929, putative L-
Ara4N transferase; arnG, putative SMR family transporter protein; arnB, putative UDP-L-Ara4N-
oxoglutarate aniinotransferase; arnC, putative undecaprenyl-phosphate 4-deoxy-4-formamido-L-
arabinose transferase; am], putative undecaprenyl-phosphate 4-deoxy-4-formamido-l-arab inose 
transferase; amnA2, putative UDP-glucuronic acid decarboxylase; arnD, putative polysaccharide 
deacetylase. 
WX 
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only BCAL 1929 is associated with the putative arn locus (Fig. 26), suggesting the 
possibility of a single arnT in the J2315 genome. AmTBc1929 also has low 
homology to other known ArnT homologs, with the highest being 24% identity to P. 
aeruginosa PA01 AmT and 24.1% identity to Francisella tularensis FlmK (see 
appendix). 
Three putative Ugds were found in the B. cenocepacia J2315 genome, one on 
chromosome 1 (ugdBcAL2946) and two on chromosome 2 (ugdBcAMosss and 
u9dBcA)n034). ugdBcAL2946, ugdBcAMoess, and ugdBcAM2034 share 52.5%, 51.8% and 
3 8.4% amino acid sequence identity with P. aeruginosa Ugd PA2022, respectively. 
The predicted proteins UgdBc4j2946 and UgdBc0855 share 73.3% amino acid 
sequence identity with each other, and UgdBc2034 shares 43.1% and 43.0% amino 
acid sequence identity with UgdBc14I2946 and UgdBcAJo855, respectively (see 
appendix). The three putative B. cenocepacia Ugds share relatively low sequence 
identity (ugdBcAL2946 21.2%, ugdBcAM0855 20.8% and ugdBcAM2034 23.3%) with the 
Streptococcus pyo genes Ugd, the structure of which was recently determined (Fig. 
27; Protein Data Bank, accession codes 1DLI and lDLJ; (Campbell et at, 2000)). 
However, a ClustalW alignment with PA01 Ugd PA2022 and PA3559 and Strep. 
pyogenes Ugd (Fig. 28) revealed that UgdBcAn946, Ugdsc0855 and UgdBc2034 
contain a predicted Rossmann fold (GxGxxG) for NAD binding at the N-terminus 
and all residues involved in the catalytic mechanism (Campbell et at, 2000). 
Residues such as Cys260 involved in thioester formation and Arg244 involved in 
UDP-sugar specificity are conserved (equivalent residues Cys274 and Arg258 in 
UgdBc44J2946, Cys270 and Arg254 in UgdBcAM0855, and Cys266 and Arg250 in 
UgdBcAM2034). 
The chromosomal arrangements of the three putative ugd genes are shown in Figures 
29-31. ugdBcAL2946 is found within a six-gene cluster directly upstream of hidA and 
hldD, which encode proteins required for the synthesis of L-glycero-D-manno-
heptose, an important sugar in the LPS inner core oligosaccharide (Fig. 29, (Looter et 
at, 2006)). ugdBcAM2034 is in a four-gene cluster that contains two open reading 
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frames similar to galE (UDP-galactose 4-epimerase) as well as a predicted 
glycosyltransferase (Fig. 30). ugdBcAMo855, was recently annotated as bceC by 
Moreira and colleagues (Moreira et al., 2003), and is part of the ten-gene bce cluster 






 26 NAD+ 
Rossmannfold 
Fig. 27: Structure of Ugd from Streptococcus pyogenes (Campbell et al 2000). (A) Ugd monomer 
with UDP-xylopyranose (UDX; pink) and NAD (blue); and (B) zoom of the active site highlighting 
active site residues surrounding the substrates UDX and NAD: C260, K204, T118, N208 and D264, 
as well as R244 and the Rossmann fold. 
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Fig. 28: Sequence alignment of Ugds from B. cenocepacia, P. aeruginosa and Strep. Pyogenes. 
Highlighted in red are the active site residues threonine, lysine, asparagine, cysteine, and aspartic acid; 
highlighted in blue is arginine involved in UDP-glucose specificity and highlighted in black is the 
Rossmann fold involved in NAW binding. 
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2013o bp 
Fig. 29: Physical organization of ugdA and surrounding genes. Bcal2940, putative histone deacetylase-
family protein; bca12941 putative exported transglycosylase; bca12942, putative cysteine synthase; 
bca12943, putative helix-hairpin-helix DNA-binding motif-containing protein; bca12944, putative 
ADP-1-glycero-D-manno-heptose-6-epimerase; bca12945, putative D-beta-D-heptose 7-phosphate 
kinase; bca12946, putative UDP-glucose dehydrogenase (ugd); bca12947, predicted N-
acetyiglucosaminyl transferase; bca12948, hypothetical protein; bca12949, putative integration host 
factor beta-subunit; bca12950, putative 30S ribosomal protein Si; bca12951, putative cytidylate 
kinase; bca12952, putative 3-phosphoshikimate 1-carboxyvinyltransferase; bca12953, putative 
prephenate dehydrogenase; bca12954, putative choristnate mutase; bca12955, putative phosphoserine 
aminotransferase; bca12956, hypothetical protein; bca12957, putative DNA gyrase, subunit A 
bcam2032 bcam2033 ugdB bcam2035 
613o bp 
Fig. 30: Physical organization of ugd,3 and surrounding genes. bcam2032, putative UDP-glucuroninc 
acid decarboxylase; bcam2033, putative UDP-glucose-4-epirnerase; bca12034, putative UDP-




Fig. 31: Physical organization of ugdc and the bce gene cluster. bceA, phosphomannose isomerase 
and GDP-D-mannose pyrophosphorylase; bceB, undecaprenyl-phosphate glucosyl- 1-phosphate 
transferase; bceC, putative UDP-glucose dehydrogenase (ugd&; bceD, phosphotyrosine phosphatase 
bceE, putative outer-memebrane lipoprotein; bceF, tyrosine autokinase bceG, putative 
glycosyltransferase; bceH putative glycosyltransferase; bcel. putative polymerase; bceJ putative 
glycosyltransferase; bceK, putative glycosyltransferase; bceL, putative repeat unit transporter (Ferreira 
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4.3.3 Characterisation of three putative B. cenocepacia J2315 UDP-
glucose dehydrogenases 
To characterize the enzymes encoded by ugdBcAL2946, u9dBcAM2034 and ugdBcAMo855, 
each gene was cloned into a pET28 expression plasmid to add an N-terminal 6 His 
tag to ease purification. UgdBc2946 and UgdBcAJVI0855 were over-expressed in E. coli 
HSM174 (DE3) and UgdBcA034 in BL21 (DE3) cells (Figure 32). 
Fig. 32: Expression of Ugd, UgdB and Ugdc in E. coli (DE3) cells. (A) Over-expression of UgdA in 
E. coli HSM 174 (DE3): lane 1, LMW marker; lanes 2-4 uninduced controls; lanes 5-7, induced with 
1 mM IPTG for 3 hours at 37°C; (B) Over-expression of UgdB in E. coli HSM 174 (DE3) and BL21 
(DE3) induced with 0.2 mM IPTG for 4 hours at 25 °C. Lane 1, LMW marker; lane 2 uninduced 
HSM174 control; lane 3, induced HSM174; lane 4m uninduced BL21 control; lane 5, induced BL2; 
(C) Over-expression of Ugck in E. coli HSM 174 (DE3). Lane 1, SeeBlue®P1us2 marker; lanes 2 and 
3 uninduced controls; lanes 4 and 5, induced with 1 mM IPTG for 3 hours at 37C. 
UgdBcu946 and UgdBc0855 were soluble and purified using IMAC nickel affinity 
(Fig. 33) and size exclusion chromatography (Fig. 34). Both Ugd proteins behaved as 
homodimers ('-106 kDa) with similar elution profiles. Molecular weights were 
confirmed by mass-spectrometry (Fig. 35 (A) and (C)) and native gel electrophoresis 
(Fig. 34). UgdBc034 was insoluble and was over-expressed at a low temperature 
and solubilised using DDM and glycerol, followed by purification using nickel NTA 
agarose beads (Fig. 36) Size-exclusion chromatography and native gel 
electrophoresis (Fig. 37) indicated a possible mixture of monomer and homodimer 
conformations of UgdBc034. The molecular weight was confirmed by mass-
spectrometry (Fig. 35 (B)). 
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Fig. 33: [MAC nickel affinity chromatography of UgdA (A) and Ugd (B). Order on gel (A): lane 1, 
LMW marker; lane 2, cell free extract; lane 3, flow through; lane 4, wash, lanes 5-13, protein eluted 
on an increasing gradient of imidazole; and gel (B): lane 1, LMW marker; lane 2, cell free extract; 
lane 3, flow through; lane 4, wash, lanes 5-10, protein eluted on an increasing gradient of imidazole. 
The enzyme assay was based on the Ugd mechanism proposed by Campbell et al. 
(Campbell et al., 2000) and Ge et al. (Ge et al., 2004) (Fig. 38), UDP-glucose is 
converted to UDP-glucuronic acid in a two-step oxidation via a covalently-bound 
thioester intermediate. Conversion of this to the final free UDP-glucuronic acid 
product requires a second mole of NAD so overall the process reduces two moles 
NAD to two moles NADH. To determine the kinetic parameters, the initial velocity 
was calculated by measuring the increase in absorbance at 340 nm, due to the 
production of NADH, divided by two. The molar extinction coefficient of NADH at 
340 nm is 6220 M' cm. The data was fitted by non-linear regression with the Hill 
equation (V = Vmax [S]hl([S]h + KnP )). The enzyme turn-over (kcat) and catalytic 
efficiency (kcat/Km) were calculated from the Vm and K.. values obtained from the 
graphs (Fig. 39). Both UgdBc2946 and UgdBc0855 show Ugd activity with very 
similar kinetic constants, comparable to the two recently characterised P. aeruginosa 
Ugds (Hung et al., 2007) (Table 11). Unfortunately, UgdBc1&J034 showed no in vitro 
activity. To investigate any variation in substrate specificity between the Ugd 
proteins, the spectrophotornetric assay was repeated with UDP-galactose, UDP-











Chapter 4: Lipopolysaccha rides and AMP resistance 
 
CT5r45000t7GD01l_UV1_18Ooss -- - CTSoIS202Ij01P0lI_Irc000 





I 148 . 








2 I 010  I ( I 0(10I2II12II3II4I10(I6(17(19I19I20I21(22( 251 2425 ( 2627 I 20 ISOI 30 1 31 ( 32 
00 lOS 150 200 250 300 521 
 
010.00,2(51 0C0l1_UV1_I80052 - - CT Ipb,.l 01OcT11 
0000 
kDa 123456 78 
250 - 
"s kDa —53 kDa 250 




22 W# 64 
19 111k .zc 
- 50 
200 6j 36 
100 
I I S I 5 I I I I 0 0 I II II I Ii I-' 5 I 2 00 II I II 20 I 1 i :0 
0 51 000 050 250 521 
Fig. 34: Size-exclusion chromatography shows that UgdA and Ugdc are dimers. (A) Chromatogram 
of Ugd.fractions 8-14 were collected and analysed by non-denaturing gel (inset): lane 1, 
SeeBIue' P1us2 marker; lanes 2-8, fractions 8-14. (B) Chromatogram of Ugck; fractions 8-14 
were collected and analysed by SDS-PAGE (inset): lane 1, SeeBluePlus2 marker; lanes 2-6, 
fractions 9-13. Fraction 4 was further analysed by non-denaturing gel (inset): lane 7, Ugd; 
lane 8, SeeBlue®Plus2  marker. 
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Fig. 35: : LC-ESI-MS data for Ugd (A), UgdB (B) and Ugd (C) UgdA shows the monomer and 
dimer size of 52913.16 +/-18.91 and 105842.02 +1-34.07 respectively (corresponding to theoretical 
masses, 53055.64 and 106111.28, minus methionine, I49.21).UgdB shows the monomer size of 
51974.82 +/-20.6 (corresponding to theoretical mass, 52112.03, minus the methionine, 149.21); and 
Ugdc shows the monomer size of 53218.36 +1-20.57 (corresponding to theoretical mass, 53388.85, 
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1 234567 
Fig. 36: Nickel NTA agarose beads purification of U-Mdc expressed in 
E. ccli BL21 (DE3) induced with 0.2 mlvi IPTG for 16 hours at 15 °C. 
Lane 1, LMW marker; lane 2, cell free extract; lane 3, flow through; 
lane 4, wash, ; lane 4-7, elution in 20, 50, 100 and 200 mM imidazole. 
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Fig. 37: Size-exclusion chromatography shows UgdB is purified as a mixture of monomer and dimer (A). 
Fractions were collected and analysed by SDS-PAGE (B): lane 1, LMW marker; lane 2-10, fractions 
8-16. A concentrated sample of UgdB was compared to UgdA  and Ugdc on a non-denaturing gel (C): 
lane 1, UgdA; lane 2, Ugd; lane 3, SeeBlue®Plus2 marker; lane 4, UgdB. 
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Fig. 38: Proposed Ugd mechanism (Campbell et al., 2000; Ge et al., 2004). UDP-glucose is converted 
to UDP-glucuronic acid by a 3-step pathway; oxidation form the primary alcohol substrate to an 
aldehyde intermediate; oxidation to a covalently-bound thioester intermediate; hydrolysis of the 
thioester to the acid product. Each oxidation reduces a NAD cofactor. The conserved active site 
lysine residue (218, 214 and 210 in UgdB0AL2946, UgdBCAM0855 and UgdBCAM2034 respectively), is likely 
to act as the general base for deprotonation of the substrate alcohol and the conserved cysteine (274, 
270 and 268 in Ugd cL294 , Ugd600855 and Ugd9c2034 respectively) is the residue involved in 
thioester formation. 
From these experiments it appears that UgdBcAI2946 and UgdBcAM0855 have identical 
enzymatic activities and confirm  biochemically the functional assignment of these 
proteins as UDP-glucose dehydrogenases. Moreover, they appear to have tight 
substrate specificity for UDP-glucose. UgdBc&Jf1034 does not have UDP-glucose 
dehydrogenase activity. 
Table 11: Kinetic comparison of Ugds from B. cenocepacia J2315 and P. aeruginosa PAOI 
(Hung et al., 2007) 
km  (MM) Vmax  (nmo!Imin) k (min") k,/km  (mM-min-1) h 
Ugd UDP-GIc 0.02 +1- 0.01 14.38 +1- 0.7 7.99 +1-0.1 392.36 +/- 0.4 1.25 +1- 0.16 
NAD+ 0.17 +1- 0.03 16.61 +1- 1.1 9.23 +/- 0.2 53.95 +1- 0.2 1.50 +1- 0.31 
Ugdc UDP.Glc 0.02 +/ 0.02 13.73 +1- 0.5 7.63 +I 0.1 340.35 +1 0.1 1.41 +I 0.12 
NAD+ 0.21 +1- 0.04 16.88 +1- 1.2 9.38 +/- 0.2 44.50 +1- 0.2 1.49 +1- 0.31 
PA 2022 UDP-Glc 0.12 +1- 0.01 11.6 +1- 0.5 14.4 +/- 0.3 117.8 +1- 2.5 1.20 +1- 0.11 
NAD+ 0.47+/-0.18 18.0+1-2.6 22.4+/-2.8 47.2+/-2.7 1.36+/-0.28 
PA 3559 UDP-Glc 0.40 +1- 0.03 32.9 +/- 2.6 48.4 +/- 1.5 120.7 +1- 3.7 1.67+/- 0.19 
NAD+ 1.99 +1- 0.67 95.8 +1- 12.0 141.0 +1- 8.9 71.0 +/- 4.5 0.84 +1- 0.09 
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Value Error Value Error 
Vma, 14.38 nmol,min' +/-0.73 Vmax 16.61 nmo1.min +1- 1.11 
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Value Error Value Error 
13.73 nmol.min" +/- 0.90 V 16.88 nmol.min" +/- 1.22 
Km 0.02mM +/- 0.01 Km 0.21 mM +/- 0.04 
h 1.41 +/-0.12 h 1.50 +/-0.31 
kcat 7.63 mm" +1-0.15 k, 9.38 min +/- 0.16 
kcat/Km 340.35 flllVf1mllf '  +/- 0.10 k5 /K0, 44.50 mM'min" +/- 0.19 
Fig. 39: Kinetic analysis of Ugd (A) and Ugd (B) UDP-glucose dehydrogenase activity assays. 














Chapter 4: Lipopolysaccha rides and AMP resistance 
4.3.4 Investigating the putative B. cenocepacia J2315 aminoarabinose 
transfe rase 
To date no structural information is available on ArnT from any organism. Previous 
studies have achieved some degree of characterisation of the isoforms from E. coli 
and Salmonella (Bretscher et al., 2006; Trent et al., 2001b). Brescher and co-workers 
isolated very small amounts of recombinant S. typhimurium ArnT expressed in E. coil 
and found that it was a highly alpha-helical 62 kDa protein (Bretscher et al., 2006). A 
PMB sensitivity assay was used to show that the Salmonella arnT could restore 
resistance in an E. coli BL21 (DE3) 4arnT mutant. Trent and colleagues further 
characterised the ArnTs from Salmonella and E. coil and showed that they are inner-
membrane proteins with 12 possible membrane-spanning domains that transfers L-
Ara4N from Upp-L-Ara4N to a lipid A substrate on the periplasmic side of the inner 
membrane (Trent et al., 2001a; Trent et al., 2001b). In addition, by using 32P-lipid 
IVA or Kd02-4'32P-lipid IVA, they showed that AmT transfers L-Ara4N to the 1-
phosphate of lipid A precursor lipid IVA, but that it requires Kdo in order to add L-
Ara4N to the 4'-phosphate (Trent et at, 2001b). To date, no laboratory has managed 
to isolate sufficient amounts to fully characterise an ArnT enzyme. 
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Characterisation of the B. cenocepacia ArnT has previously not been attempted. Like 
the E. coli and S. lyphimurium ArnT enzymes, ArnTBCAL1929 is a predicted inner 
membrane protein with 12 possible membrane-spanning domains by TMHMM 
topology prediction (Fig. 40). The aim of this study was to clone, express and attempt 
to purify recombinant ArnT from B. cenocepacia J2315, and characterise this 
important Bcc enzyme using biochemical and phenotypic techniques. 
First, B. cenocepacia J2315 arnTBcAL 1929 was cloned into pET28a with a C-terminal 6 
His tag, and expression was attempted in E. coli HSM 174 (DE3), BLR (DE3) and 
Rosetta (DE3) strain. Expression of ArnTBcA1I929 was visualised by Western Blot, 
however, only very small amounts of protein appeared to be expressed and 
expression results were difficult to reproduce (Fig. 41). To confirm that arnTc ter,1 
was expressed, an RT-PCR reaction was set up using RNA extracted from IPTG-
induced cultures of E. coli BLR (DE3) transformed with pET28aJarnTc..jerm and E. 
coli ToplO transformed with pTrc99a/arnTcr,n. Figure 42 shows clear expression of 
arnTc,erm from both plasmids in the different E. coli strains. pET28a1arnTc1, is 
expressed regardless of IPTG induction, but pTrc99aIarnTcter,,z is only expressed 
when uninduced. Since pTrc99a is a low copy number, leaky plasmid which does not 
require IPTG induction, perhaps over-inducing arnT expression is toxic to the K coli 
cells. 
Fig. 41: pET28aJarnTc te , expression in E. coli Rosetta (DE3) (lane 2 and 3) and E. coli HMS174 
(DE3) (lane 4 an 5) after induction with 1 mM IPTG at 37°C for 3 hours. (A) Expression cannot be 
visualised by SDS-PAGE and (B) expression detected by western blot using an anti-C-term His 
antibody. Lane 1, SeeBlue®P1us2 marker; lane 2, BenchMarkTM  His-tagged Protein Standard 
(Invitrogen); lane 3 and 5, uninduced; lane 4 and 6, induced. ArnT appears at 59 kDa, 
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RI + - + - + - + - + - 
Fig. 42: RT-PCR to confirm C-terminal His tagged arnT expression. Lane 1, 1 kb plus DNA ladder; 
lane 2 and 3, B. cenocepacia J2315 RT+ and -; lane 4 and 5, E. coil BLR (DE3)IpET28aIarnTcie ,,, 
induced RT+ and -; lane 6 and 7, E. coil BLR (DE3)/ pET28a/arnTcte, uninduced RT+ and -; lane 8, 
I kb plus DNA ladder; lane 9 and 10, E. coli TOP 10/pTrc99a/arnTc1  induced RT+ and -; lane 11 
and 12, E. coli TOP1O/ pTrc99aJarnTc uninduced RT+ and -; lane 13, B. cenocepacia K56-2 +ve 
DNA control; lane 14, -ye control (no DNA). The green boxes indicate RNA expression of arnT, 
pTrc99aIarnTc.,, uninduced shows weak expression, whilst pET28ai arnTc_t,nn  shows good 
expression whether induced or not. 
The pTrc99aIarnTcterm construct was then used to transform the deep-rough E. coli 
strain WBB06 by electroporation. Overnight cultures were used for small-scale LPS 
extraction, and the LPS samples were incubated with sulfo-NHS-biotin after which 
any L-Ara4N biotinylation was visualised using streptavidin in a Western blot. In 
Figure 43, WBB06 containing pTrc99aIarnTc eerm is biotinylated, whereas the Kd02-
lipidA control is not. This indicated a possible transfer of L-Ara4N to the WBB06 
lipid A by ArnTBc l929. 
(B) 1 2 3 4 5 
Fig. 43: Biotinylated LPS from E. coli WBB06 electroporated with pTrc99aJarnTc . (A) sodium-rn-
periodate silver stained gels and (B) streptavidin detected western blot: lane 1, Kd02-lipidA control; lane 2, 
WBB06I pTrc99aJarnT biotinylated aqueous phase; lane 3, WBB06IpTrc99a1arnT biotinylated phenol 
phase; lane 4, WBB06I pTrc99a/arnTc aqueous phase control; lane 5, WBB06/pTrc99a arnTcte,,ii phenol 
phase control. 
Since expression was difficult observe with a C-terminal 6 His tag, arnTBcALl929 was 
cloned into pET28a with an N-terminal 6 His tag instead. ArflTNterm expression was 
carried out in E. coli C41 (DE3) and C43 (DE3) strains and visualised by Western 
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blot. Figure 44 shows expression in E. coli C41 (DE3) using different amounts of 
IPTG and different induction times. Expression was clearly better, and reproducible, 
with arnTN..%erm compared to arnTc r,n. Therefore, E. coli C41 (DE3) or C43 (DE3) 
strains transformed with pET28a1arnTNrgr,n were used for large scale-induction. 
Attempts to purify the protein were made by isolating inner-membranes and 
solubilisation with DDM and glycerol before incubation with TALON resin. Protein 
was eluted using increasing concentrations of imidazole (Fig, 45). Only very small 
amounts of protein were purified this way, which unfortunately was not enough to 
fully characterise the ArnTBcAL1929 enzyme. 
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Fig. 44: Western blot showing ArflTN,,enn expression in E. coli C41 (DE3). (A) Effect of induction time 
induced with 1 mM IPTG: Lane 1, SeeBlue®Plus2 marker; lane 2, pET28a/arnTNLe,,, control; lane 3, 
pET28aIarnTNte induced 4 hours; lane 4, pET28aJarnTNt induced 5 hours; lane 5, pET28a control; lane 
6, pET28a induced 4 hours; lane 7, pET28a induced 5 hours; lane 8, Ugd (6His control). (B) Effect of 
different IPTG concentrations at 5 hours induction: Lane 1, SeeBlue0Plus2  marker; lane 2, 
pET28aJarnTN,C , control; lane 3, pET28a/arnTN,1enn  induced 0.1 mM IPTG; lane 4, pET28a'arnTNem, 
induced 0.5 mM IPTG; lane 5, pET28a/arnTNte ,. induced 1 mM IPTG; lane 6, Ugd (6His control). 
11 12 13 14 15  16 17 1 23456789 10 
& :, •. . 
Fig. 45: inner-membrane prep of ArnTN tCm, expressed in E. coli C41 (DE3). Lane 1, SeeBlue®Plus2 marker 
lane 2, pellet; lane 3, cell free extract after ultracentrifugation; lane 4, inner-membrane pellet; lane 5, pellet after 
incubation with DDM; lane 6, TALON resin after incubation; lane, 7, TALON resin after flow through; lane, 8, 
flow through; lane 9, initial wash; lane 10, SeeBluePlus2 marker; lane 11, second wash; lane 12, third wash; 
lane 13, elution with 20 mM imidazole; lane 14, elution with 50 mM imidazole; lane 15, elution with 100 mM 
imidazole; lane 16, elution with 200 mM imidazole; lane 17, TALON resin after elution. 
To test if the B. cenocepacia J2315 arnT gene was functional in cells, an ArnT assay 
was set up using the PMB sensitive E. coli AarnT mutant AY103 (arnT::kan) 
electroporated with either pTrc99aIarnTN..ter,n or pTrc99a control plasmid (containing 
jbpA from Neiserria gonorrhoeae). The strains were plated onto three plates: a 
kanamycin control plate, an ampicillin plasmid control plate and a PMB assay plate. 
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All E. coli AYI03 strains grew on kanamycin, all strains containing the pTrc99a 
plasmid grew on ampicillin, but only E. coli AY103 containing pTrc99aJarnTN..ter,n 
grew on PMB (Fig. 46). A PMB MIC assay was set up simultaneously and revealed a 
PMB sensitive MIC of 0.5 tg/ml for E. coli AY103 control and with pTrc99a!fbpA, 
but a PMB resistant MIC of 4 tg/m1 for E. coli AY103 containing pTrc99aIarnTN:erm 
(data not shown). These results suggest that B. cenocepacia ArnTBcAL1929 can restore 
PMB resistance of a PMB sensitive E. coli AarnT mutant. Further work is required to 
identify if the expressed protein has catalysed attachment of L-Ara4N onto the E. 
coli AY103 LPS. 
Fig. 46: B. cenocepacia J2315 arnTNte expressed on a pTrc99a plasmid can restore polymyxin B resistance in 
sensitive arnT mutant E. coil AY 103. E. coil AY 103 electroporated with pTrc99aJarnTNte , or pTrc99a/jbpA was 
streaked on (A) kanamycin, (B) kanamycin and ampicillin, and (C) polymyxin B; top of the plate pTrc99a/JbpA 
control, then clockwise: pTrc99a/arnTN,,rn 2, E. coil AY 103 and pTrc99a/arnTNt,r.  l 
In an attempt to show that L-Ara4N was being transferred to the lipid A of E. coli 
AY103 the LPS was isolated and incubated with sulfo-NHS-biotin as described 
earlier. The Western blot showed slight variations in biotinylation profiles between 
AY 103 with and without ArnT, but were not clear enough to be conclusive (Fig. 48). 
Knocking out arnT in E. coli may lead to increased PET modification to compensate 
for the loss of L-Ara4N modification. Since PET also contains primary amine groups 
it is likely to also be biotinylated in this assay. To inhibit PET modification the 
strains were grown in the presence of 1 mM EDTA and the biotinylation was 
repeated. However, this Western blot was more inconclusive than the first one and 
did not reveal any potential L-Ara4N bands (Fig. 49). Unfortunately, we were unable 
to prove that B. cenocepacia ArnTBc1929 transfers L-Ara4N to E. coli AY103 lipid 
FA 
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Fig. 48: Biotinylation of E. coli AYI03 and E. coli AY103 containing pTrc99aijbpA or pTrc99a/arnTNte . 
(A) sodium-rn-periodate silver stained gels and (B) streptavidin detected western blot. On both gels: lane 1 
and 2, E. coli AY103 water control and biotinylated respectively; lane 3 and 4, E. coli AY103 phenol 
control and biotin; lane 5 and 6, E. coli AYl03/pTrc99a/JbpA water control and biotin; lane 7 and 8. E. coli 
AYlO3/pTrc99aJfipA phenol control and biotin; lane 9 and 10, E. coli AY103/pTrc99a/arnTNte 1 water 
control and biotin; lane 11 and 12, E. coli AY103/pTrc99aJarnTN 1 phenol control and biotin; lane 13 
and 14. E. coli AY103/pTrc99a/arnTNte 2 water control and biotin; lane 15 and 16, E. coli 
AY I 03/pTrc99a/arnTN,,r 2 phenol control and biotin. 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
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Fig. 49: Biotinylation of E. coli AY103 and E. coli AY103 containing pTrc99a/jbpA or pTroWa/arnTNterm  
grown in the presence of 1 mM EDTA. (A) sodium-m-periodate silver stained gels and (B) streptavidin detected 
western blot. On both gels: lane 1 and 2, E. coli AYI03 water control and biotinylated respectively; lane 3 and 4, 
E. coli AY103 phenol control and biotin; lane 5 and 6, E. coli AY103/pTrc99a/jbpA water control and biotin; 
lane 7 and 8, E. coli AYlo3lpTrc99aljbpA phenol control and biotin; lane 9 and 10, E. coli 
AY103IpTrc99aiarnTNte 1 water control and biotin; lane 11 and 12, E. coli AY I 03/pTrc99a/arnTNtei.n. 1 phenol 
control and biotin; lane 13 and 14, E. coli AYl03/pTrc99aJarnTN, 2 water control and biotin; lane 15 and 16, 
E. coli AY103/pTrc99&arnTx 2 phenol control and biotin, 
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Another arnT complementation assay was set up in B. cenocepacia conditional 
AarnT mutant XOA11 (Ortega et al., 2007). pDA17/arnTNter,n was transferred from 
E. coli DH5a to B. cenocepacia XOA1 1 by triparental mating. B. cenocepacia 
XOA1 1 control and B. cenocepacia XOA1 I containing arnTAterm were grown on 
plates containing 0.5 % rhamnose or glucose. B. cenocepacia XOA1 1 control grew 
on rhamnose, but struggled to grow on glucose whereas B. cenocepacia XOA1 1 
containing arnTp term grew on both plates (Fig. 47). This result indicates that arnTN.. 
term can restore growth of B. cenocepacia conditional 4arnT mutant XOA1 1 under 
repressive conditions. However, this experiment needs to be repeated and optimised 
for future research. 
rhamnose (B) glucose 







Fig. 47: B. cenocepacia J2315 arnTN,, expressed on apDAl7 plasmid can restore viability in conditional arnT 
mutant B. cenocepacia XOA1 1. B. cencepacia XOAI 1 on the left and B. cenocepacia XOA1 1/pDA17/arnTN 
on the right growing on (A) 0.5% (w/v) rhamnose and (B) 0.5% (wlv) glucose. 
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4.4. Discussion 
Bee LPS is a putative virulence factor which may contribute to a detrimental host 
immune response in the CF lung, and to the innate resistance of these pathogens to 
AMPs. Compared to other Gram-negative bacteria, Bee LPS is both chemically and 
biologically unusual. Its penta-acylated lipid A core structure with constitutively 
modified phosphate groups, suggests it would be unlikely to evoke a strong immune 
response. However, Bee LPS has been shown to be highly immuno-stimulatory, with 
IL-6 and TNF-a induction as strong as that induced by E. coli LPS (De Soyza et al., 
2004; Zughaier et al., 1999). The hexa-acylated lipid A core structure present in E. 
coli LPS is considered to be crucial to its immuno-stimulatory properties (Schromm 
et al., 2000). Interestingly, Bee LPS is a poor inducer of IL-1 (Shimomura et al., 
2001), a major inflammatory cytokine. However, Shimomura and colleagues 
reported that when Bee LPS is incubated with the cationic peptide PMB, IL-143 
induction is significantly elevated, whereas Salmonella LPS is neutralised 
(Shimomura et al., 2003). Additionally, in contrast to Salmonella LPS, they found 
that Bee LPS binds PMB strongly. These interesting and unique properties have not 
been fully investigated. Studies on the structure and function of Bee LPS may be 
informative, not only to understand the complex biology of LPS but to assess the 
contribution of Bee LPS to the immunopathology of the CF lung. 
Complete structural LPS analysis is challenging and ultimately requires expertise in 
mass spectrometry and NMR. Initially, analysis may be performed by gel 
electrophoresis followed by silver staining. This method indicates whether a strain 
has rough or smooth LPS, and will provide a strain-specific ladder pattern based on 
the 0-antigen. We were interested in whether any lipid A modifications can be 
visualised by simply staining an LPS gel. In this study, LPS extracted from B. 
cenocepacia clonal ET-12 strains K56-2, J2315 and deep-rough mutant SAL-i was 
extracted and compared to an E. coli deep-rough standard LPS by gel-electrophoresis 
and different staining methods. 
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We found that alcian blue silver staining shows differences in the lipid A and core 
bands, whereas LPS gels stained by smp silver staining show clear differences 
between smooth, rough and deep-rough LPS. Interestingly, a difference between the 
deep-rough B. cenocepacia SAL-i LPS and the deep-rough E. coil LPS was 
observed, which may be due to the added L-Ara4N modifications of SAL-1 or the 
difference in FA contents. To visualise any L-Ara4N modified LPS we biotinylated 
the primary amine groups of the sugar. This resulted in clearly observed differences 
between the modified B. cenocepacia J2315 bands and the E. coil control. Notably, 
this method also revealed a slower migrating band for SAL-1, not seen by silver 
staining. The biotinylated band of SAL-i LPS correlates with a band only seen in the 
phenol phase of all three B. cenocepacia LPSs. Interestingly, previous LPS studies 
had only used the water phase, and any phenol specific bands have not been 
discussed. The chemical differences between the SAL-i and deep-rough E. coil LPSs 
is likely due to differences in the FA composition rather than L-Ara4N modification. 
Unfortunately, the SAL-i LPS structure has not been determined (Miguel Valvano, 
personal communication). 
To be able to use gel electrophoresis as a more detailed analytical tool, standardised 
analysis of LPS bands is necessary. Steps are also necessary to examine LPS without 
the denaturing process of silver staining. To investigate the nature of individual 
bands with minimum denaturation a negative staining method can be applied. This 
method allows recovery of chemically and biologically intact biomolecules that can 
be further characterised (Hardy & Castellanos-Serra, 2004). Negative staining and 
elution is a quick and easy method that can be applied to DNA, proteins and LPS. 
Unfortunately, this study was not completed in terms of individual band analysis, but 
will be continued in the laboratory alongside attempts to structurally analyse the LPS 
of the Bcc. Once a band has been eluted, it can be subjected to structural analyses by 
mass spectrometry and NMR, as well as by immuno-stimulation and AMP binding 
assays. This will allow chemical annotation of each of the bands observed in 
classical LPS ladders, may help determine the inflammatory properties of each LPS 
species and reveal the molecular details of their interactions with AMPs. This 
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information could help in designing new antimicrobial compounds to either render 
the bacteria susceptible to AMPs or help neutralise the inflammatory response. 
As well as exploring novel LPS chemical modification tools, the studies in this thesis 
have focussed on enzymes involved in L-Ara4N biosynthesis which could be 
potential targets for novel antimicrobial agents. The unique inherent resistance of the 
Bcc to AMPs has been speculated to be associated with constitutive lipid A 
modification with L-Aia4N. The enzymes involved in these modifications were 
recently shown to be essential for B. cenocepacia viability (Ortega et at, 2007), 
providing interesting drug targets of this highly resistant pathogen. This study 
focused on Ugd and ArnT, the first and the last enzyme in the L-Ara4N biosynthetic 
pathway. 
Out of the three putative ugd genes in the B. cenocepacia J2315 gcnome, only 
UgdBc2946 and UgdBCAM0855 encoded proteins with Ugd activity, converting UDP-
glucose to UDP- glucuronie acid. The role of the protein encoded by ugdBcAM2034 has 
still to be determined. UgdBcAJ2946 and UgdBc4Jo855, display high sequence 
homology, have very similar catalytic profiles and are efficient catalysts with Km 
constants for UDP-glucose and NAD in the low j.tM range and relatively fast 
turnover. 
A comparison of the roles between the Bcc and P. aeruginosa Ugds is worth 
exploring. P. aeruginosa PAOI has two well characterised active enzymes, PA2022 
and PA3559, with distinct roles (Hung et at, 2007). PA2022 is suggested to be a 
constitutively expressed house-keeping gene, whereas PA3 559 is induced by low 
Mg 2+  concentrations suggesting a role in L-Ara4N modification. This is supported by 
the fact that a PA3 559 knock-out renders P. aeruginosa PAO 1 more susceptible to 
PMB. In addition, the double knock-out produced less biofllm formation than wild 
type P. aeruginosa PA01. Compared to UgdBcAJ2946 and UgdBc&j0855, the 
pseudomonal Ugds have relatively higher Km and turnover values. The two P. 
aeruginosa Ugd proteins were also able to utilise UDP-galactose and UDP-N-
acetylglucosamine as substrates, but with lower activity compared with UDP- 
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glucose. In contrast, despite high sequence homology, the two B. cenocepacia Ugd 
proteins displayed narrower substrate specificity. This substrate specificity correlates 
with the relatively high catalytic efficiency (kcat/Km) of the enzymes. 
To probe the role of the B. cenocepacia Ugds in AMP resistance, an in depth study 
was carried out in collaboration with Slade Loutet and Miguel Valvano (University 
of Western Ontario, London, Canada). Individual knockouts were created in all three 
putative ugd genes, none of which impaired growth or altered LPS profile compared 
to wild type B. cenocepacia K56-2. However, when grown in 1024 ig/ml PMB only 
growth of the AugdBcAL2946 mutant was impaired, and the MIC of PMB was reduced 
from >1024 j.xg/ml to 128 .xg/ml. Growth in PMB could be restored by introducing a 
wild type ugdBcAL2946 or ugdBcAMoe55, but not ugdBcAM2034, on a plasmid. This suggests 
that out of the three putative ugd genes, only ugdBcAL2946 is required for the full 
resistance of B. cenocepacia K56-2 to PMB, and also that UgdBcj0855 can 
compensate for the loss of function of UgdBcAI2946. This hypothesis is supported by 
the fact that the encoded enzymes have nearly identical activity. A conditional 
ugdBcAL2946 mutant was then created in a A ugdBcAMos5s background. Normal growth 
was observed under permissive conditions (rhanmose), however, growth was 
significantly impaired under repressive conditions (glucose), suggesting the 
combined activity of the proteins encoded by ugdscAL2946 and UgdBCAM0855 is required 
for the viability of B. cenocepacia. 
Though UgdBc4J2946 and UgdBc0855 display very similar kinetic parameters and 
sequence homology, they are found in gene clusters with different functions; 
UgdBc2946 is found in a LPS related operon (Loutet et al., 2006) and UgdBa4J0855 is 
found in the bce EPS gene cluster discussed earlier. Interestingly, our collaborators 
found that using real-time PCR, the number of ugdBcAL2946 transcripts in vivo was 
significantly higher than the number of UgdBCAMO855 transcripts. Since we found that 
the bce gene cluster in B. cenocepacia ET-I2 isolates contains a disrupted bceB gene 
resulting in lack of EPS biosynthesis, this could account for the lower expression of 
119dBcAM0855 (bceC). The ugdBcAL2946 gene is found upstream of hidA and hldD, 
encoding heptose modifying enzymes. Notably, the AhldA/AhldD mutant SAL-I has 
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deep-rough LPS and is more susceptible to PMB with an MIC of 32j.xglml (Loutet et 
al., 2006). Interestingly, Burtnick and Woods observed similar reduction in PMB 
MICs for B. pseudomallel when inactivating ugd and a heptosyl transferase gene, 
waaF (Burtnick & Woods, 1999). Inactivation of u96IBcAL2946 has no polar effect on 
hidA or hldD as frill resistance can be restored when ugdBcAL2946 is expressed in trans 
and the LPS profile remains as wild type. In conclusion, ugdBcAL2946 is likely to be 
involved in the L-Ara4N biosynthetic pathway, and the high cellular expression of 
ugdBcAL2946, together with the loss of viability in the absence of any Ugd activity, 
further highlights the importance of these enzymes in B. cenocepacia. 
The last step of the L-Ara4N biosynthetic pathway is catalysed by AmT, which 
transfers L-Ara4N from an Upp-L-Ara4N to lipid A. Despite low sequence 
homology to other AnTs, there is only one strong candidate arnT gene in the B. 
cenocepacia J2315 genome, arnTBcAL1929. Ortega and colleagues found this gene to 
be essential for B. cenocepacia viability (Ortega et al., 2007). Analysis of the 
structure of Bcc LPS revealed the presence of L-Ara4N on the 1- and the 4'-
phosphates of the lipid A, as well as the Ko molecule of the inner core (Gronow et 
al., 2003; Silipo et al., 2007). These multiple sites for L-Ara4N modification suggest 
that the Bcc could possess more than one arnT. However, it has been shown that the 
Francisella tularensis arnT homolog, flmK, attaches both galactosamine onto the 1-
phosphate and mannose to the 4'-phosphate (Kanistanon et aL, 2008). Since the Bcc 
ArnT protein shares higher sequence homology to FlmK than other characterised 
amino sugar transferases, it is tempting to speculate that ArnTscAI1929 could also be a 
multi-functional enzyme. 
In our study, we attempted to purify recombinant ArnT from B. cenocepacia J2315 
expressed in E. coli. This proved to be extremely difficult regardless of the different 
fusion tags and hosts that were tried. The expression of pET-28a/arnTBcAL1929 with an 
N-terminal histidine tag was achieved in E. coli C41 (DE3) and C43 (DE3) strains. 
Furthermore, preliminary data suggest that the arnTBcAL1929 construct was active since 
it was able to restore PMB resistance to a PMB-sensitive E. coli AarnT mutant. 
Additionally, arnTBcAL1929 expressed on a Burkholderia expression plasmid (pDA17) 
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appears to restore growth of B. cenocepacia conditional AarnT mutant XOAI 1 under 
repressive conditions. Unfortunately, attempts to prove L-Ara4N transfer to lipid A 
in E. coli AarnT mutant using the biotinylation procedure were unsuccessful. In 
addition, attempts to purify sufficient quantities of ArnTBcAI1929 for biochemical 
studies were unsuccessful, which is not surprising considering it is an inner 
membrane protein. Such targets have proven to be particularly challenging (Wagner 
et al., 2007). Studies of the ArnTs from E. coli and Salmonella provided some 
insight into the substrate specificity and cellular location of these isoforms (Bretscher 
et al., 2006; Trent et al., 2001). However, to date the structures of any ArnT 
homologs remain to be determined. Future work is required to optimise ArnT 
purification methods and develop more conclusive L-Ara4N transferase assays. 
The main conclusion from these studies is that the enzymes in the L-Ara4N 
biosynthesis pathway are important for PMB resistance, and for the survival of B. 
cenocepacia, thus providing new antimicrobial targets. The question remains, 
however, as to why L-Ara4N is essential for B. cenocepacia survival? It could be 
that L-Ara4N LPS modification is essential for membrane stability, and as it is a 
constitutive modification the bacteria may not have had to develop alternative 
protective mechanisms. In addition, these experiments were carried out using LB or 
minimal media culture conditions, and it may be that as yet unknown environmental 
factors may be able to compensate for the loss of L-Ara4N. 
Another explanation could be that there is a transport defect in L-Ara4N deficient 
mutants. This would be consistent with the accumulation of membranous material 
observed by transmission electron microscopy of B. cenocepacia conditional mutants 
X0A11 and XOAl2 (Ortega et al., 2007). The LPS transport system has not been 
investigated in the Bee and could bring surprises. The best available model is that of 
E. coli (Raetz et all, 2007; Tran et al., 2008). In this organism the lipid A is flipped 
across the inner membrane to the periplasmic side by MsbA after which it is 
modified with L-Ara4N, from an Upp-L-Ara4N precursor, which itself has been 
flipped across the inner membrane by ArnEF. The core and 0-antigen are then 
added, and this modified LPS is then transported across the periplasm by the LptA 
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chaperone, and flipped across the outer membrane by LptDE. Given previous 
experience of the idiosyncrasies of Burkholderia, it might be reasonable to assume 
that the transport systems differ from that of E. coli. For example, the Burkholderia 
lipid A chaperone LptA (or its equivalent) may be absolutely specific for L-Ara4N 
modified lipid A intermediates. Furthermore, the Burkholderia flippases might be 
extremely intolerant of unmodified lipid A. It could be possible that Burkholderia 
lipid A is modified on the cytoplasmic side of the inner membrane, indicating no 
requirement for an Upp-Ara4N flippase, but a unique specificity of MsbA for already 
modified lipid A. To explore these hypotheses, it would be interesting to over-
express MsbA or LptA in B. cenocepacia XOA1 1 to determine whether such over-
expression could restore the viability of the AarnT mutant. 
To identify more specific antimicrobial targets it will be important to know whether 
disruption of the L-Ara4N biosynthetic enzymes affects LPS transport or membrane 
permeability. Nevertheless, an Achilles' heel of the Bee has certainly been exposed. 
Cycloserine, a known ArnB inhibitor (Noland et aL, 2002), and inhibitors of the 
other enzymes in L-Ara4N biosynthesis could be used alone, or in combination with 
other antimicrobial agents to overcome the notorious multi-resistance of these 
challenging pathogens. 
IP1 
Chapter 5: Genera! Discussion and Future Work 
5.1. General Discussion and Future Work 
A major aim of this thesis was to investigate putative virulence factors and novel 
antimicrobial targets of the Burkholderia cepacia complex. This group of closely-
related pathogens cause life-threatening lung infections in CF patients, largely due to 
a destructive inflammatory response. In addition, the Bcc are inherently resistant to 
all classes of antibiotics including AMPs, making Bcc infections very difficult to 
treat. To my knowledge, there are only three reports of successful antibacterial 
treatment of cepacia syndrome. These cases required combinations of 4 to 5 
antibiotics, both intravenous and nebulised, as well as mucolytic and anti-
inflammatory agents (Kazachkov et al., 2001; Weidmann et at, 2008) (Grimwood & 
Tweed, personal communication). From the armoury of putative Bcc virulence 
factors, EPS and LPS may play important roles in persistence, immuno-stimulation 
and resistance in the CF lung. In the case of resistance, the EPS may provide a 
protective shield around the bacteria which makes it difficult for antimicrobial agents 
to penetrate the bacterial cell and reach their targets. At the same time, the unique 
modifications of Bcc LPS make the outer membrane even more impenetrable. Hence, 
in addition to finding a novel antimicrobial agent that kills Bcc, it may be 
strategically important to find novel antimicrobial agents that can weaken this 
protective shield to enable penetration of existing antibiotics. 
During the EPS investigation a surprising aspect of Bcc EPS became apparent. 
Instead of a non-mucoid to mucoid conversion, which is a striking characteristic of 
P. aeruginosa infections in CF patients, the Bcc apparently revert from a mucoid to a 
non-mucoid phenotype (Zlosnik et al., 2008). This suggests that BPS may be 
important for initial persistence, and that a loss of mucoidy may contribute to 
increased virulence. This would explain why, in this study, members of the virulent 
BT-12 lineage did not produce BPS under any conditions tested. These results raise 
interesting questions in relation to the role of BPS, both in human infection and in the 
survival of the Bcc in natural environments. How can the lack of BPS production in 
B. cenocepacia be reconciled with the notorious transmissibility and virulence of this 
Bcc species? In contrast to the conversion to mucoidy of P. aeruginosa in the CF 
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lung, is loss of BPS a major factor in the transition of this rhizosphere microbe to a 
human niche? Is BPS production and its role in protection against dehydration in 
other Bee species, an important aspect of their survival in natural environments? 
Finally, if EPS is involved in human infection, how can we explain the fact that B. 
cenocepacia and B. multivorans account for 90% of all clinical Bee isolates (Govan 
et at, 2007) when these species differ in their ability to produce EPS? 
Interestingly, loss of BPS usually correlates with increased motility and increased 
exposure of LPS. The LPS of the Bee has been shown to be highly immune-
stimulatory (De Soyza et at, 2004; Shaw et at, 1995), despite having a lipid A 
structure which would suggest otherwise. It is tempting to speculate, due to the LPS 
purification methods, that flagella contamination may in fact be responsible for the 
inflammatory response observed in these studies. Bee flagella have been shown to 
directly stimulate IL-8 and NFicB through TLR-5 (Urban et at, 2004).  In addition, 
flagellin-less mutants were shown to survive longer in a rat agar lung infection model 
by evading an immune response. Interestingly, it has recently been found that TLRS, 
but neither TLR2 nor TLR4, critically regulate B. cenocepacia-induced lung 
epithelial inflammatory response in a mouse model (deVentura et at, 2008). It would 
certainly be interesting to investigate the inflammatory role of Bee flagella versus 
LPS in future studies. 
Whether the LPS is responsible for the detrimental inflammatory response associated 
with Bee infection or not, LPS remains a key factor for AMP resistance and 
membrane stability. In collaboration with Valvano, my colleagues showed that the 
enzymes involved in L-Ara4N lipid A modification are essential for Bee viability 
(Ortega et at, 2007). This important finding provides new antimicrobial targets that 
may in future improve treatment of Bee infections. In this thesis, Ugd and ArnT, the 
first and last enzyme of the L-Ara4N biosynthetic pathway, were investigated. Out of 
three putative ugd genes found in the B. cenocepacia J2315 genome, we conclude 
that UgdBc2946 is involved in PMB resistance, whereas UgdBc4&J10855 is involved in 
EPS biosynthesis. Together, these two Ugds are essential for Bee viability, and 
Ugdsc0855 is able to compensate for the loss of UgdBcAn946 in vivo. Only one arnT 
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candidate gene was found in the B. cenocepacia J2315 genome, which was 
associated with the arn gene cluster. Some progress was made in the isolation of 
recombinant AmT from B. cenocepacia J2315 suitable for biochemical studies. 
However, as intrinsic inner membrane proteins, investigations of amino sugar 
transferase enzymes remains a considerable challenge. 
The essential nature of the L-Ara4N biosynthetic enzymes in viability of the Bee 
suggests a potential Achilles' heel. For future research in this area, it will be 
important to understand why these enzymes are indispensable, and perhaps even 
more importantly, how these and other LPS modification enzymes are regulated. 
The control and regulation of Bee virulence factors and their role in bacterial 
pathogenesis remains a mystery. Though these bacteria carry the largest number of 
TCSs of any bacterial species, very little is known about Bee virulence regulation. 
No TCS has yet been discovered that controls Bee LPS modifications, and the fact 
that the modifying enzymes are constitutively expressed implies that, in contrast to 
E. co/i and Salmonella, regulation in the Bee is independent of environmental 
stimuli. The putative B. cenocepacia response regulators most similar to PhoP and 
PmrA of Salmonella and P. aeruginosa are not required for PMB resistance 
(Flannigan et al., 2007), indicating that they are not regulating LPS modifications. 
Interestingly, the suggested PhoP-binding site motif; (A/C) OTTA (Groisman, 2001), 
can be found upstream of arnT, arnB and ugdBcAL2946 in B. cenocepacia J2315, 
suggesting these genes should be under control of a TCS. In addition, lipid A from a 
B. multivorans strain isolated from a pre-transplant CF lung was heavily modified, 
whereas after a lung transplant the lipid A from the same strain was less modified 
and less immuno-stimulatory (lerano et al., 2008). This implies that something in the 
CF lung induces LPS modification of these pathogens, perhaps enhancing the 
detrimental inflammatory response. It would be very interesting to investigate the 
TCSs of the Bee and their involvement in the control and regulation of the virulence 
of these pathogens, in particular to explain the enhanced virulence of B. cenocepacia 
as a species, and of lineages such as ET-12. 
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ArnTBCAL1929 (N-term) (1692 bp, 1748 bp including 6HIS, 64845.64 Da) 
1 i'IGSSHHHHHH SSGLVPRGSH MNDTPSRLPL NRITLVLLLV ALAIVWFAPL 
51 GLRHLIPSDE GRYAEMAREM FVTGDWITPR YNGYKYFEK? PLQTWLNALT 
101 FAWFGIGEWQ ARLYTAVASF AGVLLVGYTG ARLFNPLSGF LAAVVLASSP 
151 YWNLMGHFNA LDMGLAFWMA LSLCSLLLAQ RPGLRPAPSVR GWMWACWAAM 
201 AFAVLSKGLV GLILPGVLV LYTLVARDA LWKRLYLVSG LVIFFAIVTP 
251 WFVLVQQRNP EFFNFFFIVQ QFRRYLTPEQ NRPGPLYYFV PVLLVGFLPW 
301 LSVAWQSIRH AVRMPRQPNG FAPMLVLLIW SAFIFLFFSA SHSKLISYVL 
351 PVAPALALII GAYLPLMTAD RFRRHLLGYL VFFVAFGI VFLAYQGDAR 
401 TPNALYRAFQ MWLYAGLAVA PSALTLVIAWL NRRAGVAAAL ATFGAAWLVF 
451 GTIGGTGHDE FGRYSSGALL APAVRAELAK LPPDTPFYSI EMLDHTFPFY 
501 MGHTTIMVQR QDELAFGISV EPNKtrIPTIG EWITRWKQET HALAIMPPGQ 
551 YDALVKEGVP MRVIARDNRR VIVEKPQS 
ArnTBCAL1929 (C-term) (1680 bp, 1698 bp incl. His tag, 63748.48 Da) 
1 MDDTPSRLPL NRITLVLLLV ALAIVWFAPL GLRHLIPSDE GRYAEMAREt4 
51 FVTGDWITPR YNGYKYFEKP PLQTWLNALT FAWFGIGEWQ ARLYTAVASF 
101 AGVLLVGYTG ARLFNPLSGF LAAVVLASSP YWNLMGHFNA LDNGLAFWMA 
151 LSLCSLLLAQ RPGLRPAPSVR GWNWACWASM AFAVLSKGLV GLILPGAVLV 
201 LYTLVARDWA LWKRLYLVSG LVIFFAIVTP WFVLVQQRNP EFFNF'FFIVQ 
251 QFRRYLTPEQ NRPGPLYYFV PVLLVGFLPW LSVAWQSIRH AVRMPRQPNG 
301 FAPMLVLLIW SAFIFLFFSA SHSKLISYVL PVAPALALII GAYLPLMTAD 
351 RFRRHLLGYL VFFVAPSAFGI VFLAYQGDAR TFNALYRAFQ MWLYAGLAVA 
401 AALTLVAAWL NRRAGVAPIL ATFGAWLVF GTIGGTGHDE FGRYSSGALL 
451 APAV9JELAK LPPDTPFYSI EMLDHTFPFY MGHTTIMVQR QDELAFGISV 
501 EPNKWIPTIG EWITRWKQET HALAIMPPGQ YDALVKEGVP MRVIARDNRR 
551 VIVEKPQSLE HHHHHH 
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Amino acid sequence alignment of B. cenocepacia BCAL1929 and P. aeruginosa PAOI 
ArnT shows 24% identity 
1 50 
ArnT BCAL1929 (1) MNDTPSRLPLNRITLVLLLAL1FAPLGLRHLIP3DEGRThEREM 
ArnT PAO1 (1) --------MSRRQTCSLLLAE1LVPLSNHGLWIPDETRYAQQA51 
Consensus (1) R T LLLIA Al W PL L DE RYA IA M 
51 100 
ArnT BCAL1929 (51) 
ArnT PA01 (43) LGGDWFLGLgY FEKPVAGYIALGQAVFGEN1GVIAWJ1A 
Consensus (51) L GDNISP F G KYFEKP WL AL A FG F RI S VAS 
101 150 
ArnT BCAL1929 (101) AGVLLVGYTARLN- P1GFLAALAS  S PYWNLMGHINALDNGLAFWI 
ArnT FA01 (93) LSVLLAYLLRRLRDE'1SLACAYASFGLIAGQSGANLDPQFTFWU 
Consensus (101) VLL A RLF P S ALL AS F LD FWM 
151 200 
ArnT BCAL1929 (150) ALSLILLLAQRPGLRPAAIRGWMWACWAN1VLKGLLLPGAVL 
ArnT PA01 (143) 
Consensus (151) LSL AL A G R A L GW A A A LSKG LA ILP V 
201 250 
ArnT BCAL1929 (200) ILYTLVARDWALWKRLYLVSLVIFF1VTPWE1LVQQRNPNFF FIV 
ArnT PA01 (192) PYMLWQRRWRELLG-YGALAVLAALLCLPWlAVHAREARFFFWH 
Consensus (201) L V L R N Y ALL I 9W L V A DFF FFF 
251 300 
ArnT BCAL1929 (250) 
ArnT PA01 (241) 
Consensus (251) RRF 17 N P WFFLPLL VA LPW L AIR A RQ 
301 350 
ArnT BCAL1929 (300) GFAPZVLLWSAFIFLFFSASHSKLIYPVAPALALGAYLPLMTA 
ArnT PA01 (289) --APFLIJWLLLPLAFFSLSRGKLPIYPCLLPLALGHALVQRLR 
Consensus (301) APNL L IN FFS S FL SYILP LALIIG L 
351 400 
ArnT BCAL1929 (350)  DRFRRHLLGYLIFFISAAFGIMFLAYQGDARTPNALYRAFQELYACIAV 
ArnT PA01 (337) LGNSVALRGNGLNLALL1AALAYLQLRKPVYQEEPFELVLLIG 
Consensus (351) L G L LA A L R P F LFL L 
401 450 
ArnT BCAL1929 (400) AALTLAWLNRRIAAALATFGAL1TIITGHDEFGRYSIGAL 
ArnT PA01 (387) AWA 
Consensus (401) A A LA N L A A AAWLL A I A S L 
451 500 
ArnT BCAL1929 (450) LAPAVRAELAKLPPDTPFYSE14LDHTFPFYMGHTTIVQRQDEL1GS 
ArnT PAO1 (434) FVHLDELTGAR-HLLSNDjGAASALAWRLRRSDVTYDTRGEL1GS 
Consensus (451) EL I L EL FGIS 
501 550 
ArnT BCAL1929 (500) 
ArnT PA01 (483) YPEHSQRSVPADIRQWIWRAQGSIAVRINSASDRYQLALPGDGE 
Consensus (501) I I WI R KQD IL V L G 
551 567 
ArnT BCAL1929 (542) RVIARDNRRVIIEKPQS 
ArnT PA01 (533) RYRNGNLVLAIMPQVRP 
Consensus (551) R IL 
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Amino acid sequence alignment of B. cenocepacia BCAL1929 and E coil K12 ArnT 
shows 22.3% identity 
1 50 
Arnt BCAL1929 (1) NNDTPSRLPLNRIT1LLLVAAI1FAPGLRHLIPSDEGRYAEREM 
ArnT E. coil K12 (1) --------MKSVRYLIGLFA1ACYLLPSTRLLWQ2DETRYAEREM 
Consensus (1) LI L IA W 21 2. L DE RYAEIAREM 
51 100 
Arnt BCAL1929 (51) F1CDWITPRYNGYYFEKPPLQTWNTFAWFGIGEIQARLYTAV1iF 
ArnT E. coil K12 (43) L1GDWIV?HLLGLIY FEED IAGYJNGQWLFGAN1GVRAGVI FAIL 
Consensus (51) SGDWI P G KYFEKP WINAI FG F 2. AS 
101 150 
Arnt BCAL1929 (101) AGVLLVGTGARLN-PLSIFLAA1LASSPYWNLMGHNALDMGIAFW 
ArnT E. coil K12 (93)  LTAALVTIFTLRLIRDKRLILLATVIYLSLFIVYAIGTIAVLDPFBAFWM 
Consensus (101) LV W ELF A LA VI S IG F LD IAFWL 
151 200 
Arnt BCAL1929 (150) 
ArnT E. coli 1<12 (143) VAlCSFWLAMQAQTW1KS-IGFLLLGITCFMVKGFLlPVLSl 
Consensus (151) LCS LA A A A AVLSKG LAL LP L 
201 250 
Arnt BCAL1929 (200) ILITLV1DWALWKRIYLVSIFFAIVTPW1LQQRNE'E1NFFIV 
ArnT E. coli K12 (192) IPt1ATlRWKDLFiYGWLSCVLTVLPWllAQREPN1lFF 
Consensus (201) L W K W IY ALl V 2W L I QR P F? FFF V 
251 300 
Arnt BCAL1929 (250) QQFRILTPI1R1P1YVPVVG FL?WLSAWRHVFPQPN 
ArnT E. coil K12 (241) 
Consensus (251) 2.? 5 N AP WYFVPVII G LPWL L Al A K K 
301 350 
Arnt BCAL1929 (300) G1P1IVLLI1AFI  FLFFSIIHSKLIIYLPVAPLAIAYLPLMTA 
ArnT K. coil K12 (288) _HIATYLLSVIIMPLLFFS1KGKLPIYLSCFlLAHYALLAAK 
Consensus (301) A L LL KS LFFS A EL SYIL ALALIIA Y L 
351 400 
Arnt BCAL1929 (350) DR--- FRRHLLGY§VFFVA§AFlIVFMYQGDARTPNALYRAIQMILYAG 
ArnT E. coil K12 (337) NNPLALRINGKINIAFGVTIIITFVPWG2MNTP ----- VIQTiESYK 
Consensus (351) R I F V A A LA G TP FQ F 
401 450 
Arnt BCAL1929 (397) AVAATLAALNRRAGVAAALATFGAAWLVFGTIGGTGHDEFGRYSS 
ArnT N. coil 1<12 (382) IFCAWFSIW1FGWYTLTNVEKTWPFAALCPLGLALLVGFSIPDRVME 
Consensus (401) L A Al L A? AA G G K 
451 500 
Arnt BCAL1929 (447) GALLAPAVRAELAKLPPD--TPFYSiLDHTFPFYNGRTTIMVQRQDEL 
ArnT K. coil 1<12 (432) GKHPQFFVEMTQESLQPSRYILTDS1AAGLAWSLQRDDIIMYRQTGEL 
Consensus (451) G V L P SI M IN EL 
501 550 
Arnt BCAL1929 (495) A5ISVEPNKWIPTI1WITRW1ET-H ---- ALAMPPCQYDALVKEGV 
ArnT K. coil K12 (482) 1GUNYPDAKGRFVSIEFANWLQHRQEGIITL1SVDRDEDINSLAIP 
Consensus (501) FGI K GD W N L I 5 
551 569 
Arnt BCAL1929 (540) 2MRVIARDNRRVEKPQS 
ArnT N. coil K12 (532) PADAIDRQERLVQYRPK 
Consensus (551) P I R R VII 
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Amino acid sequence alignment of B. cenocepacia BCAL1929 and F. tularensis FlmK 
shows 24.1% identity 
1 50 
Arnt BCAL1929 (1) MNDPSRLPLNRITFELLIALAVFAPLGLRHLIPSDEGRYAEAREN 
F. tularensis finK (1) MN1KN --- SYYFllLLIYIYFVFLCWRHLSIPDEGRYPEAREM 
Consensus (1) MN S I ILLI I FF LG RHL DEGRY EIAREM 
51 100 
Arnt BCAL1929 (51) FVGD1T PRYNGYIIKP PLQTWLNALFAFGIGEWQARLYTAIAS F 
F. tularensis finK (48) 
Consensus (51) SG WITP MG F DKPPL ML A S FFGI W RL AL 
101 150 
Arnt BCAL1929 (101) AGVILGYTGARLNPLGFLAj1L1S PYNLM$HlNAIDlA- -FM 
F. tularensis firnA (98) LGClSIYVFGRY1SR1GVL.11LIJNVLFFEIHANgDIIIATLLW 
Consensus (101) G I I G F AG LAA ILAR W AHF LDL LA W 
151 200 
Arnt BCAL1929 (149) ALSLCSLLLAQRPGLIPAAVRGWPJACAANAFAVLIKGLLPGAV 
F. tularensis finK (14 8) •FFLCLTSLKQT --- ITKNKRLLNAAFVSALAFLRKGLFPCMT 
Consensus (151) IA LC L Q K R NWA W A A LSKGLMAII P 
201 250 
Arnt BCAL1929 (199) VTLIARDWALWKRLY1GL1FFAIVTPWFVLVQQRNPIFFNFFFI 
F. tularensis finK (195) IEMLITNNWYRLKELIPGAIFVVIVTPWLVLAQQQNPIFLYFFFY 
Consensus (201) I LW LI W K LVI SG VIF IVTPW VL QQ NPDF FFF 
251 300 
Arnt BCAL1929 (249) VQQFRBaTPEQNRPGPLVPNLVGFLPILSL1SIRHIVRPRQP 
F. tularensis finK (245) FQQFYPGHGFNNAIGPFVULAVFLPSIILLIIFIAIWQN 
Consensus (251) QQF RFL N WFF III, FLPF L N I A KI Q 
301 350 
Arnt BCAL1929 (299) NG-1PMLLWSAFI 
F. tularensis finK (295)  RKQDITTFIMAIWCLLILIFFSIPSSKESYNLPIFAPLIIMLSLEKI 
Consensus (301) A LI 1W I IFFS SKIISYILPI LALIIA L I 
351 400 
Arnt BCAL1929 (348) TADR ------ 1RHLLIYFFVAAAFGIIFLAYQGDARTPNALYRAFI 
F. tularensis finK (345) IKNNDNVVMFKMMLTISFLVAAVAVIIFSLTQKVLLNTDAPLAYTT 
Consensus (351) K 1-iL A IIF VAA IIF Q A L 
401 450 
Arnt BCAL1929 (392) WLYLAVAATLVAAWLN1IAGVAAALATFGAAWLVFGTIGGTGHDEF 
F. tularensis finK (395) VAVLIVAFKFSFKDQIIIAITLIIFALMLLNVLGQLIIPYFDLRTS 
Consensus (401) AAL VA AL RKA A L I 
451 500 
Arnt BCAL1929 (442) GRYSSGALLApAVRAELAKLPPnTPFSIEMLFlTFPFYMG}iTT:l 
F. tularensis firaK (445) EPLVDKVLKDSNSDTIFVYYNRPQP1FILKELKQKGYEEDLPINI 
Consensus (451) L P H I D Y ILLN N 
501 550 
Arnt BCAL1929 (492) DEAJGISVEPN1IPTIGEWITIKQETHALAIMPPGQ!DALIKEGVPM 
F. tularensis finK (495) IYIVtAlNT ---- jKPEIDNWSRElYYGINQYKQAHNGQPKYlITYPEF 
Consensus (501) I F W P I W F GQW L 
551 597 
Arnt BCAL1929 (542) RVRARDNIFJIIEKPQS______________________________ 
F. tularensis finK (541) TELNN1-J1IIFTPEKQLEKLKQTYPNINFEIKGRYNKNVVVSVVK 
Consensus (551) I NK III P 
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Amino acid sequence alignment of B. cenocepacia BCAL1929 with P. aeruginosa 
PA01, S. typhimurium and E. coil ArnT 
1 50 
Arnt BCAL1929 (1) MNDTPS1PLNIIT—VAVIFAPlGLIHLIPSDEGRTh___—F4 
ArnT PA01 (1) -------- 
ArnT E. coil (1) -------- 1 
ArnT S. typhimurium (1) ------- r4 
51 100 
Arnt BCAL1929 (51) 
ArnT PA01 (43) ILGGDS 
ArnT E. coli (43) 
ArnT S. typhimurium (44) 
101 150 
Arnt BCAL1929 (101) AGLTGARLN -LJ LASSPYWNLHNALDMGWI 
ArnT PA01 (93) 
ArnT E. coil (93) ITAALITIFILRL1LTS—-_LDIEWI 
ArnT S. typhimurium (94) 111AAL FRLMI< LDLWI 
151 200 
Arnt BCAL1929 (150) LSQRPPLI 
ArnT PA01 (143) NVHDGS' RT -LTLAEKGWLMPA 
ArnT E. coil (143) VAGF 1Q h')  
ArnT S. typhimurium (144) TAGCFIQWT  
201 250 
Arnt BCAL1929 (200) "1' '.AADWALWK4 
ArnT PA01 (192) 1 0YML4-G HAPIMRIFFIH 
ArnT S. coil (192) 2A 
ArnT S. typhimurium (193) W/I 
300 
Arnt BCAL1929 (250) YT PQ'(r '1 --FLPWlSAWQHIVIMPPN 
ArnT PA01 (241) .L:n PaACLPWSSH -- 
ArnT E. coil (241) H1, LD0HPJ PALPW —YTNLH-- 
ArnT S. typhimurium (242) ML----
301 350 
Arnt BCAL192 9 (300) GFVLJAFI IFFSAIHSKLIYPVAPIA IIAPI4TA 
ArnT PA01 (289) -- _LAWLAFFSKLUYPILL 44QR 
ArnT E. coil (289) --TLSW_FFSKLUYO 
ArnT S. typhimurium (288) HN 
351 400 
Arnt SCAL1 929 (350) 
ArnT PA01 (337) LGISRG GLVAYIQLRKYQ ------- EIPIE 
ArnT S. coil (337) 
ArnT S. typhimurium (336) 
401 450 
Arnt BCAL1929 (396) GIAIAATLVLNRIAG1ARTFGA1LIFGTUGGHIEFGRYS 
ArnT PA01 (380) 
ArnT S. coil (384) IAIS_ TNVEITIPFAL GI 
ArnT S. typhimurium (383) _ - S 
451 500 
Arnt BCAL1929 (446) IGAILAPAVRELIKLPPDTPFYMEMLDHTFPFYMGHTTMVQRQDELA 
ArnT PA01 (430) 
ArnT S. coil (434) HF_ESLQP- AACLAQ_RQTIELI 
ArnT S. typhimurium (432) Q PLlS -4IN TAACiJ&)9IGHAjELI 
501 550 
Arnt BCAL1929 (496) MGMVEPNI---- 
ArnT PA01 (479) 
ArnT S. coll (483) - 
ArnT S. typhimurium (481) IC- 
551 573 
Arnt BCAL1929 (542) RVIAIDII ----- --EIPQS 
ArnT PA01 (529) ERNGNLVLPIVIP-- 
ArnT S. coil (533) §MDPIEI ----  
ArnT S. typhimurium (531) UNIDEGI---- P.- 
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Appendix II: Ugd plasmid maps and sequences 
B. cenocepacia J2315 UGD expressing plasmid maps: 
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UgdRcAL2946 (1398 bp, 53055.64 Da) 
1 MGSSHHHHHH SSGLVPRGSH MKITIIGTGY VGLVTGAOLA EIGHDVFCLD 
51 VDPRKIDILN NGGMPIHEPG LLDIIARNRT AGRLRFSTDI EASVAHGEIQ 
101 FIAVGTPPDE DGSADLQYVL EAARNIGRHM TSFKVIVDKS TVPVGTAQRV 
151 RGVVDEALAA RGLAGSVAHR FSVVSNPEFL KEGAAVEDFE'1 RPDRIIIGVD 
201 DDETGTIARE KMKKLThPFN RNHERTIYMD VRSAEFAKYA ANAMLATRIS 
251 FMNEMSNLAD KVGADIEAVR RGIGSDPRIG YHFLYAGVGY GGSCFPKDVQ 
301 ALIRTAGENG QPLRILEAVE AANHAQKDVL IGKIEQRFGA DLTGREFAVW 
351 GLAFKPNTDD MREAPSRRLI AALLERGATV RYDPVAVDE ARRVFALDFG 
401 DDADALARLH LVDTQDVAVT GADALVIVTE WKEFRSPDFT RLKELKAPV 
451 IFDGRNLYEP DAMAELGIDY YAIGRPYVDP QLSSRG 
UgdBCAM0855 (1436 bp, 53388.85 Da) 
1 MGSSHHHHHH SSGLVPRGSH MNLTIIGSGY VGLVTGACLA DIGHDVFCLD 
51 VDQAKIDILN DGGVPIHEPG LKEVIARNRS AGRLRFSTDI EAAVAHGDVQ 
101 FIAVGTPPDE DGSADLQYVL AAARNIGRYM TGFKVIVDKS TVPVGTAERV 
151 RAAVAEELAK RGGDQMFSVV SNPEFLKEGA AVDDFTRPDR IVIGCDDDVP 
201 GERARELMKK LYAPFNRNHE RTLYMDVRSA EFTKYAPNAM LATRISFMNE 
251 LANLADREGA DIEAVRRGIG SDPRIGYHFL YAGCGYGGSC FPKDVEALIR 
301 TADEHGQSLQ ILKAVSSVNA TQKRVLADKI VARFGEDLSG RTFALWGLAF 
351 KPNTDDI'1REA PSRELIAELL SRGARVAAYD PVAQQEARRV IALDLADHPS 
401 WLERLTFVDD EAQARDADA LVTVTEWKAF KSPDFVALGR LWKTPVIFDG 
451 RNLYEPETMS EQGIEYHPIG RPGSRQAVAA RVPGAARSA 
UgdPCAM2034 (1413 bp, 52001.05 Da) 
1 MGSSHHHHHH SSGLVPRGSH MNVRIAIVGT GYVGLVSGTC LAELGHDVVC 
51 IDNNRGKIDA LNEGRMPIYE PGLDAVVARN VERGTLRFSN DLPASVRDRD 
101 AVFIAVGTPT LPGTDHADLQ YVEPAAREIA ANLTGFAVIV TKSTVPVGTN 
151 RIVAQIVDCC APDGVDAIA SNPEFLREGS AIDDFMHPDR IVFGAEHPA 
201 IEINKAIYAP LEAAGHLVLA TEIETAELVK YANAFLAVK ISYINEISDL 
251 CEAVGADVEL VANGMGLDRR IGASFLKAGP GWGGSCFPKD TRALKATASQ 
301 HAVPLRIVSA AIESNALRKE QILRRIENAC GGSIKGKRIA VLGLTF'KGQT 
351 DDVRESPSID VIQLLVGAGA HIRAYDPARP HEASRLLPQV FMEGSAVDAV 
401 RSADAVVVMT EWKAFETLDL ADLADHMADP VMLDNRNLFS ERLAADSGFR 
451 RYERVGRSCG ERSPADPAAE PANASADTRP QRGLLQH 
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Amino acid sequence alignment of B. cenocepacia BCAL2946 and P. aeruginosa 
PA2022 shows 52.5% identity 
1 50 
UGD BCAL2946 (1) 
UGD PA2022 (1) 
Consensus (1) MEl hG GYVGLVTAAC AEIG V CLD D El L G MPIHEPG 
51 100 
UGD BCAL2946 (51) LLDIIA1RT4RLRITIEASAIEQFIAVGTPPDEDGS ADLIVL 
UGD PA2022 (51) LES IIRDILDAIRLTFIASjAEGIA1EUVFIAVGTPCGEDC-SADLSFL 
Consensus (51) L II N AARL FS I LA AEI FIAVGTP EDGSADL HVL 
101 150 
UGD BCAL2946 (101) EAARGRHITSFKVDKSTVPVGTAQRVRGD4LAARGLAGSVAHR 
UGD PA2022 (101) AVAEGA1RQACVNKSTVPVGTAERVEERLLARR ---- RKRFR 
Consensus (101) A NIG L liv KSTVPVGTA RV II ALA R R 
151 200 
UGD BCAL2946 (151)  FIVVSDIPEFLKECJAVIDFMRPDPIIIGVDlDETGTIAREKEKLYAPFN 
UGD PA2022 (147) 
Consensus (151) AV SNPEFLKEGAAVDDF R9DR111G D G E LE LYAPF 
201 250 
UGD BCAL2946 (201) RNHERTUYMDVRSAEIKYAANAMLATIISFMNEINLADEVGADIEAVR 
UGD PA2022 (193) RNRERVJLNGRREAE1KYAANAFLA'11ISFMNEIGLCALTGVDIEDVR 
Consensus (201) REHER I H R AEFAKYAANA LATKISFMNEMA L G DIE VR 
251 300 
UGD BCAL2946 (251) RIc-SD2RIGYi1F1YAGVGYGGSCFPKDVQALIRAGEGQPLRILEAVE 
UGD PA2022 (243) RIGS0ERIGTH1YAGCGYGGSCFPKDVRALIRAEIGYDSQILRAVE 
Consensus (251) RGIGSD RIG HFIYAG GYGGSCFPKDV ALIRSA HG IL AVE 
301 350 
UGD BCAL2946 (301) AANHAQKLI G1EQRFIDLTGREF2JEGLAFKPNTDDREAPSRRL 
UGD PA2022 (293) ARNARQKLFETGELFIRWQGRTVAWGLAFKPGTDDREAPSLVLI 
Consensus (301) A N QKDLL I F A GR ALWGLAFKP TDDLREAPS LI 
351 400 
UGD BCAL2946 (351) AALLERGATVRAIDPVAVDEARRVFALDFGDIADALARLHLVDQDVAVT 
UGD PA2022 (343) EALLRHGVRVR.1DPVAN--AGVAARYP --- IAVACARLTLHDPYAAVE 
Consensus (351) ALL G VRAHDPVA A DA A ARL L DS AV 
401 450 
UGD BCAL2946 (401) GADALVIVTEWKEFRSPDFTEAPFDGRNLYEPDANAELGIDY 
UGD PA2022 (388) GADALVIVTEWKQFRQPDFQSTPVDGRNLYAPARMAELGFIY 
Consensus (401) GADALVIVTEWK FR PDF KIKA LK PLI DGRL4LY P MAELG Y 
451 467 
UGD BCAL2946 (451) YIIGRPYVDPQLS1- 
UGD 9A2022 (438) IIGRPRAGHC1SIJ- 
Consensus (451) AIGRP AS A 
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Amino acid sequence alignment of B. cenocepacia BCAM0855 and P. aeruginosa 
PA2022 shows 51.8% identity 
1 50 
UGD BCAM0855 (1) 
UGD PA2022 (1) 
Consensus (1) H L IIGAGYVGLVTAAC ADIG V CLD 0 Fl L G MPIHEPG 
51 100 
UGD BCANO 855 (51) LKEA1RSAELR1T1EAAHVQFIAVGTPPDEDGSADL1VL 
UGD PA2022 (51) LESRILDARLTFASIAEADaVVFIAvGTPCGEDGSADLSivL 
Consensus (51) L II N AARL FS I ALA ADV FIAVGTP EDGSADL HVL 
101 150 
UGD BCAM0855 (101) AAARCR1TGFKVDKSTVPVGTAERVRA14$AEELAIRC-GDQM1VV 
UGD PA2022 (101) AVAEGAlRQACVNKSTVPVGTAERVEEIIRLGLAIRRKRFRVVA 
Consensus (101) A A NIG L liv KSTVVGTAERV I LAKA AV 
151 200 
UGD BCASIO 855 (151) SNPEFLKEGAVDDFTRPDRIGCIDVPGERARELKLYAPFNRNHE 
UGD PA2022 (151) SNPEFLKEGAVDDFRRPDRIGSAETQAG ---- ETQLYAPFLRNHE 
Consensus (151) SNPEFLKEGAAVDDF RPDRIIIG D G F LK LYAPF RNHE 
201 250 
UGD BCAM0855 (201) RTLYNDVRSAE IK?AANAMLATI SFMNEANLADRFGADIEAVRRGIG 
UGD PA2022 (1 97) RVLLMGRPSEAEFKYAANAFLATISFKNEAGLCALTGVDIEDVRRCIG 
Consensus (201) R L N R AEFSKYAANA LATKISFMNELA L C DIE VRRGIG 
251 300 
UGD BCAN0855 (251) SDPRICYH1GCGYGGSCFPKDVEALIREHGQSLQILAVSVNA 
UGD 2A2022 (247) SDKRIGTHiYAGCGYGGSCFPKDVRALIIk1QQC-YDSQILAVERNA 
Consensus >251> SD RIG HFIYAGCGYGGSCFPKDV ALIRSAD G QILKAV A NA 
301 350 
UGD BCAM0855 (301) TQKILA1VARFGEDLSGRTFALWGLAFKPNTDDIREAPSRELIAELL 
UGD PA2022 (297) RQKEIL1TIGELFQGRWQGRTVALWGLAFKPGTDDREAPSLVLIEALL 
Consensus (301) QK LL D I F GRT ALWCLAFKP TDDLREAPS LI LL 
351 400 
UGD 5CAM0855 (351) SRGARVAADPVAUQEARRVIALDADHPSWLERLTFVDDEAQAARDADA 
ODD PA2022 (347) RHGVRVRAMDPVAAGVAARYPEAIA ----- CARLTLHDSPYAAVEGADA 
Consensus (351) G RV AHDPVAN LA RLT D A ADA 
401 450 
UGD BCAN0855 (401) LVIVTEWKAISPDFV1GRL1TPFDGRNLYEPETMEQGIEYHPIG 
UGD PA2022 (392) LVVTEWKQIQPDFQ1RGS1TPVDGEWLYA2AR5lELGFI YQGIG 
Consensus (401) LVIVTEWK FK PDF I KTPLI DGRNLY P MAE G I IC 
451 471 
UGD BCAN0855 (451) RPGSRQAVAARVPGAAIASA- 
UGD PA2022 (442) RP--R ------- AGHCASAA 
Consensus (451) RP R G KASA 
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Amino acid sequence alignment of B. cenocepacia BCAM2034 and P. aeruginosa 
PA2022 shows 38.4% identity 
1 50 
UGD bcam2034 (1) 
UGD PA2022 (1) _-MRØCBGAGYVGLVACFAEGNQVRCRDREARLRRGEMPIYE 
Consensus (1) ERI hG GYVGLVSA C AELG V CID R KI L G MPIYE 
51 100 
UGD bcam2034 (51) PGLAR1TLRFINDLAASNRDRAV FIAVGT PTLPGTDHADLQ 
UGD PA2022 (49) PGLRD1RLTE1ASLAEGIADAIVVFIAVGTPCG-EDGSADLS 
Consensus (51) PGLDAIL NLD A L FS LA L D D VFIAVGTP ADL 
101 150 
UGD bcam2034 (101) NVEAAARE1LTGFAVTKSTVPVGTNRIVAQIDCCAPDG-- VDA 
UGD PA2022 (98) MVLAVAEQALRQACMVNKSTVPVGTAERVEEIIRLGLARRRKRFRV 
Consensus (101) NV A A IAANL liv KSTVPVGT V II 
151 200 
UGD bcam2034 (148) AIASNPEFLIEGS1DDFMHPDRF1EHPRAIEI1YAPLEAAGHL 
UGD PA2022 (148) AIASNPEFLIEGS1DDI!RRPDRIGIAETQAGETIYAPFLRNHER 
Consensus (151) AIASNPEFLKEGSAIDDF PDRII GA A E LK IYAP 
201 250 
UGD bcam2034 (198) VLATEIETAELVKYAANAFLAVKISNEDLCEAVGADIELVANGMGL 
UGD PA2022 (198) 
Consensus (201) VL AE KYAANAFLA KISFINEIA LC G DIE V GMG 
251 300 
UGD bcam2034 (248) 
UGD 2A2022 (248) IRIGTH1YAGCGIGGSCFPKDVRALIRAEQQYDSQ1RAVEARNAR 
Consensus (251) DKRIG Fl AG GWGGSCFPKD RAL SA Q A IL A NA 
301 350 
UGD bcam2034 (298) RKEILRRIENACGGSIKIRI1LGLTFKGQTDIREiPSIDRQLLIG 
UGD PA2022 (298) QKELrFETIGELFQGRwQGTlAIWGLAFKPGTDD$REPSIVaEALIR 
Consensus (301) KE I I G GE hAL GL FK TDDLREAPSI LI LL 
351 400 
UGD bcam2034 (348) AGAHlRADPARPHENRLLPQVFMEl------- SAVDAVRSADIJVTE 
UGD PA2022 (348) HGV1RAIDPVANAGVARYPEAVACIRLTLHDS PYAAVEGADA!VTE 
Consensus (351) C IRAHDP A P A S AV ADALVLMTE 
401 450 
UGD bcam2034 (392) WKAFETLDLADIADHNADPMDMRNLERLA1SGFRRYE1GRSCIE 
UGD 2A2022 (398) 
Consensus (401) WE F D I N PLLLD RNLFA AD GF Y IGR A 
451 477 
UGD bcam2034 (442) RSPADPAAEPANASADTRPQRGLLQH- 
UGD PA2022 (447) HCKASAA -------------------- 
Consensus (451) A A 
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Amino acid sequence alignment of B. cenocepacia BCAL2946 and BCAM0855 shows 
73.3% identity 
1 50 
UGD BCAL2946 (1) t41TIIGlGYVGLVTGACLrJIGHDVFCLDVDPRKIDILNNGGPIHEPC- 
UGD BCAM0855 (1) MNITIIIGYVGLVTGACL1IGHDVFCLDVDQAKIDLNDGG!IHEPG 
Consensus (1) H ITIIGSGYVGLVTGACLADIGHDVFCLDVD KIDILN GGMPIHEPG 
51 100 
UGD BCAL2946 (51) LLIARN1AGRLRFSTD1EAVAHGQFIAVGTPPDEDGSADLQYVL 
UGD BCAMO 855 (51) 1,KIARN4AGRLRFST  DI E7JVAHGQFIAVGT P PL)EDGSADLQYVL 
Consensus (51) L DIIARNRSAGRLRFSTDIEAAVAHGDIQFIAVGTPPDEDGSADLQYVL 
101 150 
UGD BCAL2946 (101) EAARNIGPf1TSFKVIVDKSTVPVGTAQRVRVVDEALAARGLAGSVAHR 
UGD BCA510855 (101) AARNIGFJNTGFKVIVDKSTVPVGTAERV1JAVAEELAKR ---- GGDQM 
Consensus (101) AARNIGRHMT FKVIVDKSTVPVGTA RVRA V E LA R 
151 200 
UGD BCAL2946 (151) FSVVSNPEFLKEGAAIDFMRPDRIIIGV000ETGTIAREKNKKLYAPFN 
UGD BCAH0855 (147) FSVVSNPEFLKEGAAV1DFTRPDRIIIGCDDDVPGERARELI4KKLYAPFN 
Consensus (151) FSVVSNPEFLKEGAAVDDF RPDRIIIG DDD G ARE MKKLYAPFN 
201 250 
UGD BCAL2946 (201) RNHERTIYMDVRSAEFAKYAANANLATRISFNNENLADVGADIEAVR 
UGD 8CA140855 (197) RNHERTIYNDVRSAEFTKYAAN ANLAT RIS FMNENLADFGAD1AVR 
Consensus (201) RNHERTIYMDVRSAEF KYAANAI4LATRISFMNELANLADK GADIEAVR 
251 300 
UGD BCAL2946 (251) RGIGSDPRIGYHFLYAGVC-YGGSCFPKDVQALIRTAGENCQPLRILEAVE 
UGD BCAM0855 (247) RGIGSDPRIGYHFLYAGCGYGGSCFPKDVEALIRTADEHGQSLQILKAVS 
Consensus (251) RGIGSDPRIGYHFLYAG GYGGSCFPIKDV ALIRTA E GO L IL AV 
301 350 
UGD BCAL2946 (301) ANHAQKDVLIGKIEQRFGAOLGREFAWGLAFKPNTDDNREAPSRRM 
UGD 5CAN0855 (297) FNATQKRVLADKIVARFGEDLGRTFAWGLAFKPNTDDMREAPSRELI 
Consensus (301) A N QK VL KI RFG DLSGR FALWGLAFKPNTDDNREAPSR LI 
351 400 
UGD BCAL2946 (351) AALLERGATVRAYDPVAVDEARRVFALD1DDADALARLHLVDTQDVAVT 
UGD BCAM0855 (347) AELLSRGARVAAYDPVAQQEARRVIALDLIDHPSWLERLTFVDDEAQAAR 
Consensus (351) A LL RGA V AYDPVA EARRV ALD AD L RL VD A 
401 450 
UGD BCAL2946 (401) GADALVIVTEWKEFMSPDFTRLKAELKAPVIFDGRNLYEDArJELGIIY 
UGD 5CAM0855 (397) DADALVIVTEHKA1SPDFVALGRLWKTPVIFDGRNLYEPTMIEQGIIY 
Consensus (401) ADALVIVTEWK FKSPDF L K PVIFDGRNLYEPD 5AE GIDY 
451 475 
UGD BCAL2946 (451) IAIGRPYVDPQRG--------- 
UGD BCN40855 (447) PIGRPGSRQARVPGAARASA- 
Consensus (451) H IGRP LAAR 
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Amino acid sequence alignment of B. cenocepacia BCAL2946 and BCAM2034 shows 
43.1% identity 
1 50 
UGD BCAL2946 (1) --ITIGTGYVGLVIGACLAEC-HDVFCDVDPRKIDILNNGGMPIUE 
UGD bcam2034 (1) MNEIAINGTGYVGLVIGTCLAEIGHDVVCIDNNRGKIDALNEGRMPIIE 
Consensus (1) MKI IIGTGYVGLVSG CLAEIGHDV CID KID LN G MPIHE 
51 100 
UGD BCAL2946 (49) 2GLLDARNRTAGRLRFST1EASVAHlIQ7IAVGTP-PDEDGSADLQ 
UGD bcam2034 (51) EGLDAAPNVERGTLRFSNDiAASVRDRIAVFIAVGTPTLPGTDHADLQ 
Consensus (51) PGL IIARN C LRFS DI ASV D FIAVGTP ADLQ 
101 150 
UGD BCAL2946 (98) YVLEAARNIiRHiTSFKVIVDKSTVPVGTAQRVRGiVDEALAARGLAGSV 
UGD bcam2034 (101) YVEAAAREIIANITGFAVIVTKSTVPVGTNRIVAVDCCAPDG ----- V 
Consensus (101) YV AAR IA LT F VIV KSTVPVGT V IVD V 
151 200 
UGD BCAL2946 (148) AHRFVSNPEFLIEC1ADFMRPDRIiIG1DDETGTIAREKNK1YA 
UGD bcam2034 (146) DA--ASNPEFLiEGADFMHPDRIiFGlHPR ---- AIEIMKAIYA 
Consensus (151) Al SNPEFLKEGAAIDDFM PDRII G D A E 14K IYA 
201 250 
UGD BCAL2946 (198) PFNRNHERTIYNPIAEFAKYAANAMLATiI SNEiSNL1KVGA1E 
UGD bcam2034 (190) PLEAAGHLV$ATEIAELVKYAANAFLA1I SNEISDLCiAVGA0IE 
Consensus (201) 2 I DI SAE KYAANA LA KISFINEIS L D VGADIE 
251 300 
UGD BCAL2946 (248) AVRRGGSDPRICYHFLYAGVGiGGSCFPKDVQALIRTAGENiQPLRIIE 
UGD bcam2034 (240) LVANGiGLDRRIC-ASFLKAGPC-iGGSCFPKDTRALKATASQHiVPLRIIS 
Consensus (251) V GIG D RIG FL AG GWGGSCFPKD AL TA A PLRIL 
301 350 
UGD BCAL2946 (298) AVEAINHAQK*VmIIEiRFIITGIEFAVWGLAFKPITDDiREiPSR 
UGD bcam2034 (290) AAIEINALRKIQ1IEiACGiS1KGIRIAVLGLTFKGiTDDREIPSI 
Consensus (301) A AN ED II KIEN GA I GE AV GL FE NTDDMREAPS 
351 400 
UGD BCAL2946 (340) 1IALUERGATiRAYDPVAVDEARRFALDFGIDiDALARLHLVDTQDV 
UGD bcam2034 (340) 1IQLLIGAGAH!RAYDPARPHEASRLPQVFEGi ----------- AVD 
Consensus (351) LI LL GA IRAYDP EA EL F C A 
401 450 
UGD BCAL2946 (398) AVTGADAiVTEWKEF1PDFTRLKAEPViFDGRNLiEPDANb1LG 
UGD bcam2034 (379) AVRSADAIVTEWKAFEiLDLADLADHiADPVgLDMRNLiSERLAAiSG 
Consensus (401) AV ADALVIETEWE F S D L L PVI D RNLF AD G 
451 490 
UGD BCAL2946 (448) IDYYAIG ------ RPYVDPQLSSRG--------------- 
tJGD bcam2034 (429) FRRYERVGRSCGERSPADPAAEPANASADTR2QRGLLQFi- 
Consensus (451) Y R DP 
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Amino acid sequence alignment of B. cenocepacia BCAM0855 and BCAM2034 shows 
43.0% identity 
1 50 
UGD BCA140855 (1) 
UGD bcam2034 (1) NNlAIlGYVGL1GTCLAC-HDVVC DNNlKI DALNGIPIE 
Consensus (1) N I IIGSGYVGLVSG CLADIGHDV CID AKID LNDC- MPIHE 
51 100 
UGD BCAN0855 (49) PGLKEVIARNRSAGRLRFSTDUEAIVAHGDVQFIAVGTP-PDEDGSADLQ 
UGD bcam2034 (51) PGLDA1ARNVERGTLRFSNDAAIVRDRDAVFIAVGT PTLPGTDHADLQ 
Consensus (51) PGL VIARN G LRFS DI AAV D FIAVGTP ADLQ 
101 150 
UGD BCAN0855 (98) YVLAAARNIR1TGFKVIVDKSTVPVGTAE1R1UIAIELAKRGGDQNF 
tJGD bcam2034 (101) YVEAAAREIAlTGFAVIVTKSTVPVG-TN1VAlVCCAPDG--VDA 
Consensus (101) YV AAAR IA LTGF VIV KSTVPVG RI A I D A G 
151 200 
UGD BCANOBSS (148) 
UGD bcam2034 (148) 
Consensus (151) Al SNPEFLKEGAAIDDF PDRIV G D A EINK IYAP 
201 250 
UGD ECAM08 55 (198) NHERTLYMaIAEFTKYAANAMLATII  SNENLARFGADEAVRR 
DOD bcam2034 (194)  AGHLVLATMEJAELVKYAANAFLAVIISENENDLCIIAVGADJELVAN 
Consensus (201) L DI SAE KYAANA LA KISFINEIR L D GADIE V 
251 300 
GOD BCAM0855 (248) GIc-sDPRIGYHFLYAGC1GGscFPKDvEALIRTDEHQsLQIKAvss 
UGD bcam2034 (244) GGLDRRIGASFLKAGPGIGGSCFPKDTRALKATASQH!VPLRISAAIE 
Consensus (251) GIG D RIG FL AG GWGGSCFPKD AL TA HA L IL A 
301 350 
UGD BCAM0855 (298) 
GOD bcam2034 (294) SNALRKEQL1IENACGGSIKGURIAILGLTFKITDDMREf?SIIQ 
Consensus (301) NA K I KI G I OK AL GL FE NTDDMREAPS DLI 
351 400 
UGD 3CAM0855 (348) ELISRGA4AAYDPVAQQEARBALDLAIHPSWLERLTFVDDEAQAARD 
UGD bcam2034 (344) LLIGAGAHIRAYDPARPHEASRPQVFNIG ----------- SAVDAVRS 
Consensus (351) LL GA I AYDP EA RLI D A R 
401 450 
GOD BCAMO 855 (398) 
UGD bcam2034 (383) ADAIVTEWKAFELDLADLDHMADPVILDMRNLSERLAUSGFRRY 
Consensus (401) ADALVINTEWEAF S D LA PVI D RNLF AD G V 
451 486 
UGD BCAt40855 (447) HPIGRPGSRQIVAARVPGAARASA------------ 
UGD bcam2034 (433) EEJGRSCGE1PADPAAEPANASADTRPQRGLLQH- 
Consensus (451) IGR A A A ASA 
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Appendix III: BceB plasmid maps and sequences 
B. cenocepacia J2315 BceB expressing plasmid maps: 
X#d 65o3) 
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BceB PC184 long (1506 bp with His tag, 1440 without, 55041.55 Da) 
1 MRHGLHKELF GKRLFKEEMT MLSVLARVID IAMVVAGALI APJILHRGNVW 
51 FSDLQRTMVL FDCLLVVVCF 9AFGIYQSWR GKRLVGLGR VAFAWLVVEL 
101 AGILMSFSFH QSGELSRLWL GYWAIATVTL LAGSKkCVHO VLRRLRRGGF 
151 NLKTVAIVGG TPAARRLIAQ MRARPEAGFN PVCVYDEDP1A PGDVLDDVR 
201 IERQFESLVW LVRSR1IREL WLTLPISEER RIHQIVTVFR HDFVNIRFIP 
251 DVRSLSFFNQ EVVEVLGVPA INLAASITD VRILPKFVFD RIiFALAALVN 
301 LAPLMLVIAC LIKATSPGPV FFRQKRKGID GHEFEIYKFR SMKVHQEAAG 
351 TVTQATKNDS RVTPVGRFLR RTSLDELPQF INVLKGEVSV VGPRPHALH 
401 DDIYKDLVKG YMFRYRIKPG ITGWAQINGY RGETDQIEKM MGRVKLDLYY 
451 MQNWSFWLDI KIVALTLr,KG FTGSNAYLEH HHHHH 
BceB PC184 short (1446 bp with 6 His, 1380 bp without, 52486.44 Da) 
1 MLSVLARVID IAMVVTGALI AAALHGGSIG LSDLQRTTVL FDCLLVVVFF 
51 PAFGIYQSWR GKRLVGLGR VVFAWLAVEL AGILMSFSFH QSGDLSRLWL 
101 GYWALATTVL LAGSKACVHV VLRQLRRGGY NLKPNAIVGG TPAARRLIAQ 
151 MRRPEAGFN PVCVYDESEA PGEVALDDVR IERQFESLVW LVRSRAISEL 
201 WLTLPITEER RIHQIVTVFR HDFVNIRFIP DVRTLSFFNQ EVVEVLGVPA 
251 INLSPITD VRILPKFVFD RLFALLTA LAPVMVLIAA LIKLTSRGPV 
301 FFRQKRKGID GHEFEIYKFR S4KVHQEVAG QVTQATKNDS RVTPVGRFLR 
351 RTSLDELPQF INVLKGEESV VGPRPHALAH DDIYKDLVKG YMFRYRIKPG 
401 ITGWAQINGY RGETDQIEKM MGRVKIDLYY MQNWSFWLDI KIVVLTLWKG 
451 FTGSNAYLEH HHHHH 
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Appendix Ill: BceB plasmids maps and sequences 
Nucleotide sequence alignment of B. cenocepacia J2315 and B. cenocepacia PC184 
BceB long and short shows 85.9% identity. 
1 75 
bceb j2315 (1) ---G TCG C ______ 
bceB long (1) CAT CT-P A ---GilrTGTTGIl 
bceB short (1) ---------------------------------------------------------------CATATGTTG.!GT 
76 150 
bceb j2315 (73) GTGCTc-GCGAGAGTCATcGATATCGCc-ATGTGC'fGACGGGCGCGCTGTCGCG0CO3CCTFGCACGPCG00AGC 
bceB long (73) 
bceB short (13) GTc-CTGGCGA0AGTCATCGATTCGCG?1GGTIGT0J0GGG*0CGCTGATCGCIGCCGCCIt 3CPCGGCJ0 
151 225 
bceb j2315 (148) 
bceB long (148) 
bosS short (88) IT.GC.TCAGCGCCTGC2\GCGCACGJGGTGCTGTTCGACTGCCTGCTIGTCGTCGTGTICTTTCClGCaTC 
226 300 
bceb 12315 (223) GGCATCThCCAGTCGTGGCGCGGCMGCGTCTCGTCGGGCTGATGGGG0GCGTCGCGTTCGG?GGCCGCGGTC 
bosS long (223) 
bceB short (163) GGCATCT?ICAGTCITGGCGCGGCAAGCGlCTCGTCGGGCTGATGC-GICCCGTCGCGTTCGCTGGCTC3UGTC 
301 375 
bceb 12315 (298) AGCTCGCGGGATCCTGJlTGGCTTC7GCTTTCACCAGTCCGGCGACCTGTCGCGGCTGTc-GTGGGTTACTGG 
bceB long (296) GA0CT10C1000ATCCT0ATGA01TT0\GCTTTO,ICAGTC000CGPICTGTCO-CGGCTGT000TIGGLACTc-G 
bceB short (238) GGCTIGCICGCATCCTGATGAcITTCAGCTTTCUCAGTCGGGCGPLTGTCGCGGCTGTGGCTjGGIACTGG 
376 450 
bceb j2315 (373) GCGCTGGTGACGATGGCGCTGCTCGCCGGCTCGAAGGCCTGCGTGCACGTCGTGCTGCGGCAGTTGCGCCGCGCC 
bceB long (373) GCGITIr1GACGITUCGCTGCTCGCCGG1TCGAAGGCFGCGTGC9IGGTGCTGCGGcIG1TGCGICGCGGC 
bceB short (313) GCTIGlGACiTMCGCTGCTCGCCGlTCGAAc-GcITGCGTGC)IGGTCCTGCGGcIGITGCGICGCGGC 
451 525 
bceb j2315 (448) GGCTACAACCTGAAGGCGGTCGCGATCGTCGGCGGC ----------- GCGGCGGCTGATCGCGCAGATGCGGGCG 
bosS long (448) GGCTICAACCTGAAGGCGGTCGCGATCGTCGGCGGC llllllllllGCGGCGGCTGATCGCGCAGATGCGjGCG 
bceB short (388) GC-CTICACCTGAAGGCGGTCGCGATCGTCGGCCGC llllllllllGCGGCGGCTGATCGCGCA&kTGCGjGCG 
526 600 
bceb j2315 (512) CGGCCGGAGGCCGGCTTCAACCCGGTGTGCGTGTACGACGAAAGCGPGGCGCCGGGCGAAC-TCGCGCTCGACGAC 
bceB long (523) CICCGGAGGCIGGCTTCACCCGGTGTGCGTGTACGACGP.CGIGGCGCCIGGCC7%IGTCGCGCTCGACGAC 
bosS short (463) CICCGGAGGc1GGCTTCAACCCGGTGTGCGTGTACGACGACGIGGCCCCIGGCGIGTCGCGCTCGPCGAC 
601 675 
bceb j2315 (587) GTC-CGCATCC-AGCGGcGTTCGArTCGCTGGTGTGC-CTGGTGCGCAGCCGCGCGATCAGCGAGCTGTGGCTCCG 
bceB long (598) GTGCGTCGAGCGGCC.TTCGPATCGCTGGTIrGGCTTC-CGCACCCGCGCGATCIGCGAGCTGTGGCTCG 
bosS short (538) CTGCTCGAGCGGCAGTTCGAATCGCTGGTITGGCTIGTC-CGCAGCCGCGCGTCIGCGAGCTGTGGCTIACG 
676 750 
bceb j2315 (662) crGCcGATCACGGAGGAGcGCCGC-ATTCACCAATCGrGACGGTGTTCCGCC2CGACTTCGTG?kACATCCGCTTC 
bceB long )673) ITGCCGATUCGG1GAGCcJCGGATTCAGATCGTIC2GTGTTICGICACGACTTCGTI9ACATCCGCTTC 
bceB short ) 613) 
751 825 
bceb j2315 (737) ATTCCGG-ACGTGCGC2CGCTGTCGTTCTT CAI,  CCAGGAGGGTCGAGGTGCTCGGCGTGCCG3CGATCACCT 
bceB long (748) 
bceB short (688) 
826 900 
bceb j2315 (811) 
bceB long (822) CGCGG0GTCGCCGATCCC2ACGTGCGGATCCTGCCGhGTTCGTGTTCGACCGc1TGTTCGCGCTIC1GCGCT 
bosS short (763) CGCC.GCGTCGCCGATCACCGACGTGCGATCCGCCGAAG2TCGTGTTCGACCGCRTGTTCGCGCTICIGCGCT 
901 975 
bceb j2315 (886) CCGGCC-CTCGCGCCGGTGATGGTGCTGTCGCGGCGCTC-ACAAGCTGACCTCC-CGCGGCCCC-GTGTTCTTTCG 
bceB long ) 897) CRC  GCTCGCGcCGITGr.TG1'rUTGATCGcGCTGA:CAAGEGACcTCSCRcCGCCIoTc-TTcTTICG 
bceB short (838) CRC GCTCCCGCCGITGJTCITUTCPTCGCCCTGATCAAc-RGACCTCGCRCCGCCIGTCTTCTTICG 
976 1050 
bceb j2315 (961) 
bceB long (972) 
bceS short ) 913) 
1051 1125 
bceb j2315 (1036) GCCCCGGCAGC-TcACGCACGCCCGCCCTCGCGCGTGACCCC0-GTCGGCCGGTTCCTGCGCCGCACGAG 
bceB long (1047) 
bceB short (988) 
1126 1200 
bceb j2315 (1111) 
bceB long (1122) 
bceB short (1063) CCTCGACGjCTGCCGCAGTTCTC.ACc-TGCTC?ACCCCC2.RTGTCCG1G1GCLC5Cc-JCCG0ATGCGCT 
1201 1275 
bceb j2315 (1186) CGCGCACGACGCATCTACCGATCTGGTCGGGCTACATTCCCCTACCGGcCCCGCCAiCACCCG 
bceB long (1197) 
bceB short (1138) CGCCCACCACGACATCTACAGTCTGGTCCCGCT2TGTTCCCCTCCCCA'CCPAGCCCGGCATCACCGG 
1276 1350 
bceb j2315 (1261) GTGGGCGCAGATCAACGGCTTTCGCCC-CGkAA0CGACCACATCGAGAAGi1GATCC3CCCCGTGACCTCGACCT 
bceB long (1272) 
bceB short (1213) ITGcGCGCAGATCAACc-GCTFCGCGGCc-JACCGCcAGAC0AGAP.G2TGATGCGICGCGTGAAGCTCG2ICT 
1351 1425 
bceb j2315 (1336) c-TACTACATc-C?ACTCGTCc-TTCTGGCTCGACATC?IGA7CGTCGTGCTGACGCTGTGc-AAGGGTT0ACCGG 
bceB long (1347) c-TACTACTc-CAGCTGG:CGTTCTCGCTCGACATC.AIGA:CGTCCICCTGACCCGTGGMAGGITTCACCGG 
bceB short ) 1288) 
1426 1444 
bceb j2315 (1411) CAGC_CCCGT7CTG-A--- 
bceS long (1422) CACCACCCGTAU 
bceB short (1363) CJGCCCCCTC 
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Appendix IV: Sephacryl S-200 calibration 
Data from Marine Raman, School of Chemistry, University of Edinburgh 
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The species that presently constitute the Burkholderia cepacia complex (Bcc) have multiple roles; 
they include soil and water saprophytes, biorernediators, and plant, animal and human pathogens. 
Since the first description of pathogenicity in the Bcc was based on sour skin rot of onion bulbs, 
this study returned to this plant host to investigate the onion-associated phenotype of the Bcc. 
Many Bcc isolates, which were previously considered to be non-mucoid, produced copious 
amounts of exopolysaccharide (EPS) when onion tissue was provided as the sole nutrient. EPS 
production was not species-specific, was observed in isolates from both clinical and 
liJifl environmental sources, and did not correlate with the ability to cause maceration of onion tissue. 
Chemical analysis suggested that the onion components responsible for EPS induction were 
primarily the carbohydrates sucrose, fructose and fructans. Additional sugars were investigated, 
and all alcohol sugars tested were able to induce EPS production, in particular mannitol and 
glucitol. To investigate the molecular basis for EPS biosynthesis, we focused on the highly 
conserved bce gene cluster thought to be involved in cepacian biosynthesis. We demonstrated 
induction of the bce gene cluster by mannitol, and found a clear correlation between the inability 
of representatives of the Burkholderia cenocepacia Eli 2 lineage to produce EPS and the r presence of an 11 bp deletion within the bceB gene, which encodes a glycosyltransferase. Insertional inactivation of bceB in Burkholderia ambifaria AMMD results in loss of EPS production 
on sugar alcohol media. These novel and surprising insights into EPS biosynthesis highlight the 
Received 6 August 2007 metabolic potential of the Bcc and show that a potential virulence factor may not be detected by 
Revised 2 May 2008 routine laboratory culture. Our results also highlight a potential hazard in the use of inhaled 
Accepted 5 May 2008 mannitol as an osmolyte to improve mucociliary clearance in individuals with cystic fibrosis. 
INTRODUCTION 
The genus Burkholderia includes three closely related 
microbial species that highlight diverse evolutionary 
adaptation to different niches and hosts. Burkholderia 
mallei is a soliped-specific pathogen that only occasionally 
infects humans. Burkholderia pseudomallei is a free-living 
soil microbe and the causative agent of the subtropical 
human disease melioidosis. The species that presently 
Abbreviations: Bcc, Burkholderia cepacia complex; CF, cystic fibrosis; 
CGD, chronic granulomatous disease; EPS, exopolysaccharide; HPAE-
PAD, high-performance anion-exchange chromatography with pulsed 
amperometric detection; TFA, trifluoroacetic acid. 
Three supplementary tables and a supplementary figure are available 
with the online version of this paper. 
constitute the Burkholderia cepacia complex (Bcc) have 
multiple roles; they include soil and water saprophytes, 
rhizosphere parasites, bioremediators, plant growth pro-
moters and plant, animal and human pathogens. Members 
of the Bcc are particularly associated with life-threatening 
respiratory infections in patients with chronic granuloma-
tous disease (CGD), and are the most potentially virulent, 
transmissible and inherently resistant microbes to have 
emerged as cystic fibrosis (CF) pathogens in recent decades 
(Govan, 2006; Mahenthiralingam et aL, 2005). 
Although most species within the Bcc produce a variety of 
putative virulence factors, the role of these factors in the 
pathogenesis of human infection is unclear 
(Mahenthiralingam et al., 2005). Evidence from various 
model systems (mouse, rat, plant and nematode) suggests 
2008/019216 © 2008 SGM Printed in Great Britain 2513 
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that the importance of individual virulence factors, or 
combinations of factors, depends on the infection model 
used (Bernier et al., 2003). In addition, studies of Bcc 
infections in CF patients also suggest a key role of host—
pathogen interactions, since clinical outcome in individual 
patients cannot be predicted even during epidemic out-
breaks when multiple patients are infected by the same 
strain (Govan et a?., 1993). The first description of 
pathogenicity in the Bcc was based on sour skin rot of 
onion bulbs (Burkholder, 1950). In this study, we returned 
to this plant host to investigate the onion-associated 
phenotype of the Bcc, and reveal a link between growth 
conditions and exopolysaccharide (EPS) production. 
EPS is a putative Bcc virulence factor that is involved in 
persistence of the bacteria in CF lungs (Conway et al., 
2004), interactions with antimicrobial peptides 
(Herasimenka et a?., 2005) and the formation of bioflims 
(Cunha et a?., 2004). The EPSs of Burkholderia species have 
recently been comprehensively reviewed (Goldberg, 2007). 
Recent studies (Zlosnik et al., 2008) have also challenged 
the previous belief that mucoid, EPS-producing colonial 
morphotypes of Bcc are rare in both environmental and 
clinical isolates (Govan & Deretic, 1996). Other studies 
have shown that mucoid Bcc isolates mostly synthesize one 
type of EPS, with a highly branched heptasaccharide 
repeating unit, which was named cepacian (Moreira et a?., 
2003; Sist et a?., 2003). EPS production has been shown to 
increase when the Bcc are grown in mannitol-rich yeast 
extract medium (MYEM) (Sage et aL, 1990; Zlosnik et al., 
2008). 
Here we report the novel observation that many Bcc 
isolates, found to be non-mucoid on typical culture media, 
produce copious amounts of EPS when onion tissue is 
provided as the sole nutrient. Chemical and molecular 
analyses suggest that EPS biosynthesis is strain-specific and 
that the plant compounds responsible are primarily sugars 
and sugar alcohols. We show that the EPS phenotype on 
onion media is associated with the previously described bce 
cluster (Moreira et a?., 2003), thought to be involved in 
cepacian biosynthesis. 
METHODS 
Bacterial strains and culture conditions. Bcc isolates used in this 
study are described in Table 1 and include 16 isolates from the two 
published Bcc strain panels (Coenye et a!, 2003; Mahenthiralingam et 
al., 2000). Additional Bcc strains investigated included Burkholderia 
pyrrocinia BTS7, Burkholderia cenocepacia BTS2, as well as 19 
Burkholderia multivorans, 14 Burkholderia cenocepacia lilA and 11 
Burkholderia cenocepacia IlIB isolates from our collection. Isolates 
were recovered from storage at —80 'C by subculture on nutrient 
agar (NA; Columbia base agar, Oxoid) and subsequently grown on 
media composed of 1.5% (w/v) bacteriological agar (Oxoid) 
containing 2% (w/v) sugars and fractions from various isolation 
methods below. 
Sugars and other related chemicals were purchased from Sigma-
Aldrich, BDH AnalaR, MP Biochemicals, Fluka BioChemika or Acros 
Organics. 
Onion maceration. White onion slices were placed in Petri dishes 
and inoculated with stationary-phase Bcc cultures (10 c.f.u.) that 
had been cultured overnight in 2.5% (w/v) nutrient broth No 2 
(Oxoid) with 0.5% (w/v) yeast extract. The onions were left at 30 'C 
for 5 days. The results were assessed by eye, and onion maceration 
recorded as positive or negative. 
Onion extract agar. Peeled white onions (1 kg) were chopped, 
homogenized in a blender at room temperature, and filtered through 
muslin. The filtrate was filter-sterilized through a 0.22 pm filter and 
lyophilized to give a yellow sticky powder (typical yield 62 g). Twenty 
grams of lyophilized onion extract and 15 g bacteriological agar were 
made up to 11 with distilled H70, then autoclaved at 121 'C for 
15 min. Strains were subcultured onto onion agar and incubated for 
72 h at 30 'C. Mucoidy was recorded on a scale ranging from non-
mucoid ( — ) to very mucoid (+ + +). 
Sugar agar. Sugar agar contained 20 g of the sugar of interest, 2 g 
yeast extract, and 15 g bacteriological agar dissolved in 11 distilled 
H20 (Sage et al., 1990). The sugars used were as follows: D-fructose, 
o-galactose, D-mannitol, D-glucose, glycerol, lactose, L-rhamnose, o-
mannose, maltose, sucrose, niyo-inositol, ribitol (adonitol) and n-
glucitol (sorbitol). The fructan polysaccharide inulin was also tested. 
As a control, isolates were grown on bacteriological agar containing 
0.2% (w/v) yeast extract alone. 
Reverse-phase chromatography. Twenty millilitres of onion 
extract, 2% (w/v) in distilled H20, was loaded onto a pre-packed 
C8 column (10 g/60.0 ml, Varian, Anachem) and bound material was 
eluted stepwise using three concentrations of methanol (20%, 50% 
and 80%, v/v; Fisher Scientific). Each fraction was lyophilized, 
dissolved in distilled H2O and incorporated into 1.5% (w/v) 
bacteriological agar. 
Ethyl acetate partitioning. To separate any lipids, non-polar, non-
acidic and polar compounds, the resolubilized onion extract was 
brought to pH 7.0 using NaOH and partitioned against ethyl acetate 
(Fisher Scientific) at 1: 1 (vlv), The phases were separated, and the 
aqueous phase was brought to pH 2.0 using HCl and the extraction 
was repeated. Following both extractions, the organic and aqueous 
layers were evaporated or lyophilized respectively, and then redis-
solved in distilled H20, pH adjusted to 7.0, and incorporated into 
1.5% (w/v) bacteriological agar. 
Acid hydrolysis. The aqueous phase residue of the ethyl acetate 
partitioned onion extract was redissolved in distilled H20 (50 mg 
mV') and was hydrolysed in 2 M TFA (trifluoroacetic acid; Sigma) at 
60 'C or 120 °C for 1 h. 
Paper electrophoresis. To fractionate the extract based on the 
presence or absence of functional groups, the freeze-dried aqueous 
phase of the onion extract was weighed and resuspended in distilled 
H2O to a final concentration of 50 mg ml'. One millilitre was 
loaded at a central origin on a Whatman no.1 paper (57 x 42 cm). 
The following standards were added in the margins of the paper: 
glucose 6-phosphate, glucose, glucosamine, methyl green (Sigma) and 
orange G (BDH). Electrophoresis was conducted at 1 kV for 20 min, 
in volatile buffers at pH 2.0 or 6.5 with white spirit or toluene as 
coolant (Fry, 2000). 
Paper chromatography. One millilitre aliquots of each of the 
redissolved aqueous phase of the onion extract and the TFA-
hydrolysed samples (50 mg ml— ') were chromatographed on 
Whatman no. 1 paper alongside markers (ferulic acid, rhamnose, 
glucose, lactose, mannose, galactose, fructose, mannitol and glycerol) 
in butan-1-ol/acetic acid/water (12:3 :5, by vol.) for up to 60 h. 
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Table 1. EPS biosynthesis of B. cepacia complex species when grown on agar supplemented with various substrates 
All strains tested are from the two published Bcc panels (Coenyc et al., 2003; Mahenthuralingam et al., 2000), except for BTS2 and BTS7, which were donated by Paola Cescutti. EPS production was 
scored on a scale from - (no EPS) to + + + (very mucoid). Mucoid growth described as + + + is shown in Fig. 1(b). YE, yeast extract agar. 
Species Strain Source YE Onion Glucose Sucrose Fructose Inulin Glycerol Mannitol Glucitol Ribitol Inositol Mannose 
B. cepacia ATCC25416 Onion - ++ - ++ +++ - +++ +++ +±+ +-I-+ +++ + 
B. cepacia CEP509 CF - - - + + + + + + + + + + + - 
B. multivorans C1576 CF - + + - + + + + + + + + + -I- + + + + + + + + + 
B. multivorans ATCC 17616 Soil - + + - + + + + + + + + + + + + + + + + + + + - 
B. cenocepacia J2315" CF - - - - - - - - - - - 
B. cenocepacia K562* CF - - - - - - - - - - - - 
B. cenocepacia BC7* CF - - - - - - - - - - - - 
B. cenocepacia PC184 CF - + + - + + + + + + -I- + + + - 
B. cenocepacia BTS2 CF - -F + - + + + + + -I- + + + + + + - 
B. stabilis LMG14294 CF - - - - + - - + - - - - 
B. vietnarniensis LMG10929 Rice - + + + - + + + + + + + + + + + + + - + + + + + 
B. vietnainiensis PC259 CF - + + - + + + + + + + + + + + - - 
B. dolosa E12 CF - ++ - - +++ - ++ ++ - + +++ 
B.arnhfaria AMMD Soil - +++ - + +++ + +++ +++ +++ +±+ +++ - 
B.anthina W92  Soil - +++ - - +++ + +++ +++ +++ +++ +++ ++ 
B. anthina C1765 CF - + - - + + + - + + + + + + - + + + + + 
B.pyrrocinia BTS7 CF - +++ - + +++ +++ +++ +++ +++ +++ +++ + 
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Staining and elution methods. Electrophoretograins and chroma-
tograms were stained with silver nitrate (Fry, 2000) to reveal 
monosaccharides, oligosaccharides, alditols, saccharinic acids and 
phenols, and with aniline hydrogen phthalate to reveal monosac-
charides and reducing disaccharides. The paper strips of interest from 
both methods were eluted by a syringe method with distilled H20 
(Eshdat & Mirelman, 1972). The eluted material was incorporated 
into 1.5% (w/v) bacteriological agar with 0.2% (w/v) yeast extract. 
High-performance anion-exchange chromatography with 
pulsed arnperometrlc detection (HPAE-PAD). Twenty microlitres 
each of the aqueous phases of the onion extract and the TFA-
hydrolysed samples (0.1 mg m1 l)  were analysed by HPAE—PAD 
(Dionex). The system consisted of an AS3500 autosampler, GP40 
gradient pump, ED40 electrochemical detector, and PCiO pneumatic 
controller. The amperometry detector cell contained a gold electrode 
and a pH-Ag/AgCl combination reference electrode, CarboPac MA- 1, 
PA-1 and PA-100 columns and guard columns were used for the 
separation of alditols, monosaccharides and oligosaccharides, respect-
ively. Eluents, degassed by bubbling with helium, were as follows: 
MA-1, 600 mM NaOH at 0.4 ml min (isocratic); PA-1, 20 mM 
NaOH for 3 mm, then H20 for 32 min, then a 0-200 mM NaOH 
gradient over 10 mm (all at 1.0 ml min' with post-column addition 
of base); PA-100, 100 mM NaOH throughout, supplemented with a 
0-200 mlvi NaOAc gradient over 30 mm, then 200-800 mM NaOAc 
over 10 mm (all at 1.0 ml min'). Analytes were identified by 
comparison of retention times to those of standards and quantified by 
integration of peak area with Chromeleon software (Dionex). 
Investigation of conserved EPS gene clusters in Bcc species. 
Genome sequences representing five Bcc species were examined to 
determine if two previously published EPS gene clusters within B. 
cenocepacia J2315, the bce gene cluster (Moreira etal., 2003) and the 
wcb gene cluster (Parsons etal., 2003), are conserved across the Bcc. 
The amino acid sequences for every ORF within each of the two 
gene clusters within B. cenocepacia J2315 (genome sequence 
available at the Wellcome Trust Sanger Institute; http://www.sanger. 
ac.uk/) were used to search by TSLASTN the following Bcc genome 
sequences: Burkholderia ambifaria AMMD, Burkholderia vietna-
miensis G4, B. multivorans ATCC 17616, Burkholderia sp. 383 (all 
sequences are available at the US Department of Energy Joint 
Genome Institute; http://www.jgi.doe.gov/) and Burkholderia dolosa 
AUO 158 (available at the Broad Institute; http://www.broad.mit. 
edu/). TBLASTN searches were performed using default parameters 
(BLOSUM 62, Word size 3). 
RT-PCR analysis of EPS biosynthetic gene clusters. The EPS-
producing strain, B. ambifaria AMMD, was cultured in 0.2% (w/v) 
yeast extract with or without supplementation with 2% (w/v) 
mannitol. RNA was extracted from mid-exponential phase cultures 
(RNeasy Protect Bacteria Mini kit; Qiagen) and DNase I-treated 
(RNase-free DNase set; Qiagen), prior to reverse transcription with 
1.5 pg RNA template, random primers and SuperScript III Reverse 
Transcriptase (Invitrogen). cDNAs and corresponding non-RT 
controls were used as template in PCR reactions specific for two 
distinct wza homologues (Bamb....5549 and Bamb...3621) located 
within two separate putative EPS biosynthetic gene clusters. Primer 
sequences are available upon request. 
PCR analysis of bceB gene. Using the bceB gene sequence of B. 
cenocepacia J2315, bceB homologues were identified within the 
publicly available genome sequences of B. ambifaria AMMD, B. 
cepacia sp. 383, B. cenocepacia AU 1054, B. cenocepacia H12424, B. 
cenocepacia PCl84, B. vietnamiensis G4 and B. dolosa AU0158. The 
eight gene sequences were aligned, and PCR primers flanking the 
location of the previously described ii bp deletion in B. cenocepacia 
J2315 (Moreira etal., 2003) were designed based on conserved regions  
across the eight aligned sequences (For 5'-TGAAGGCGGT[G/ 
C]GCGATCGTC-3'; Rev 5 '-TCGAT[G/CICGCACGTCGTCGAG-3'). 
For preparation of genomic DNA, one or two bacterial colonies were 
resuspended in 20 p1 lysis solution [0.25% (w/v) SDS, 0.05 M NaOH] 
and incubated at 95 °C for 15 mm. After brief centrifugation, 180 il 
sterile water was added and centrifugation performed at 13000 g for 
5 mm. Two microlitres of supernatant containing genomic DNA was 
used as template in PCR assays. PCRs were performed in a 50 0 
volume containing 300 nM forward and reverse primer, 1.5 mlvi 
MgCl2, 260 pM of each dNTP, 4% (v/v) DMSO, 1 U Taq polymerase 
(Invitrogen) and appropriate manufacturer's reaction buffer. Thermal 
cycling was performed on a GeneAmp PCR System 9700 (Applied 
Biosystems) with the following parameters: 94 CC  3 mm; 40 cycles of 
94 °C (30 s), 60 CC  (30 s) and 72 °C (30 s); 72 °C 10 mm. PCR 
products were electrophoresed on a 4% E-Gel (Invitrogen) and 
visualized by UV illumination. The B. cenocepacia J2315 bceB gene 
sequence harbouring the ii bp deletion yields a PCR product of 
140 bp, compared to 151 bp from the wild-type sequence found in B. 
cenocepacia 1ST 432 (Videira et al., 2005). 
PCR analysis of BCESM and cblA. Genoinic DNA was prepared as 
described above. PCRS were performed as described previously 
(Mahenthiralingam et al., 1997; Sajjan et al., 1995). 
Insertional Inactivation of bceB In B. ambifaria AMMD. 
Insertional inactivation of bceB was performed using the pGPciTp 
suicide vector, essentially as described previously (Flannagan et al., 
2007). In brief, a 300 bp fragment internal to the bceB ORF of B. 
ambifaria AMMD and flanked by Xbal and EcoRI sites was PCR-
amplified and ligated into the corresponding sites in pGPciTp 
following appropriate restriction. Resulting plasmids were trans-
formed into Escherichin coli GT1 15 competent cells (InvivoGen) and 
subsequently introduced into B. ambifaria AMMD by triparental 
mating. Resulting exconjugants were selected using gentamicin 
(50 mg l) and trimethoprim (100 mg l_'), and mutants identified 
by PCR using a chromosomal-specific primer in conjunction with the 
vector-specific primer RSF1300 (Flannagan et al., 2007). 
RESULTS 
EPS production on onion agar 
When a lyophilized onion extract was incorporated into 
agar at 2 % (w/v) as the sole nutrient, members of the Bcc 
were not only able to grow, but a majority of isolates also 
produced copious amounts of EPS, as typified by B. 
ambifaria AMMD (Fig. la, b). This phenotype is not 
observed when the Bcc are cultured on B. cepacia media 
(Mast Diagnostics), nutrient agar and other common 
laboratory media. Induction of EPS biosynthesis on onion 
agar was observed in all Bcc species investigated, but was 
not observed in all strains within a species (Table 1 and 
Supplementary Tables Si, S2 and S3, available with the 
online version of this paper). The exception was the single 
strain of Burkholderia stabilis available for testing. Of 
particular interest was the failure of the well-characterized 
B. cenocepacia ET12 representatives J2315, K56-2 and BC7 
to produce EPS on onion agar. In addition, there was no 
correlation between induction of Bcc EPS on onion agar 
and the ability of individual Bcc strains to cause 
maceration of onion bulbs (data not shown). 
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(a)  (b) (c) 
Fig. 1. Growth of B. ambifaria AMMD on (a) nutrient agar (non-niucoid); (b) onion agar (mucoid), and (c) comparison of AMMO 
bceB mutant (left) and AMMO wild-type (right) on mannitol agar. 
The onion factor 
Attempts were made to identify the 'onion factor' 
responsible for inducing EPS biosynthesis by use of 
standard biochemical methods for extracting and fraction-
ating phytochemicals. The causative factor was retained on 
drying in vacuo, and remained in the aqueous phase after 
partition with ethyl acetate at pH 7.0 and pH 2.0. When 
further physicochemical analyses discounted the role of 
proteins and lipids, attention was turned to the carbohyd-
rate content of onion extract. After preparative paper 
electrophoresis in buffers at pH 2.0 and 6.5, the only 
biological activity recovered from paper strips co-migrated 
with the standard glucose, indicating the absence of 
ionizable functional groups such as phosphate, acid or 
amine (data not shown). Analytical paper chromatography 
and HPAE-PAD identified the major carbohydrate com-
ponents as sucrose, glucose, fructose and fructans (Fig. 2). 
The HPAE-PAD chromatograms in Fig. 2 show character-
istic peaks of glucose, fructose and sucrose. Sucrose breaks 
down to fructose and glucose upon mild hydrolysis, as do 
the fructans to fructose. Fructose breaks down under 
complete hydrolysis as expected for a ketose sugar, whilst 
the aldose sugar glucose remains stable. The ability of these 
and related compounds to stimulate EPS biosynthesis in 
Bcc was then investigated (Table 1). Glycerol and mannitol 
were included as these sugar alcohols have previously been 
noted to enhance EPS biosynthesis in Pseudomonas 
aeruginosa (Whitchurch et al., 1996) and the Bcc (Sage et 
al., 1990; Ziosnik et al., 2008). Glucitol was included 
because of its close degradative relationship with fructose 
and mannitol (Allenza et al., 1982). These experiments 
showed that within a particular Bcc species, EPS biosyn-
thesis was strain-specific and that the most potent inducers 
of EPS were fructose and all alditols tested, most 
significantly mannitol and glucitol, as well as the cyclitol 
myo-inositol. Importantly, the profile of EPS biosynthesis 
production with these sugars was similar to that observed 
with onion extract (Table 1). EPS biosynthesis was not 
observed on agar containing yeast extract alone, nor in the  
presence of glucose (Table 1), galactose, lactose or maltose 
(data not shown) with any Bcc strains tested. 
Investigation of the molecular basis for EPS 
biosynthesis 
With the exception of the single B. stabilis strain tested, all 
Bcc species were shown to be capable of producing EPS 
when grown on onion agar (Table 1 and Supplementary 
Tables S1—S3), suggesting the presence of a conserved EPS 
biosynthetic gene cluster. Therefore genome sequences 
representing five Bcc species (B. ambifaria, B. multivorans, 
B. vietnamiensis, B. dolosa and Burkholderia sp. 383) were 
examined to determine if two putative EPS gene clusters 
within B. cenocepaciaJ2315, the bce gene cluster (Moreira et 
al., 2003) and the wcb gene cluster (Parsons et al., 2003), 
are conserved across the Bcc. The wcb gene cluster was 
found to be poorly conserved, with between one-third and 
one-half of J2315 ORFs having no direct homologues 
within the species examined (data not shown). Notably, 
within the EPS-producing B. ambifaria AMMD strain, over 
half of the J2315 wcb-associated ORFs have no homo-
logues, and the remaining homologous ORFs are not 
organized within a gene cluster. In contrast, the bce gene 
duster was conserved across all species examined, in terms 
of both sequence homology and organization of ORFs 
(Supplementary Fig. Si). In the course of these genome 
comparisons, a third putative polysaccharide biosynthetic 
gene cluster was observed on chromosome 2 of B. 
cenocepacia J2315. This cluster encodes two putative EPS 
transporter proteins (BCAM1330 and BCAM1331), an 
acyltransferase (BCAM 1333), several glycosyltransferases 
(BCAM1335, BCAM1337, BCAM1338), a polysaccharide 
biosynthesis protein (BCAM1336) and a mannose-6-
phosphate isomerase (BCAM1340). This cluster is con-
served amongst several Bcc species, albeit to a lesser extent 
than the bce gene cluster (data not shown). In the EPS-
producing B. ambifaria AMMD, this gene cluster maps to 
ORFs Banib_3621 through to Bamb_3629. 
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Fig. 2. HPAE-PAD chromatograms: Carbopac 
PA-1 00 column separation of sugars in onion 
extract. (a) Crude onion extract; (b) onion 
extract hydrolysed by 2 M TFA 60 'C 1 h; (c) 
onion extract hydrolysed by 2 M TFA 120 'C 
1 h. Glucose, fructose and sucrose peaks 
were clearly identified based on standards (not 
shown), and hydrolysis pattern. Peaks with 
retention times between 12 and 36 mm 
appear to be oligosaccharides of fructose 
based on their degradation to fructose under 
mild hydrolysis. 
To investigate which polysaccharide gene cluster is induced 
by growth on mannitol, the expression of representative 
genes from two distinct EPS gene clusters was assessed in B. 
ambifaria AMMD grown in the presence and absence of 
mannitol. The genes studied each encode homologues of 
the Wza EPS export protein: Bamb5549 of the bce gene 
cluster (equivalent to bceE, BCAMO8S8 of B. cenocepacia 
J2315), and Bamb_3621 of the novel putative polysacchar-
ide gene cluster described above (BCAM 1330 of B. 
cenocepacia J2315). As shown in Fig. 3, expression of 
Bamb_3621 was not observed under either growth 
condition. In contrast, expression of the bceE homologue 
(Barnb_5549) was clearly induced by the presence of 
mannitol. We therefore focused on the bce gene duster to 
investigate why some Bcc isolates, most notably those of 
the B. cenocepacia ET12 lineage, failed to produce EPS 
under any growth conditions. 
A PCR assay was designed to screen isolates for an 11 bp 
deletion in the bceB gene that has been suggested to be 
responsible for loss of EPS production in the CF isolate B.  
cenocepacia J2315 (Moreira et al., 2003). Of the panel of 
strains shown in Table 1, only the B. cenocepacia ET12 
isolates J2315, K56-2 and BC7 harbour the 11 bp deletion 
(data not shown). This result prompted us to test a panel of 
B. cenocepacia lilA strains containing both ET12 and non-
ET12 isolates. There was a clear correlation between the 
11 bp deletion and the presence of both cbL4 (cable pilus) 
and BCESM (B. cepacia epidemic strain marker), indicating 
that this deletion is a conserved feature within the E112 
lineage (Fig. 4). In our study, with the exception of strain 
E3051, the presence of the deletion correlated with the lack 
of EPS production in all B. cenocepacia lilA isolates 
examined (Fig. 4; Supplementary Table Si). Furthermore, 
the 11 bp deletion in the bceB gene was not observed in any 
B. cenocepacia IlIB or B. multivorans isolates studied (see 
Supplementary Tables S2 and S3). 
Using proven methods for the complementation of gene 
function in B. cenocepacia (Ortega et al., 2005), attempts 
were made to complement BceB function within B. 
cenocepacia K56-2 by introducing a wild-type bceB ORF 
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i) G) bceE Bamb_3621 + 
YE YE+Man YE YE+Man U+ 
o RI + - + - + - + - Q C9 
Fig. 3. Induction of the bce gene cluster by mannitol. RT-PCR 
analysis was performed to assess the expression of two distinct 
wza homologues (bceE and Bamb_3621) of B. ambifaria AMMO 
in the absence and presence of mannitol. The bceE gene 
(Bamb_5549) is located within the bce gene cluster, whilst 
Bamb_3621 is located within a distinct putative EPS biosynthetic 
gene cluster. Expression was assessed in yeast extract (YE) and 
yeast extract supplemented with 2°Io (w/v) mannitol (YE+Man). 
Expression of Bamb_.3621 was not detected in YE or YE+ Man. In 
contrast, bceE expression was strongly induced by growth in 
YE+Man. For each sample, RT and non-RT reactions (+1—) are 
shown alongside each other. Genomic DNA positive controls are 
shown for each gene (bceE +ve, 3621 +ve). 
NMNMNMNMNMM MNMM EPS 
200 bp- 
100 bp— - - -r 
- bceB 
1.65 kb- 
650 bp— — - _ chiA 
Fig. 4. bceB PCR analysis of representative B. cenocepacia lIlA 
isolates. For each isolate, EPS production is indicated as mucoid 
(M) or non-mucoid (NM) alongside PCR analysis of bceB, and the 
epidemic strain markers cblA and BCESM, All PCR products are 
pictured alongside the 1 kb Plus DNA Ladder (Invitrogen). NTC, 
no template control. The bceB PCR assay yields a 151 bp product 
from wild-type sequence and a 140 bp product from sequence 
harbouring an 11 bp deletion (as previously reported within 
J2315). With one exception (E3051), lack of EPS production 
within B. cenocepacia lilA isolates correlated with the 11 bp 
deletion within bceB. This deletion was only observed within 
strains that were positive for both cblA and BCESM, indicating it to 
be a conserved feature of the ET1 2 lineage. The bceB deletion 
was not observed in a strain harbouring just one of the two 
epidemic strain markers (E1001). 
amplified from B. cenocepacia PC184. Whilst expression of 
6His-tagged BceB was detected in E. coil C41(DE3) cells, 
previously shown to support expression of membrane-
bound proteins (Miroux & Walker, 1996), we were unable 
to detect expression within B. cenocepacia K56-2 (data not 
shown). Consequently, we chose to disrupt the bceB ORF 
of an EPS-producer. Insertional inactivation of the bceB 
gene resulted in loss of EPS production in B. ambifaria 
AMMD when grown on mannitol agar (Fig. ic) and on 
onion agar (data not shown). 
DISCUSSION 
In this study, we returned to the original Bcc host and 
report that Bcc isolates previously considered non-mucoid 
produce copious amounts of EPS when onion tissue is 
provided as the sole nutrient, highlighting the metabolic 
potential of this group of organisms. This novel and 
surprising observation is not species-specific, and is 
exhibited by isolates of both clinical and environmental 
origin. The onion components responsible for EPS 
induction are primarily the carbohydrates sucrose, fructose 
and fructans. Additionally, all alcohol sugars tested are able 
to induce EPS production, in particular mannitol and 
glucitol. 
The reasons why EPS biosynthesis is readily induced by 
onion extracts and, in particular, by fructose and the 
hexitol sugars mannitol and glucitol require further 
investigation. An ability to respond to inulin was confined 
to certain strains, all of which responded well to fructose. 
This suggests that the fructan polysaccharide was only 
active in bacteria that can hydrolyse it to fructose. The 
ability of one strain (BTS7) to respond particularly strongly 
to inulin could possibly be due to its enhanced ability to 
hydrolyse inulin to fructose. Interestingly, the similar 
profile of EPS induction shown by fructose and alcohol 
sugars agrees well with a previous study which showed that 
the initial steps of utilization of these sugars in the Bcc 
differ from those in most other pseudomonads. Growth of 
Bcc on fructose involves active transport followed by 
fructokinase conversion to fructose 6-phosphate then 
degradation via the Entner—Doudoroff pathway (Allenza 
et aL, 1982). Growth on mannitol and glucitol also requires 
this pathway following active uptake and intracellular 
oxidation to fructose. 
The role of Bcc EPS as a putative virulence factor is unclear. 
The influence of mannitol and other alcohol sugars on EPS 
production suggests that the prevalence of EPS in the Bcc 
may have been underestimated. In addition, given the 
variety of human, animal, plant and other models studied, 
the role of EPS may be influenced by the host involved and 
the route of administration. EPS has been associated with 
altered Bcc clearance in a mouse model of infection 
(Conway et aL, 2004), and EPS-deficient Bcc mutants 
displayed reduced mortality within a CGD mouse model 
(Sousa etal., 2007a). Similarly, a role for EPS in persistence 
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in human airways is suggested by its capacity to scavenge 
reactive oxygen species and inhibit neutrophil chemotaxis 
(Bylund et al., 2006). In our study, EPS biosynthesis did 
not correlate with the ability to cause onion rot, which is 
perhaps to be expected since pectinases rather than EPS are 
likely to play the major role in the maceration of plant 
tissue. Cunha et al. (2004) did not observe a clear 
correlation between EPS biosynthesis in vitro and the 
ability of Bcc strains to establish chronic infections within 
the CF lung. Recent evidence, however, suggests a subtle 
and unexpected role for Bcc EPS in CF lung infection. 
Consistent with our findings, Zlosnik et al. (2008) reported 
that isolates of B. cenocepacia, the most virulent Bcc 
species, are most frequently non-mucoid. They also 
observed a mucoid to non-mucoid conversion in sequen-
tial isolates of Bcc from chronically infected CF patients. 
This apparent loss of mucoidy in vivo, and its absence in 
the virulent B. cenocepacia ET12 lineage, provides an 
intriguing contrast with the characteristic non-mucoid to 
mucoid conversion observed with alginate-producing P. 
aeruginosa. Ziosnik and colleagues suggest that Bcc EPS 
could be responsible for the persistence of Bcc in CF 
airways whilst loss of EPS leads to increased disease 
severity. 
In our investigation of EPS biosynthesis determinants, we 
focused on the highly conserved bce gene cluster. 
Previously described by Moreira et al. (2003), the bce gene 
cluster has had several of its encoded proteins characterized 
(Ferreira et al., 2007; Sousa et al., 2007b; Videira et al., 
2005) and is thought to be involved in cepacian 
biosynthesis. In the present study, we demonstrated 
induction of the bce gene cluster by mannitol, and found 
a clear correlation between the inability of representatives 
of the B. cenocepacia ET12 lineage to produce EPS and the 
presence of an 11 bp deletion within the bceB gene, 
originally described within the genome sequence of B. 
cenocepacia J2315 (Moreira et al., 2003). Consistent with 
this correlation, insertional inactivation of bceB, which 
encodes a glycosyltransferase, resulted in the loss of EPS 
production by B. ambifaria AMMD when grown on onion 
media. Combined, these observations highlight the pivotal 
role of the bce gene cluster in onion-induced EPS 
biosynthesis, and suggest that the observed EPS is cepacian. 
However, mutations elsewhere within the bce gene cluster, 
or in other EPS-related gene clusters, must be responsible 
for the lack of EPS biosynthesis in B. cenocepacia strain 
E3051 (Supplementary Table Si), and in other EPS-
negative Bcc strains in our study which lack the ii bp 
deletion in bceB (Supplementary Tables S2 and S3). 
The ability of hexoses and hexitols, in particular mannitol, 
to enhance EPS biosynthesis in the B. cepacia complex has 
disturbing implications for therapeutic intervention in CF. 
Recent attempts to improve airway clearance with 
hypertonic saline 5 % (wlv) have been handicapped by 
the problem of salty taste and the salt-sensitive nature of 
many antimicrobial peptides. Thus, attention has turned to 
the use of non-ionic osmolytes, including inhaled mannitol  
(Daviskas et al., 2008; Robinson et al., 1999; Wills, 2007), 
which is marketed as Bronchitol (Pharmaxis). Robinson 
and colleagues acknowledged that the majority of P. 
aeruginosa and Bcc isolates are able to utilize mannitol as 
a carbon and energy source. However, they felt that the 
nutritional influence of mannitol as a therapeutic osmolyte 
would be minimal given the abundance of other nutrients 
already present in CF respiratory secretions. On a 
cautionary note, they state that this potential problem 
would need to be confirmed by quantitative microbiology. 
The potential induction of virulence determinants during 
osmolyte therapy has to our knowledge not been 
considered. Our results also provide justification for the 
continued exclusion of CF individuals known to be 
infected with Bcc from ongoing trials of inhaled mannitol 
(http://clinicaltrials.gov; identifier NCT00117208 and 
NCT0025 1056). 
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Burkholderia cenocepacia is highly resistant to antimicrobial peptides and we hypothesized that 
the conversion of UDP-glucose to UDP-glucuronic acid, a reaction catalysed by the enzyme UDP-
glucose dehydrogenase (Ugd) would be important for this resistance. The genome of B. 
cenocepacia contains three predicted ugd genes: and 
all of which were individually inactivated. Only inactivation of UgdBCAL2946  resulted in increased 
sensitivity to polymyxin B and this sensitivity could be overcome when either UgdBCAL2946 or 
ugd AO555 but not was expressed from plasmids. The growth of a conditional 
ugdB 2945 mutant, created in the LugdecAMo855 background, was significantly impaired under 
non-permissive conditions. Growth could be rescued by either ugdscA 94e or ugdBçAMQ55  
expressed in trans but not by ugd5034. Biochemical analysis of the purified, recombinant 
forms of Ugd CAL2946 and UgdBCAM0855 revealed that they are soluble homodimers with similar in 
vitro Ugd activity and comparable kinetic constants for their substrates UDP-glucose and NAD. 
Purified UgdscAM2034 showed no in vitro Ugd activity. Real-time PCR analysis showed that the 
expression of was 5.4- and 135-fold greater than that of ugd CA .55 and 
Received 16 January 2009 UgdBCAM2034, respectively. Together, these data indicate that the combined activity of 
Revised 7 March 2009 UgdBCAL2946 and UgdBCAM0855 is essential for the survival of B. cenocepacia but only the most 
Accepted 16 March 2009 highly expressed ugd gene, u94cAL2946, is required for polymyxin B resistance. 
INTRODUCTION 
Burkholderia cenocepacia belongs to the Burkholderia 
cepacia complex (Bcc), a group of ten phenotypically 
similar environmental Gram-negative bacteria (Balandreau 
et al., 2001), which are also opportunistic human 
pathogens causing chronic, sometimes fatal, pulmonary 
infections in cystic fibrosis (CF) patients (Isles et al., 1984; 
Mahenthiralingam et al., 2005). Treatment of these 
infections is difficult as Bcc bacteria are inherently resistant 
to most clinically relevant antimicrobial agents (Aaron 
et al., 2000; Burns et al., 1996; Gold et al., 1983), including 
Abbreviations: AFs, antimicrobial peptides; Ara4N, 4-amino-4-deoy-L-
arabinose; OF, cystic fibrosis; DDM, dodecylmaltoside; pmB, polymyxin B; 
Ugd, UDP-glucose dehydrogenase. 
Supplementary methods and tables of strains and primers are available 
with the online version of this paper. 
antimicrobial peptides (APs) (Loutet et al., 2006; Turner 
et al., 1998). 
APs are short, amphipathic, positively charged peptides 
produced by organisms from bacteria to mammals 
(Brogden, 2005). They are part of the innate immune 
response (Ganz, 2003; Zanetti, 2004) and have been shown 
to kill bacteria through the disruption of the inner 
membrane (Brogden, 2005) and also through inhibition 
of intracellular processes (Patrzykat et al., 2002). APs have 
been proposed as agents for treatment of infections by 
other CF lung pathogens, such as Pseudomonas aeruginosa 
(Zhang et al., 2005). Unfortunately, due to the extraord-
inary resistance of B. cenocepacia to the killing effects of 
APs, they are unlikely to be useful agents for treatment of 
lung infections by B. cenocepacia. Understanding the 
determinants of AP resistance in B. cenocepacia is 
important because they could provide targets for the 
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development of novel antimicrobial agents that could be 
co-administered with APs. For example, in B. cenocepacia 
L-glycero-D-manno-heptose sugars of the lipopolysacchar-
ide (LPS) core oligosaccharide are required for AP 
resistance and in vivo survival (Loutet et al., 2006) and 
small molecule inhibitors of the synthesis of these sugars 
have been identified (De Leon et al., 2006). 
A widely recognized mechanism of AP resistance in Gram-
negative bacteria is the decoration of lipid A phosphate 
residues with the positively charged sugar 4-amino-4-deoxy-
L-arabinose (Ara4N), which requires the synthesis of a UDP-
Ara4N precursor (Ernst et al., 1999; Helander et al., 1994; 
Nummila et al., 1995; Vaara et al., 1981). Ara4N substitution 
reduces the net negative charge of the lipid A molecule and 
hampers the ability of APs to bind to the outer membrane 
(Vaara et al., 1981). In P. aeruginosa and Salmonella enterica, 
these substitutions are induced upon treatment with APs 
(Bader et al., 2005; McPhee etal., 2003) and are dispensable 
for growth under normal laboratory conditions. In B. 
cepacia, a species closely related to B. cenocepacia, Ara4N is 
constitutively incorporated into both lipid A and the LPS 
core oligosaccharide (Silipo et al., 2005). Preliminary 
evidence suggests that this is also true in B. cenocepacia 
(X. P. Ortega & M. A. Valvano, unpublished data) and UDP-
Ara4N synthesis was recently shown to be essential for B. 
cenocepacia viability (Ortega et al., 2007). These results 
highlight the importance of Ara4N in this organism and its 
abundance in LPS likely contributes significantly to the 
organism's unusually high AP resistance. 
The initial step in the synthesis of UDP-Ara4N is the 
conversion of TJDP-glucose to UDP-glucuronic acid, which 
is catalysed by the enzyme UDP-glucose dehydrogenase 
(Ugd) (Breazeale et al., 2002; Raetz & Whitfield, 2002; 
Strominger et al., 1957). A recent study by Hung et al. 
(2007) described two Ugd-encoding genes in P. aeruginosa. 
Both Ugd enzymes were purified as homodimers, and 
biochemical analysis confirmed Ugd activity, but revealed 
distinct expression and enzymic properties, indicating 
different roles for the two Ugd proteins in vivo. 
The B. cenocepacia genome (Holden et al., 2009) contains 
three predicted ugd genes, designated ugd3c 294  
ugdBCO855 and ugd fic 2034 (gene designations correspond 
to the Sanger Centre annotation of the strain J2315 genome, 
http://www.sanger.ac.uk/Projects/B—cenocepacia/, where 
BCAL denotes genes in the large chromosome and BCAM 
genes in the mid-size chromosome). In this study, we 
examined in detail the function of these genes and show 
that only ugd C6 is required for resistance to polyniyxin 
B (pmB), while the combination of ugdBCAL2946 and 
UgdBCJ 0855 is required for bacterial survival. We purified 
Ugd5cA2946, Ugd5CM0855 and Ugd c2034 but only the 
recombinant forms of UgdBcAL2945 and Ugd 0855  
possess Ugd activity with similar substrate reaction kinetics. 
Finally, we show that in cells the number of RNA transcripts 
of ugd cL2946 is substantially higher than either ugdBA55  
or 1194CAM2034. 
METHODS 
Reagents. Unless otherwise noted all chemicals and antibiotics, 
restriction endonucleases and DNA polymerases were purchased from 
Sigma-Aldrich, Roche Diagnostics and Qiagen, respectively. 
Bacterial strains and culture conditions. Strains and plasmids 
used in this study are described in Supplementary Table Si, available 
with the online version of this paper. B. cenocepacia and Escherichia 
coli strains were routinely cultured at 37 'C either in Luria Broth (LB) 
supplemented with 1.6% (w/v) Bacto Agar (Becton Dickinson) or in 
liquid LB. When required, trimethoprim or tetracycline was added at 
a final concentration of 100 jig mF for selection of B. cenocepacia 
strains, and at 50 jig nil— ' and 20 jig in[— ', respectively, for selection 
of E. coli strains. Kanamycin and gentamicin were used at 40 jig m1 
and 50 jig ml, respectively. 
Mutagenesis and cloning. A complete description of the mutagen- 
esis and cloning experiments can be found in Supplementary 
Methods and the primers used are listed in Supplementary Table 
S2, To inactivate the putative ugd genes, suicide plasmids containing 
internal fragments of each ugd gene were created. The fragments were 
PCR amplified, restriction enzyme digested, ligated into the plasmid 
pGPlox (Table 51), used to transform E. coli SY327 (Miller & 
Mekalanos, 1988), and confirmed by colony PCR and restriction 
digest. The resulting plasmids - pSL23 (ugd5c 94), pSL29 
(ugdBcAM2o34) and pSL31 (u9d9C4M0855) - were transferred into B. 
cenocepacia strain K56-2 (Mahenthiralingam et a!, 2000) by 
triparental mating with the pRK2013 helper plasmid (Figurski & 
Helinski, 1979). Exconjugants were screened for plasmid insertion 
into the correct location by PCR and Southern blot hybridization. 
The resulting mutants were named SAL8 (ugd5Aj29.: : pSL23), 
SAL12 (ugdflc M234: :pSL29) and SAL15 (u9d5AL55: :pSL31). 
To construct an unmarked UgdBCAMORSS deletion mutant, two 
fragments of this gene were PCR amplified, restriction enzyme 
digested, ligated as a triple ligation into pGPI-Scel (Flannagan et al., 
2008), screened as described above, and the resulting plasmid, pSL43, 
was transferred to K56-2. Putative mutants (SAL22) were screened by 
PCR for recombination of the plasmid into the chromosome. To 
delete the backbone of pSL43 from the chromosome, pDAI-Scel 
(Flannagan et at, 2008) was introduced into SAL22, and this resulted 
in the isolation of strain SAL23, which carries a 986 bp deletion 
removing most of ugdac.j,soass, pDA1-Scel was cured from SAL23 by 
serial passage in the absence of tetracycline for 1 week. The final 
mutant construct was confirmed by Southern blot hybridization. 
Piasmids for the conditional mutagenesis of hidA and ugdBCAL2946  
were constructed as described above with fragments corresponding to 
the 5' ends of the two genes cloned into the plasmidpSC201 (Ortega 
et al., 2007), resulting in plasmids pSL26 (hidA) and pSL27 
(ugda 2946). These plasmids were transferred into SAL23, resulting 
in strains SAL25 (conditional hidA) and SAL26 (conditional 
ugd5cL2946). A conditional ugd5AL2945 mutant in the K56-2 
background (SALIO), also constructed with pSL27, was previously 
described (Ortega et at, 2007). 
For complementation experiments each of the putative ugd genes was 
cloned into pDA17 (Aubert et at, 2008). Plasmids were confirmed as 
described above, inserts were verified by sequencing (Robarts 
Research Institute DNA Sequencing Facility, London, ON, Canada), 
and the resulting plasmids were named pSL37 (ugdRCL2946)1  pSL38 
(ugd c , 2034) and pSL39 (ugd cjq0855). 
For expression and purification of the Ugd proteins, the B. 
cenocepacia J2315 ugdaCA L2946, UgdECAMOS55 and ugdBcAM2034 genes 
were PCR amplified, cloned using the pGEM-T Easy vector system 
(Promega), and sequenced. Genes were liberated by restriction 
enzyme digest, ligated into pET28a (Novagen), and used to transform 
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B. coil Top 10 cells. The resulting plasmids were confirmed by 
restriction digests and named pJB1 (pET28a/u9d L2946)1 pJB2 
(pET28a/ugdsci0855) and pJB3 (pET28a/u9dBM20)1 with each 
ugd expressed with an N-terminal His6 fusion tag. 
Growth curves. Cells were cultured overnight to stationary phase 
and then diluted to an 0D600 of 0.05 in LB. Cultures were aliquoted 
to 100-well honeycomb plates in 300 p1 volumes. Plates were 
incubated in a Bioscreen C automated growth curve reader at 
37 °C with constant, low shaking for 24 h with OD600 readings taken 
every hour. For growth curves with pmB, cells were diluted to 
approximately 2 x 105 c.f,u. m1 in LB. Then 10 x stock solutions of 
pmB dissolved in 0.2% (w/v) BSA + 0.02% (v/v) acetic acid were 
added to cells to give final concentrations of pmB ranging from 16 to 
1024 tg ml in twofold increments. Cells were also treated with the 
pmB diluent indicated above as a vehicle control. Triplicate 300 sI 
aliquots of the cells with either vehicle control or the various 
concentrations of pmB were incubated in the Bioscreen C automated 
growth curve reader, as described above, for 18 h. M1050 values 
reported are the mode of three independent experiments. An assay for 
growth of conditional mutants was performed as previously described 
(Ortega et al., 2007). Expression of putative essential genes was 
repressed with 1.0% (w/v) glucose and induced with 1.0% (w/v) 
rhamnose. 
LPS extraction and analysis. LPS samples were prepared and 
analysed as previously described (Hitchcock & Brown, 1983; Loutet 
et al., 2006). 
Western blotting. Cells were grown overnight in liquid LB with 
appropriate antibiotics. A volume of culture equivalent to 1 ml at an 
0D600 of 0.2 was centrifuged for 1 min at 8000 g, cells were 
resuspended in 20 p1 H20 and 10 1d of 3 x loading dye, and boiled 
for 10 mm. Aliquots (15 p1) of boiled samples were separated by gel 
electrophoresis using 14% (w/v) SDS-polyacrylamide gels and 
transferred to a nitrocellulose membrane. The membrane was washed 
briefly with H20 and stained with a solution of 0.1 % (w/v) Ponceau S 
in 5% (v/v) acetic acid to confirm the transfer of equal amounts of 
protein to the membrane in each lane. The membrane was rinsed with 
Tris-buffered saline, pH 7.5 (TBS) to remove Ponceau S stain and 
then blocked for 2 h with 10% (v/v) Western blocking reagent 
(Roche) in TBS at room temperature and incubated with murine 
anti-FLAG M2 monoclonal antibody diluted 1: 10000 overnight at 
4 °C. The membrane was incubated at room temperature for 2 h with 
goat anti-mouse IgG antibody conjugated to Alexa Fluor 680 
(Molecular Probes) diluted 1:20000. Proteins were visualized using 
a Licor Infrared Imaging System with Odyssey software version 2.1. 
Purification of recombinant Ugd proteins. To prepare recombin-
ant UgdBcAL2946 and UgdBcAM0855 proteins for biochemical analysis, a 
large-scale culture (4 1 LB with kanamycin) was performed with B. coli 
HMS 174 (DE3) transformed with pJB1 or pJB2. Each batch was 
grown to an OD600  of 0.6, and induced with 0.5 mM IPTG for 3 h at 
37 °C with shaking. Both Ugd A 2946 and UgdBcAM0355 were highly 
overexpressed in soluble forms and cell-free extracts were prepared by 
sonic disruption of the E. coil cell paste. The enzymes were isolated 
from ultrafiltered cell-free extracts by FPLC (AKTA Basic instrument) 
using a 5 ml HisTrap column (GE Healthcare). The binding buffer 
consisted of 20 mM Tris, 500 mM NaCl, 5 mM imidazole, pH 7.5, 
and the elution buffer was identical except that it contained 500 mM 
imidazole. The eluted His-tagged Ugd proteins were judged >90% 
pure after this step. The enzymes were dialysed against 150 mM NaCl 
and 20 mM Tris, pH 7.5, and further purified by size exclusion 
chromatography using a HiPrep 26/60 Sephacryl S-200 column (GB 
Healthcare). The calibrated column was equilibrated with 150 mM 
NaCl and 20 mM Tris, pH 7.5. The molecular masses of the Ugd 
proteins, estimated from their column elution volumes and by non- 
denaturing gel electrophoresis, were consistent with dimers (data not 
shown). The subunit molecular masses were confirmed by electro-
spray-mass spectrometry (EST-MS) and were within 0.1% of the 
theoretical values (data not shown). The protein concentration was 
determined by a BCA assay (Pierce) and a typical yield was —3 mg 
Ugd per litre of E. coil culture. 
To prepare recombinant Ugd5534, a large-scale culture (4 1 LB 
with kanamycin) was performed with B. coil BL21 (DE3) transformed 
with pJB3.  Each batch was grown to an OD 5 of 0.6, and induced by 
addition of 0.2 mM IPTG for 16 h at 15 °C with shaking. To 
solubilize UgdBCAM203,4  for purification, the pellet was resuspended 
and homogenized in 5 ml binding buffer containing 25 % (w/v) 
sucrose, 1 mlvi EDTA and a protease inhibitor tablet per gram of cell 
pellet. Thirty mg lysozyme, 5 p1 DNase and 5 mM MgCl2 were added 
and the cell paste was left to stir for 1 h at 4 °C. A cell-free extract was 
prepared by sonic disruption of the E. coli cell paste, which was 
incubated with I % (w/v) dodecyhnaltoside (DDM) and 20% (v/v) 
glycerol for 1 h at 4 °C with stirring before centrifugation at 25000 g 
for 45 mm. The supernatant was incubated with equilibrated nickel 
NTA agar beads (Qiagen) for 3 h. The beads were then washed in 
elution buffer [20 mM Tris, pH 7.5, 500 mM NaCl, 0.1 % (w/v) 
DDM and 10% glycerol] with 10 mM imidazole. Protein was eluted 
in elution buffer containing 20, 50, 100 or 200 mM imidazole. The 
molecular mass of 1JgdB ,kM2034 was estimated from size-exclusion 
chromatography (as above), ESI-MS and non-denaturing gel 
electrophoresis (data not shown). 
In vitro Ugd activity assay. Ugd oxidizes UDP-glucose to UDP-
glucuronic acid, and in the process also reduces 2 mol NAD+  to 
2 mol NADH. The absorption coefficient of NADH is 6.220 mM' 
cm-1  at 340 run. A standard Ugd activity assay was set up using 
200 p1 H.O, 100 p1 purified Ugd (1 mg mF'), 200 il buffer 
(100 mM Tris, pH 7.5), 250 p1 NAD (10 mM; Roche) at 25 °C. 
The reaction was initiated by the addition of 250 p1 UDP-glucose 
(1 mM; Calbiochem) and the production of NADH was monitored at 
340 nm on a Cary 50 UV visible spectrophotometer (Varian). Initial 
velocities were determined for UDP-glucose using concentrations 
ranging from 0 to 0.25 mM, and for NAD + using concentrations 
ranging from 0 to 2.5 mM. To determine kinetic constants, one 
substrate was held constant at the maximum concentration, while the 
other was varied. The kinetic parameters (iç, K,,,, Vms,,) were 
determined by non-linear regression from V= V,,,,. [S]"/([S]+ Km" 
using Origin 6.1 software. Substrate specificity was investigated by 
replacing the substrate UDP-glucose with either UDP-galactose, 
UDP-acetylglucosamine or GDP-mannose (Calbiochem), and per-
forming the standard assay. 
Real-time PCR analysis. B. cenocepada strain K56-2 was grown 
overnight in liquid LB, diluted to an 0D500 of 0.1 and grown to a final 
OD600 between 0.5 and 0.7. RNA was prepared from approximately 
5 x 108 c.f.u. with the Ribo-Pure Bacteria kit (Ambion) according to 
the manufacturer's instructions. RNA was treated with DNase I 
(Ambion) and the concentration of RNA was determined with an 
ND-1000 spectrophotometer (NanoDrop Technologies). One micro-
gram of RNA was converted to cDNA using Transcriptor Reverse 
Transcriptase (Roche) in a reaction volume of 30 p1 with reverse 
primers 3136 (hisD), 3246 (ugd5cflM08$5), 3247 (ugd5cn129 ) and 
3364 (ugdac.c2034) according to the manufacturer's instructions and 
supplemented with Protector RNase Inhibitor (Roche), 0.5 x Q 
solution (Qiagen) and 10% (v/v) DMSO. A second reaction 
containing nuclease-free water (Qiagen) instead of Transcriptor 
Reverse Transcriptase was included as a negative control. 
The real-time PCRs were conducted using the Rotor-Gene 6000 
(Corbett Life Science) in final reaction volumes of 20 p1. Reactions of 
18 0, containing FastStart SYBR Green (Roche), primer pairs 
3247/3255 (ugdBCAf46), 3361/3364 (49424), 3246/3248 
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(u94cM055) or 3136/3143 (hisD), and nuclease-free water were 
prepared and to these 2 d of the reverse transcription reactions was 
added in triplicate. Negative controls were 2 il of the reverse 
transcription reaction done without Transcriptor Reverse 
Transcriptase and 2 ii of nuclease-free water. The segment of each 
gene analysed was also amplified from chromosomal DNA and used 
in standard curve reactions containing 10, io, 104, 10 and 102 
copies of the PCR products per reaction. The thermal cycling 
conditions were 95 °C for 10 mm, 35 cycles at 95 °C for 10 s, 60 °C 
for 15 s, and 72 °C for 30 s. Data were acquired on the green channel 
at the end of each cycle. After the PCR a melt curve was obtained by 
increasing the temperature from 72 °C to 95 °C in 1 °C increments, 
with data acquired on the green channel at each degree. Data were 
analysed using the Rotor-Gene 6000 software provided by the 
manufacturer. For each analysed gene, the number of copies per 
reaction was quantified by comparison to the standard curve and 
adjusted based on the PCR efficiency calculated from the standard 
curve. A mean value from three replicates was calculated for the 
internal control hisD. Each replicate value of each ugd gene was 
divided by the mean of the hisD results in order to obtain a ratio of 
each value to hisD. 
Statistical analyses. Statistical analyses were done with GraphPad 
Prism 4. 
RESULTS 
Identification of three putative ugd genes in B. 
cenocepacia 
A TBLASTN analysis of the genome of B. cenocepacia strain 
J2315 (Holden et al., 2009) using the P. aeruginosa strain 
PAO1 Ugd (PA2022; accession no. NP _250712) gave three 
high scoring hits: ugd J946, ugd cAM0855 and 
ugdBCA, 034. The presence of these genes was also 
confirmed in strain K56-2, which is clonally related to 
J2315 (Mahenthiralingam et al., 2000), but much more 
amenable to genetic manipulation. The chromosomal 
arrangements of these genes are shown in Fig. 1(a). 
ugdBCAL2946 is directly upstream of hidA and hldD within a 
six-gene cluster. hidA and hldD encode proteins required 
for the synthesis of L-glycero-D-manno-heptose, a critical 
residue of the LPS inner-core oligosaccharide (Loutet et al., 
2006). ugdBCAJVI08S5, annotated as bceC by Moreira et al. 
(2003), is in a ten-gene cluster (the final five genes of which 
are not depicted in Fig. la) that plays a role in 
exopolysaccharide synthesis in B. cepacia (Moreira et al., 
2003). This exopolysaccharide is not produced in B. 
cenocepacia strains J2315 or K56-2 due to the presence of 
transposable insertion elements within other genes of this 
cluster (M. S. SaldIas & M. A. Valvano, unpublished data). 
ugdfl AM2034 is irs a four-gene cluster that contains two 
open reading frames similar to galE (UDP-galactose 4-
epimerase) as well as a predicted glycosyltransferase. The 
sequences of the three predicted ugd genes in strain K56-2 
are identical to those in the sequenced J2315 strain. 
The three loci ugdBCM29 , ugdBCO855 and ugd cA, 34  
are predicted to encode proteins sharing, respectively, 
53 %, 52 % and 39% amino acid sequence identity with P. 
aeruginosa PA2022. The predicted proteins UgdncAL2946  
and UgdBCAM0855 share 74 % amino acid sequence identity. 
The predicted UgdBCJ2034 shares 44% and 45% amino 
acid sequence identity with UgdBCAL2946  and Ugd8o855, 
respectively. Fig. 1(b) shows a CLUSTAL w alignment of the 
three predicted Ugd proteins of B. cenocepacia, P. 
aeruginosa Ugd PA2022 and Streptococcus pyogenes Ugd 
(accession no. AAA26899). Despite mw pair-wise sequence 
identity (-..21 %) with the S. pyogenes Ugd, for which high-
resolution crystal structures are available (Protein Data 
Bank, accession nos 1DLI and 1DLJ) (Campbell et al., 
2000), each of the three predicted Ugd proteins contains a 
predicted Rossmann fold for NAD binding (Rossman, 
1981) at the N terminus, and residues involved in the 
catalytic mechanism (Campbell et al., 2000), such as 
Cys260 involved in thioester formation and Arg244 
involved in UDP-sugar specificity, are conserved (equival-
ent residues Cys274 and Arg258 in UgdB12946, Cys270 
and Arg254 in Ugd5c0855, and Cys266 and Arg250 in 
UgdBc .j2034). 
A mutation in ugdBCAL2946 confers sensitivity to 
polymyxin B 
To assess the function of the candidate ugd genes, three 
mutant strains were constructed, each with a different 
putative ugd gene inactivated by insertional mutagenesis: 
SAL8 (ugdBcAL2946: : pSL23), SAL12 (ugdBCA1,12034 : : pSL29) 
and SAL15 (u9dBcAM1855: :pSL31). SAL12 and SAL15 grew 
similarly to the parental strain, 1(56-2 (Fig. 2). In contrast, 
SAL8 exhibited a slightly slower growth rate in exponential 
phase, but eventually reached the same cell density as K56-
2, SAL12 and SAL15 (Fig. 2). There were no detectable 
differences in the LPS profiles of mutant strains compared 
to that of the parental K56-2 when LPS was prepared from 
cells, separated by gel electrophoresis, and stained with 
silver (data not shown); however, detection of subtle 
changes to LPS structure may require a more sensitive 
method of analysis. The ugd mutants were tested for their 
ability to grow in LB medium containing pmB at a 
concentration of 1024 i.g  ml-1. Fig. 3(a) shows that the 
growth of SAL8 was significantly impaired at this 
concentration of pmB, in comparison to K56-2 and the 
other two mutants. In vehicle control incubations, K56-2, 
SAL12 and SAL15 all grew equivalently and the growth of 
SAL8 was slightly slower in the exponential phase of 
growth (Fig. 3a inset), similar to the results shown above 
with LB alone. The M1050 values for pmB were also 
calculated for all the strains. For K56-2, SAL12 and SAL15 
the M1050 values for pmB were all greater than 1024 tg 
m1' (the highest concentration tested). For SAL8, the 
M1050 value for pmB was 128 tg ml-1. 
Next, SAL8 was transformed with a series of plasmids, each 
containing a different putative ugd gene fused to the FLAG 
epitope at the 3' end of the gene. Growth of SAL8(pDA17) 
containing a vector control or SAL8(pSL38) encoding 
ugdBCAM2034 was poor in 128 jig ml-1  pmB (Fig. 3b). In 
fact, the plasmids actually appeared to exacerbate the 
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Fig. 1. Identification and chromosomal arrangement of putative ugd genes. (a) Each ugd gene is schematically depicted with 
neighbouring genes. The nomenclature below each gene is that used in the annotation of the sequenced genome of B. 
cenocepacia strain J2315. Designations above the genes are based on either TBLASTX analysis or previous publications 
(Iwanicka-Nowicka et al., 2007; Loutet et al., 2006; Moreira et al., 2003). The grey bars within the ugd genes represent the 
internal fragments that were cloned into the ugd mutagenesis plasmids (pSL23, pSL29 and pSL31 for ugdBCAL2945, 
ugdACAM2034 and ugdBA55, respectively). The dashed lines below hidA and ugdacAL2946 represent the PCR fragments 
used to generate plasmids for conditional mutagenesis (pSL26 and pSL27 for hidA and UgdBCAL2946,  respectively). The dotted 
lines below ugd5Q355 and its neighbouring genes represent the two fragments that were cloned into the plasniid (pSL43) 
used for unmarked mutagenesis of ugdsCAM0855. The solid lines below each ugd gene represent the regions analysed by real-
time PCR. (b) CLUSTAL w alignment of the three putative Ugd proteins of B. cenocepacia, P. aeruginosa PA2022 and Ugd from 
S. pyogenes. Residues conserved in all five proteins, four of the five, or three of the five are highlighted in black, dark grey and 
light grey, respectively. The tine below the alignment indicates the conserved GXGXXG motif of the Rossmann fold required for 
NAD binding. Asterisks denote residues Arg-244 and Cys-260 of S. pyogenes Ugd shown to be important for catalysis. 
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Fig. 2. B. cenocepacia K56-2 and the panel of ugd mutants grow 
similarly. Growth of K56-2 (L, SAL8 (A), SAL1 2 (7) and SAL1 5 
(4) was monitored in a Bioscreen C automated growth curve 
reader for 24 h. Shown are the means of data from three 
independent experiments done in triplicate; error bars denote the 
standard error of the mean. 
sensitivity to pmB in SAL8 since growth was impaired by 
>95 % at this concentration of pmB. The growth of SAL8 
transformed with pSL37 (ugdBC4,L2) after 18 h was not 
statistically different in the presence or absence of 128 ig 
pmB mF', similar to the growth of K56-2 under these 
conditions. SAL8 transformed with pSL39 (ugd5U855) 
regained in part the ability to grow in the presence of 128 ig 
pmB ml— '. Western blot analysis showed that all three 
putative Ugd proteins were expressed in SAL8 (Fig. 4), 
although not to the same levels. The predicted masses 
for Ugd-FLAGBCAL29I6, Ugd-FLAG8CAM2034, and Ugd-
FLAGBCAMOSSS are 51.7 kDa, 50.9 kDa and 52.1 kDa, 
respectively. Bands indicated with arrows correspond 
approximately to the predicted sizes. In addition, we 
observed numerous faster-migrating bands for the Ugd-
FLAG constructs that were consistent between experiments. 
These bands were interpreted as degradation products due 
to proteolytic cleavage either in the cell or during the sample 
preparation. Ponceau S staining of the membrane before 
Western blotting indicated that equal amounts of protein 
were transferred to the membrane in each lane (data not 
shown). Similar complementation results were obtained 
with a series of vectors expressing Ugd proteins not fused to 
the FLAG epitope (data not shown). Together, these 
experiments indicate that of the three putative ugd genes, 
only ugd 2946 is required for the full resistance of B. 
cenocepacia strain K56-2 to pmB and also that the protein 
encoded by ugdBcAMO855 can compensate for the function of 
the protein encoded by ugd512946. 
The combined activity of Ugd A949 and 
U9dBCAM0855 is essential for viability 
Due to the role of Ugd in the synthesis of UDP-Ara4N, we 
hypothesized that the combined Ugd activity of B. 
cenocepacia is essential for viability of the organism. 
Based on the results described above, we predicted that 









Fig. 3. SAL8 is the only ugd mutant that is sensitive to pmB, (a) 
Growth of K56-2 (E), SALB (A, Q, SAL12 (7, V) and SAL15 
(4, ) in either a vehicle control (filled symbols, shown in inset) or 
1024 tg  pmB m1' (empty symbols) was monitored for 18 h. (b) 
End point 0D600 of K56-2 and SAL8 with either pDA1 7 (plasmid 
control), pSL37 (ugdacAL2946 , pSL38 (ugdBcAM204) or pSL39 
(ugd5555) grown for 18 h in either a vehicle control 
(horizontally striped bars) or 128 .tg pmB m1 1  (vertically striped 
bars). Shown are the mean and standard error of the mean for 
data from three independent experiments done in triplicate. 
*, Statistically significant difference (P<0.05) between vehicle 
control and pmB treatments by unpaired t-test. 
essential. To test this, a strain containing an unmarked 
ugdBcAMO855 deletion was created (SAL23). Like SAL15, 
SAL23 did not show impaired resistance to pmB (data not 
shown). SAL23 was then used for the creation of 
conditional mutants in ugd flL2946 (SA1,26) and the 
downstream gene, izidA (SAL25). 
These strains were tested for their ability to grow under 
inducing (rhamnose) and repressing (glucose) conditions. 
The wild-type strain K56-2 transformed with pSCrhaB2 (to 
allow for growth in medium supplemented with trimetho-
prim) grew equally well on plates with either glucose or 
rhamnose (Fig. 5, first lane). XOA11, a positive control for 
a conditional mutant of an essential gene required for 
Ara4N transfer to lipid A, grew well in the presence of 
rhamnose but growth was substantially impaired in the 
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Fig. S. The combined activity of Ugd5cAL94e and UgdBcAM0855 is 
essential for viability of B. cenocepacia strain K56-2. Left panels: 
K56-2 with pSCrhaB (for growth of wild-type on agar plates with 
trimethoprim), XOA1 1 (positive control for a strain with a 
conditional mutant in an essential gene), SAL1 0 (negative control, 
UgdBCAL2946 conditional mutant in the presence of a functional 
COPY of ugdBcAMo855), SAL25 (negative control, EwgdBCAM0855 
strain with a conditional mutation in hidA, the gene downstream of 
ugdB945 and SAL26 (ugdacAM055 strain with a conditional 
mutation in ugd5cL946) were grown overnight, serially diluted 
and 10 III drops were plated on media containing either rhamnose 
(inducing conditions, top panel) or glucose (repressing conditions, 
bottom panel). Mutants with a conditional lethal phenotype grow 
well on agar plates with rhamnose but grow much more poorly on 
glucose. Right panels: growth of SAL26 in the presence of either 
pDA1 7 (plasmid control), pSL37 (094C945), pSL38 
or pSL39 (ugd5co555) under inducing or 
repressing conditions of chromosomally encoded ugdBcA945. 
Shown is a representative image of three independent experi-
ments. 
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Fig. 4. All three Ugd-FLAG constructs are expressed in SAL8 and 
SAL26. Western blot analysis using anti-FLAG antibodies was 
done for both SAL8 and SAL26 containing either pDA1 7 (plasmid 
control), pSL37 (ugdBcAL2946), pS1_38 (ugdcM2034) or pSL39 
(ugdBcAMo855). Arrows indicate bands that correspond to the full-
length Ugd-FLAG constructs. This is a representative image of 
three independent experiments. 
presence of glucose (Fig. 5, second lane), as previously 
demonstrated (Ortega et al., 2007). Two negative control 
strains, SAL10 (a ugdBCAU946  conditional mutant with an 
intact ugdBCAM0855 gene) and SAL25 (the conditional hidA 
mutant lacking ugdBcAM0855 but with ugdacn294& intact) 
both grew equally well in the presence of either glucose or 
rhamnose (Fig. 5, third and fourth lanes, respectively). 
Finally, SAL26, the conditional ugdBCAL2946 mutant lacking 
an intact UgdBCAM0855  gene, grew well in the presence of 
rhamnose but like XOA1 1 its growth was very poor in the 
presence of glucose (Fig. 5, fifth lane). 
Next, experiments were carried out to determine which of 
the three putative ugd genes could complement the 
conditional growth defect of SAL26. In the presence of 
rhamnose, the growth of SAL26 transformed with any of 
the plasmids was similar to that of untransformed SAL26 
cells (Fig. 5, top right panel). However, growth of SAL26 in 
the presence of glucose improved significantly in cells 
transformed with either pSL37 or pSL39 but not with 
pSL38 or the plasmid control, pDA17 (Fig. 5, bottom right 
panel). Western blot analysis showed that all three Ugd-
FLAG constructs were expressed in SAL26, with protein 
profiles similar to those in SAL8 (Fig. 4); Ponceau S 
staining of the membrane showed that there was equal 
transfer of proteins in each of the lanes (data not shown). 
Together, these experiments indicate that the combined 
activity of the proteins encoded by ugd fl2946 and 
is required for the viability of B. cenocepacia. 
and UgdacAM0855 have similar 
reaction kinetics 
To further characterize the proteins encoded by 
ugdBCA946, UgdBCAJVIO855 and vgdBcAm2n34, the genes were 
cloned into a pET28 vector to add an N-terminal His6 tag. 
UgdBCAL2946 and UgdBCJVOSSS were overexpressed in E. cali 
and purified using nickel affinity and size exclusion 
chromatography. The UgdBC2946 and UgdBC,A0855  
proteins were soluble and behaved as homodimers 
(-106 kDa) with similar elution profiles (data not shown). 
UgdBc2034 was insoluble and required low-temperature 
induction and an additional solubilization step prior to 
purification as a mixture of monomer (-52 kDa) and 
homodimer (-104 kDa) (data not shown). The enzyme 
assay was based on the Ugd mechanism proposed by 
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Campbell etal. (2000) and Ge etal. (2004): UDP-glucose is 
converted to UDP-glucuronic acid in a two-step oxidation 
via a covalently bound thioester intermediate. Conversion 
of this to the final free UDP-glucuronic acid product 
requires a second mole of NAD + so overall the process 
reduces two NAD to two NADH. To determine the 
kinetic parameters, the initial velocity was calculated by 
measuring the increase in absorbance at 340 nm, due to the 
production of NADH, divided by two. The data were fitted 
by non-linear regression with the Hill equation (V 
Vm ,.x  [S]1,/([S]/+ Km ' ). The enzyme turnover (kcat) and 
catalytic efficiency (kcat/Km) were calculated from the Vma , 
and Kn,  values obtained. Both UgdBCAL2946 and 
UgdBc, oBss showed Ugd activity with very similar kinetic 
constants (Table 1), while Ugd5cM2034 showed no in vitro 
activity with UDP-glucose as a substrate To investigate any 
substrate specificity variation between the Ugd proteins, 
the spectrophotometric assay was repeated with three 
additional UDP-sugars (UDP-galactose, UDP-acetylglucos-
amine and GDP-mannose) that replaced UDP-glucose. 
None of these molecules were substrates for any of the 
enzymes (data not shown). From these experiments we 
conclude that UgdBCL2946 and Ugd5555  have very 
similar enzymic activities and confirm biochemically the 
functional assignment of these proteins as UDP-glucose 
dehydrogenases. 
Expression of ugdBCAL2946 is higher than that of 
ugdM0855 or ugdBcAM2034 
Since both Ugd 2946 and UgdBAM0855 demonstrated 
very similar kinetic parameters, we investigated whether 
these proteins are differentially expressed in vivo. RNA was 
prepared from B. cenocepacia cells in exponential growth 
and the number of RNA transcripts of each ugd gene was 
quantified and compared to the number of transcripts of 
the constitutively active gene hisD. The number of 
119dBcAU946 transcripts was on average 5.4 times and 135 
times higher than the number of ugd 0B55 or 
ugdac2034 transcripts, respectively (Fig. 6). Melting 
curves for each portion of each gene analysed by real-time 
PCR were similar to the positive controls and there were no 
detectable differences in band sizes by agarose gel  
electrophoresis (data not shown), indicating that the 
products amplified after the reverse transcription reaction 
were the same as those amplified in the positive controls. 
These results indicate that ugdBCAL2946 is highly expressed 
relative to the expression of ugdBCO,Sss, while the 
expression of UgdBCAM2034  under the condition tested 
(exponential growth) is negligible. These results help to 
explain why only the mutant defective in ugdBcflL2946 has a 
phenotype in terms of pmB sensitivity, and also why the 
double mutant (A ugdBc QSS5, ugd A946 conditional) 
fails to grow under non-permissive conditions. 
DISCUSSION 
We demonstrate here that the proteins encoded by two B. 
cenocepacia genes, ugdac 2946  and ugdfl 555, possess the 
predicted dehydrogenase activity, which results in the 
conversion of UDP-glucose into UDP-glucuronic acid. 
Ugd5L2945 and Ugdac0855 are efficient catalysts with 
low micromolar K 1 values for UDP-glucose and NAD + 
and relatively fast turnover. The similar catalytic profile for 
these enzymes is not surprising since they show 74 % 
amino acid sequence identity. The two P. aeruginosa Ugd 
proteins described by Hung et al. (2007) utilized UDP-
galactose and UDP-N-acetylglucosarnine as substrates, but 
with much lower activity compared with UDP-glucose. 
However, apart from UDP-glucose, the two B. cenocepacia 
Ugd proteins did not exhibit any activity when any of the 
other three UDP-sugar substrates were used. This substrate 
specificity correlates with the high catalytic efficiency 
(k,at/Km) of the enzymes, and the similar biochemical 
profiles of UgdB L2946 and Ugd cM0855 explain why they 
can compensate each other's function in vivo during 
complementation assays. 
B. cenocepacia is highly resistant to AlPs and understanding 
the molecular basis of this resistance is a longstanding goal 
of our groups. Here, we show that only ugdBCAL2946  is 
necessary for resistance to the AP pmB, as the insertional 
inactivation of this gene led to an eightfold increase in 
sensitivity to pmB. This phenotype does not appear to be 
due to a polar effect on hidA and hldD, the two genes 
downstream of ugdliCAL29 , based on two experimental 
Table 1. Kinetic parameters of UgdBCA 946 and UgdBCAM0855 
Parameters were determined by non-linear regression from v= V,,.,3 [S]'/([S]" -f- K,," using 0rigin6.1 software. 
Protein V, 
(nmol min'') 
Km (mM) h k (min') k.at/Km 
(mM' min) 
UDP-glucose 
UgdB2946  14,38+0.73 0.02+0.01 1.25+0.16 7.99+0.13 392.36 ± 0.37 
Ugdfl0855  13.73+0.90 0.02+0.01 1.41+0.12 7.63+0.15 340.35 ± 0.10 
NAD 
16.61 +1.11 0.17±0.03 1.51±0.31 9.23±0.15 53.95±0.19 
Ugd5 . 0855 16,88+1.22 0.21+0.04 1.50 4- 0.31 9.38±0.16 44.50 +0.19 
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Fig. 6. U9dBCAL2a46 is more highly expressed than either 
ugdscAM2034 or V94CAM0855. Shown are real-time PCR results 
from three experiments completed in triplicate error bars represent 
the standard error of the mean. For each ugd gene the data are 
standardized to values obtained for the internal control gene, hisD. 
* Statistically significant difference (P<0.01) compared to results 
for ugdBcAL2946 by unpaired t-test. 
observations: (i) the sensitivity can be restored in trans 
when ugdBCAL2946 is expressed from a plasmid, and (ii) 
disruption of hidA and hldD has a profound effect on the 
structure of the LPS molecule (Loutet et al., 2006), which 
we did not observe in the ugd RCAL29 mutant. In fact, no 
differences were found in the LPS profiles of any of the ugd 
mutants compared to the LPS profile of the parental strain, 
although we cannot rule out subtle modifications in the 
LPS molecule that would require a more detailed analysis, 
currently under way in our laboratories. The pmB-sensitive 
phenotype of the ugdBL2946 mutant was also comple-
mented by a plasmid-encoded UgdBCQ.A0855 but not by 
ugdBM2034. The lack of complementation by ugdc M2034  
was not due to lack of protein expression since all three ugd 
genes revealed a polypeptide of the expected molecular 
mass when cloned in a plasmid and expressed as protein-
FLAG fusions. Also, lack of complementation was not due 
to the presence of the C-terminal FLAG epitope, since the 
same results were obtained in experiments using untagged 
proteins. These data suggest that UgdBCAL2946 accounts for 
the cellular Ugd activity required for the resistance of B. 
cenocepacia to pmB. 
We have previously demonstrated that the synthesis of 
UDP-Ara4N is essential for the viability of B. cenocepacia 
(Ortega et al., 2007). Since the conversion of UDP-glucose 
into IJDP-glucuronic acid is an obligatory step for the 
synthesis of UDP-Ara4N, we reasoned that a mutant 
lacking both ugdBcAU946 and ugdBcAM55 would not be 
viable. Indeed, a double mutant in which ugdscAM0855 is 
deleted and u9dBC4L2945 is conditionally expressed was 
non-viable under non-permissive conditions. This result 
suggests that UgdBc2946 and Ugdsogss  account for the 
majority of the cellular Ugd activity required for UDP-
Ara4N synthesis. 
Studies in other Gram-negative bacterial species have 
shown that the expression of ugd genes can be complex. In  
Salmonella, a variety of regulatory systems control the 
expression of the ugd gene. In the presence of high Fe3+, 
ugd expression is upregulated by PmrA, the response 
regulator of the two-component regulatory system PmrA-
PmrB (Wösten et al., 2000). Under low Mg2 conditions, 
activation of the two-component regulatory system PhoP-
PhoQ occurs, activated PhoP upregulates expression of 
another protein, PmrD, which in turn activates the PmrA-
PmrB system, and ugd expression is upregulated by PmrA 
(Kox et al., 2000). Finally, the RcsC-YojN-RcsB phospho-
relay system can also control the expression of the ugd gene 
in Salmonella from a second promoter that is independent 
of PmrA (Mouslim & Groisman, 2003). A recent study in 
P. aeruginosa demonstrated that this common CF lung 
pathogen also possesses two ugd genes and that the two 
genes are differentially expressed (Hung et al,, 2007). Hung 
et al. (2007) showed that in P. aeruginosa strain PAUl the 
expression of PA3559 was induced under low Mg 2+ 
conditions and that this gene was required for pmB 
resistance, while PA2022 was more constitutively expressed 
and was not required for pmB resistance. Similar results 
were obtained for PA3559 by McPhee et al. (2006), who 
also showed that the promoter of PA3559 has two binding 
sites each for the PhoP and PmrA proteins of P. aeruginosa. 
With three genes predicted to encode UDP-glucose 
dehydrogenase, the regulation of Ugd activity may be even 
more complicated in B. cenocepacia. We have shown that in 
cells in the exponential growth phase ugdBc 2946 is more 
highly expressed than either ugd lQ855 or 
Little else is known about the regulatory control of 
expression of ugdBcflL26, ugdBCAM855 and ugd flcAM2034  
and it is something we are currently investigating. None of 
these ugd genes is directly linked to the arn locus in B. 
cenocepacia, which itself has an unusual gene order (Ortega 
et al., 2007), and this also suggests that there are differences 
in operon regulation between Burkholderia and other 
Gram-negative organisms. It is interesting to note that 
the response regulators of B. cenocepacia most similar to 
the PhoP and PmrA proteins of P. aeruginosa and 
Salmonella are not required for pmB resistance 
(Flannagan et al., 2007), which suggests that they are 
probably not required for expression of at least u94CAD946. 
B. cenocepacia does, however, contain numerous other two-
component regulatory systems that could participate in the 
response to pmB. The finding that UgdBCAL2946  is more 
highly expressed than the other two ugd genes suggests to 
us that this difference may account for the fact that 
sensitivity to pmB is only seen in the ugd ficAL2946 mutant 
strain. 
We have shown that the protein encoded by ugd 034 
does not appear to be a player in the total cellular Ugd 
activity: mutation of the gene neither affects pmB 
resistance nor is required for the essential synthesis of 
UDP-Ara4N, the gene cannot rescue the pmB sensitivity of 
SAL8 or the inability of SAL26 to grow under non-
permissive conditions, the gene is poorly expressed in 
rapidly dividing cells, and the purified form of the protein 
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does not have in vitro Ugd activity under the conditions we 
tested. Further analysis of the protein encoded by 
BCAM2034 is required before an enzymic function can 
be assigned to it. 
In summary, we have demonstrated that the most highly 
expressed ugd gene of B. cenocepacia is required for 
resistance to pmB and that the two most highly expressed 
genes are required for viability. However, we cannot 
conclusively state why disruption of ugdflCAL2946 results in 
increased sensitivity to pmB. We hypothesize that it is due to 
small decreases in UDP-Ara4N in the LPS molecule of SAL8 
at some point in growth; however, it is also possible that 
UDP-glucuronic acid is required for some other pathway 
required for pmB resistance in B. cenocepacia. Studies are 
ongoing in our laboratories to determine why UDP-Ara4N 
is essential for the survival of B. cenocepacia, where Ara4N is 
located in the LPS molecule and whether there are changes 
in the Ara4N content of the LPS molecules of our 
conditional mutants as well as the LPS molecules of the 
individual ugd mutants described in this study. 
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